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Abstract
As part of the inﬂammation response, white blood cells (leukocytes) bind nearly statically to blood vessel
walls before they transmigrate through the endothelium and exit the vessel. The inter-cellular interactions
between the wall-adhered leukocyte and ﬂowing red blood cells (erythrocytes) play a critical role in this
process. We present a quantitative investigation of the forces exerted on a leukocyte at this stationary stage.
The simulation tool is based on a fast O(N logN) boundary integral formulation, which permits the red cells
to be realistically ﬂexible and to approach to small separation distances. The red blood cells are modeled
as elastic shell membranes enclosing Newtonian ﬂuid with a larger viscosity than the Newtonian plasma
outside of them. Membrane inertia is taken to be negligible, so motion matches ﬂuid velocity. They allow
for a ﬁnite deformation with strong resistance to surface dilatation and relatively small but ﬁnite resistance
to bending. The no-slip condition is applied both on the leukocyte and the vessel walls. The tube diameters
for all cases are less than 20 microns. We will show that at these scales the cellular character of blood
signiﬁcantly aﬀects the forces that the leukocyte experiences. For a tube hematocrit of 25% and a spherical
protrusion with a diameter 0.75 that of the tube, the average forces are increased by about 40%, and the
local forces by more than two folds relative to forces from an eﬀective-viscosity-homogenized blood. For
constant pressure gradients along the tube, the wall-bound leukocyte could cause blockage in that vessel;
this cannot be addressed with a homogeneous model. Diﬀerent contact angles for the leukocyte as well as
diﬀerent mechanical properties for the erythrocytes are examined. The eﬀects of ﬂow conditions as well as
the vessel geometry is also considered. It is found that at the scales comparable to the size of the cells, a
homogeneous model of blood will result in large errors when calculating the forces on a wall-bound leukocyte.
Also, stiﬀer models for red cells such as rigid or rubber discs, overpredict these forces.
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Chapter 1
Introduction
Blood behavior is thought to be strongly dependent on the details of its cellular structure, especially in
vessels that are comparable to the size of the cells. A particularly important situation is the interaction
between ﬂowing red blood cells and a cell adhered to the vessel wall. Inﬂammation involves the recruitment of
leukocytes to the vascular endothelium, where it must resist hydrodynamic forces to become ﬁrmly adhered.
Cancer metastasis can occur when cancer cells are transported in the blood, which involves both their
entering and leaving the ﬂowing blood stream, both of which have mechanical components. It has also been
observed that endothelial cells sometime bulge out of line and cause bumpiness on the surface of the vessel.6
This situation can also arise during bioﬁlm formation.7 We focus particularly on the cases of a stationary
leukocyte adhered to the vessel wall.
Blood primarily is composed of plasma, red blood cells (RBCs or erythrocytes), white blood cells (leuko-
cytes) and platelets. Figure 1.1 shows a leukocyte adjacent to an erythrocyte. Erythrocytes are the most
prominent. By volume they systemically constitute 45% of whole blood,5 though this hematocrit value is
smaller in the small vessels of the microcirculation.8–10 For every leukocyte in the whole blood there are
around 1000 erythrocytes.11 Therefore, it is expected that red cells generally dominate the mechanics of
blood, though leukocytes, because they are larger and stiﬀer than red cells, can be dynamically signiﬁcant
in smaller capillaries despite their low concentration.12 In their longest dimension, blood platelets are about
a third the size of the red blood cells and are 15 times less numerous. They are therefore not expected
to be dynamically important, and we neglect them in this study. It is well known that the particulate
character of blood strongly aﬀects its dynamics, especially in ﬂow characteristics of erythrocytes,13 leuko-
cyte margination,14 leukocyte-endothelium interactions,15, 16 leukocyte-leukocyte interactions,17–21 rolling of
leukocytes,19, 22 dynamics of vascular networks4 and the design of blood microﬂuidic instruments.23–25
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(a) Scanning electron micrograph.26 Reproduced with
permission.
(b) Numerical representation in this work.
Figure 1.1: White and red blood cells. Bar length = 10 μm.
1.1 Inflammation
One of the motivating phenomena for this eﬀort is leukocyte dynamics as part of the inﬂammation response.
Inﬂammation can arise due to bacterial, viral, fungal or parasitic infections, anaphylaxis, rheumatoid arthri-
tis, gout, environmental, intestinal, endocrinological or autoimmune diseases.26 Recent evidence suggests
the presence of inﬂammation in chronic arterial and venous disease,27, 28 myocardial ischemia,29–31 acute
cerebral stroke and Alzheimers chronic disease,32–37 arterial hypertension,38 cancer,39–41 osteoarthritis,42–44
shock and multiorgan failure,45, 46 depression.47, 48 Statistically, obesity49, 50 and lack of exercise51, 52 have
been linked to inﬂammation. Inﬂammation is also a problem in biomaterial interfaces between a living tissue
and non-living implant or a living graft,53, 54 design of blood substitutes55 and tissue engineering in general.
In all cases, inﬂammation is part of the process of tissue repair, though runaway inﬂammation can itself be
fatal. In the following, we discuss the details of the inﬂammation response, particular aspects related to
microcirculatory dynamics involving leukocytes.
1.1.1 Inflammation cascade
The inﬂammatory cascade consists of several stages. It starts with a trigger mechanism, which in turn causes
cellular responses with microvascular consequences. The target outcome of the cascade is to heal tissue and
resolve the inﬂammation, however it can also fail to resolve in some cases leading to chronic inﬂammation.26
Leukocyte margination,14, 15, 56–58 aggregation, rolling,12, 59 attachment59 and migration into the tissue all
fall into the category of microvascular consequences of this cascade (Figure 1.2). Parts of the cascade have
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been studied,26 but a quantitative picture of this cascade as a whole is far from complete.
(a) Suspended leukocyte. (b) Marginated leukocyte.
(c) Leukocyte rolling. (d) (e) (f)
(g) Firm adhesion. (h) (i) (j)
(k) Leukocyte transmigration.
Figure 1.2: Model geometries and conﬁgurations for diﬀerent portions of the leukocyte dynamics as part of
the inﬂammation cascade.
Activation
In the inﬂammation response, leukocytes adhere to endothelial cells using two types of adhesion molecules
and their ligands: integrins and selectins. Selectins are ﬁrst activated at the initial stages of adhesion, and
later integrins form ﬁrm adhesion that are engaged during spreading of the leukocyte. Integrin activation
is associated with stimulation of the leukocytes and this is achieved either by humoral inﬂammatory me-
diators or ﬂuid mechanical stress.26 Leukocyte adhesion to the endothelial cells is one of the causes of
elevation in endothelial permeability,60 which is thought to be important for extravasation of leukocytes at
the inﬂammation site.
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Margination
Suspended leukocytes are approximately spherical and relatively stiﬀ. Theoretically, a homogeneous New-
tonian viscous ﬂow could not marginate a spherical leukocyte because of the symmetry of the leukocyte and
the well-known reversibility of Stokes ﬂow. For relatively slow ﬂows, it has been observed both in vitro61, 62
and in vivo18 that leukocytes are preferentially transported toward the vessel wall15, 56, 57 presumably via
hydrodynamic interactions with the relatively smaller and more ﬂexible red blood cells.14, 58 In the absence
of red blood cells, leukocytes are not observed to attach to the endothelium in postcapillary venules.63 A
number of studies show that red cell aggregation promotes margination as well as leukocyte adhesion,64–66
but it does not seem to be essential for margination.14 Abbitt and Nash62 show that red cell aggregation
increased both the number of leukocytes near the wall as well as the ones adhered.
Rolling
In acute local inﬂammation, after the contact is made by margination, neutrophils (one type of white blood
cells) attach to and accumulate in post-capillary venules, which are typically 10 to 12 μm in diameter. The
force and torque exerted on the neutrophil deform it into a teardrop-like shape67 and causes it to roll along
the vessel wall. The rolling velocity is a function of shear rate68, 69 and distribution and tethering of selectins
to the cytoskeleton.70 This is observed with or without inﬂammation in the narrower postcapillary venules.
However, when they enter a larger vessel in the absence of inﬂammation, leukocytes detach from the wall
due to forces from the erythrocytes. In general, the number of adhered leukocytes decreases with increasing
shear rates.61, 69 In larger venules and when inﬂammation is present, stronger expression of selectin and
enhanced red cell aggregation keep the leukocytes attached and rolling.
Early models for rolling sought to explain the observed adhesion phenomenon in terms of peeling energy
and anticipated that bond length and ﬂexibility governs rolling dynamics.71 Other modeling approaches
have assumed that the average rolling velocity reﬂects a balance of the ﬂuid mechanical energy, viscoelastic
deformation energy of the leukocyte, and the adhesion energy.72–74 The peeling velocity has also been
correlated to the applied force and the rate constants of the adhesion molecule.75 Models have also been
developed suggesting that adhesion energy is inversely dependent on the rolling velocity and a function of
deformation.67 Stochastic bond formation and breakage as a function of rolling velocity, ﬂuid force and
kinetic constants have been proposed to study the adhesive dynamics in the form of individual bonds.76, 77
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Firm adhesion
The focus of the present eﬀort is on the stage after the leukocyte has adhered to the vessel wall, and is either
rolling slowly relative to the blood ﬂow velocity or ﬁrmly adhered and thus stationary. Firm adhesion to the
endothelium is achieved by activation of integrin molecules on the leukocyte and receptors like ICAM-1 and
VCAM-1 on the endothelium.78, 79 A large number of studies has investigated this process because interfering
with it could interrupt inﬂammation and therefore be used as a therapeutic intervention.80 Therefore, it
is important to understand the types and magnitudes of the forces acting on an adhered leukocyte. The
adhesion forces generated by the receptor-ligand bonds are balanced by these hydrodynamic forces from the
ﬂow.81, 82
Extravasation
In the ﬁnal step we consider here, leukocytes project a pseudopod, which leads to their extravasation through
the endothelium. Two models of transmigration of leukocytes across the endothelium83, 84 have been stud-
ied: through the junction between adjacent endothelial cells85, 86 or though pores in individual endothelial
cells.26, 87 The more spread out and non-spherical conﬁgurations of the leukocyte studied here will provide
a model for assessing the forces the cell experiences during transmigration.
1.1.2 Leukocyte response to forces
After the ﬁrm adhesion stage, transmigrating neutrophils with cyclic projection of pseudopods will retract
these pseudopods in response to shear.88 Monocytes (another type of white blood cells) behave the same.
However, when deactivated, neutrophils project pseudopods as a response to shear.89 This behavior seems to
depend on the presence of red cells.90 Neutrophils adhered through β2 integrins readily respond to ﬂuid shear
but the ones attached via β1 integrins respond less.
91 If neutrophils are exposed to increasing concentration
of inﬂammatory mediators, their response to ﬂuid shear decreases.92 Therefore, biomechanical stresses play
an important role in the behavior of inﬂammatory cells. Diﬀerent mechanisms for mechanosensing of shear by
the membrane of the cell has been hypothesized but none explain the high level of speciﬁcity in the response
of diﬀerent cells. However, preliminary results show that humoral signaling pathways and biomechanical
signaling pathways overlap in inﬂammation.26 In the present study, we investigate in detail the magnitude
of the forces that an adhered leukocyte experiences including the unsteady loading due to individual red
cells.
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1.2 Cancer metastasis
Forces on wall-bound cells are also important in cancer metastasis, which in turn is extremely important in
terms of treatability of the cancer and survival chances of the patient.93 Metastasis occurs when a cancer cell
detaches from the tumor culture and re-adheres to a substrate at a secondary location, where it starts a new
culture,94 which can occur within the blood stream95 and there hemodynamic forces will be important. Also,
physiologically, fusion of tumor cells with leukocytes has been recently suggested as a unifying explanation
for metastasis.96 As a result of this fusion such hybrids have shown increased expressions of cell surface
LAMP1, a preferred substrate that mediates binding to endothelial cells for both leukocytes and tumor
cells.97–99 Therefore, these cancerous hybrids that appear in blood stream are similar to leukocytes in size
and shape with enhanced adhesion characteristics. The interactions mentioned above inﬂuence the forces
exerted on the cancerous cell both in a global (average) sense that could lead to detachment and in a local
sense that could lead to diﬀerent signaling pathways with a mechano-biochemical stimuli response.
1.3 Physiology
1.3.1 Leukocytes
There are ﬁve classes of circulating leukocytes: neutrophils, eosinophils, basophils, lymphocytes, and mono-
cytes.100 The ﬁrst three types are sometimes referred to collectively as granulocytes, distinguished by the
color and size of their granules. Neutrophils are the most prevalent, constituting 85% of the circulating
white cells. Lymphocytes and monocytes have smaller granules and therefore are recognized by their color,
size and nuclear shape.100 All of these diﬀerent types have a tendency to adhere to the endothelium.101, 102
From experiments, the size distribution of white blood cells has two peaks in an isotonic solution, 5.75 μm,
which corresponds to lymphocytes, and 7.25 μm, which corresponds to neutrophils.103 Schmid-Scho¨nbein has
suggested an average lymphocyte diameter of about 6.5 μm and an average neutrophil diameter of about 8
μm. These are smaller than the diameters often reported in the hematology textbooks, because it is thought
that the latter has been determined using blood smears in which the leukocytes are ﬂattened from their
spherical shape.100 The slightly larger-size distributions reported elsewhere are as follows: granulocytes
(range from 10 to 15 μm), eosinophils (10 to 13 μm), basophils (7 to 10 μm), monocytes(10 to 12 μm),
and lymphocytes (10 μm).104 A diameter of 10 μm has been commonly used in modeling and simulation
studies.22, 59, 105
Circulating leukocytes are approximately spherical, and we model our wall-bound leukocytes as spheres,
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but observations indicate that cells adhered to the vessel wall do not always remain spherical.71, 106, 107 They
appear to deform somewhat due to hydrodynamic stresses. Leukocytes are also relatively stiﬀ, and we follow
the common practice of modeling them as rigid.7, 104, 108–112
1.3.2 Red blood cells
Red cells have a radically diﬀerent mechanical character from leukocytes. When at rest, they assume a
biconcave shape that is approximately 8 μm in diameter and 2 μm thick (Figure 1.3), but they are highly
ﬂexible and undergo large deformations that allow them to ﬂow through capillaries with diameters well less
than 8 μm. The typical neutrophil to erythrocyte volume ratio is 2.7.113
8 μm
2 μm
Figure 1.3: Schematic of a red blood cell.
Red cells encapsulate a concentrated solution of hemoglobin, which has not been thoroughly studied
in terms of its rheological properties. We assume this solution to be approximately Newtonian114, 115 and
based on limited evidence,116 its viscosity has been taken to be ﬁve times that of plasma.116 We will use this
value, but for comparison, we will also consider some cells with interior viscosity that matches that of the
plasma, and we will see that this viscosity diﬀerence does not signiﬁcantly aﬀect the results and conclusions
of this study. The membranes of red cells are nearly constant area due to their strong resistance to surface
dilatation.117 However, they are ﬂexible in response to shear117 and bending.118 The membrane shows ﬂuid
characteristics, but its overall viscosity is high.119 Here, we neglect the ﬂuidity of the membrane.
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The forces on a wall-bound leukocyte are expected to depend upon the volume fraction of red cells in
the vessel, and we will also consider this in our study. In a series of papers, Lipowsky et al.120, 121 reported
values of hematocrit (cell volume fraction) of 13.7% and 9.8% in pre-capillaries with diameters of 30 and 20
μm respectively. In post-capillaries, these values were 15.6% and 8.74% for 30 and 20 μm diameter vessels.
They also found a hematocrit of 8.84% for capillaries with a diameter of 10 μm.121 Pries et al. measured
hematocrit in microvessel networks.122 They show that in the arteriovenular region, where the arteriolar
and venular ends of capillaries meet, the diameter distribution is between 5 and 22 μm and the hematocrit
is between 40% to 60% of the systemic hematocrit of about 48%. These experiments were carried out on
rat mesentery. Based on such data, we consider hematocrits of up to 25%. Particularly low-cell-density
cases with tube hematocrit of 4% are also considered; in low tube hematocrit cases the single interaction
between a red cell and a wall-bound cell is expected to be indicative of the types of forces experienced by
the leukocyte. Also, in the small capillaries the red cells ﬂow in a single ﬁle regardless of the hematocrit.123
We consider vessels from 10 to 20 μm in diameter.
1.3.3 Flow characteristics
There are a range of ﬂow velocities and diameters present in the microcirculation. Lipowsky et al.121
reported mean velocities of 5.8 and 6.0 mm/s in pre-capillaries of diameters 20 and 30 μm, mean velocities
of 1.1 and 3.2 mm/s in capillaries of 10 and 20 μm, and mean velocities of 3.0 and 4.3 mm/s in larger
post-capillaries of 30 and 40 μm.121 In other experiments the maximum (centerline) velocities in the venules
with diameters ranging from 18.3 to 42.9 μm are reported to be 0.7 to 2.3 mm/s.124 Schmid-Scho¨enbein et
al.125 measured the ﬂow in rabbit vessels ranging from 16 to 54 μm and the reported maximum velocities
in two post-capillaries (diameter 21 μm) and two small venules (diameters 25 and 26 μm) were 3.1, 4.0, 4.8
and 3.9 mm/s.125 In the present study, average tube velocities of 0.3 to 1.5 mm/s in a 11.28 μm model
capillary are examined. We will show in Chapter 4 that in higher velocities, the forces experienced by the
adhered leukocyte due to the presence of the red cells, approach the homogeneous approximation.
In vessels less than around 100 μm, blood cells lead to an overall non-Newtonian ﬂow with a blunted
velocity proﬁle,126 but it is not so strongly non-Newtonian that we can use the eﬀective Newtonian viscosity
to show that microcirculatory ﬂows are in a Stokes ﬂow regime. Considering the Reynolds numbers of the
ﬂow regimes here, Stokes ﬂow is a well justiﬁed assumption.10, 127 For example, the Reynolds number based
on an 8 μm diameter leukocyte at an average vessel velocity of 1 mm/s (typically observed in microcirculatory
ﬂows121, 124) with a plasma kinematic viscosity of 1.2 m2/s is 6.7 × 10−3. Based on a tube diameter of 40
μm, it is 3.4 × 10−2. At these Reynolds numbers inertial forces are negligible and because cell density is so
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close to that of the plasma,128 gravitational forces are not signiﬁcant.
1.4 Previous studies
The attachment and rolling of leukocytes was ﬁrst reported more than half a century ago,101, 129, 130 but
quantitative information about the force of interaction between the endothelium and the leukocyte remains
unknown and is of crucial importance in formulating the biochemical theory of these interactions. In the
present work we study both the steady and unsteady forces acting on an adhered leukocyte, which in turn
suggest the magnitude of the adhesion forces necessary to counter it. In this section we brieﬂy review some
of the work that has led to our current understanding of wall-bound leukocytes.
1.4.1 Forces on leukocytes
Average forces on an adhered leukocyte have been measured in vivo based on diﬀerential pressures across
the leukocyte and Newtonian shear stress.131 In vitro studies often model the conﬁguration as the ﬂow
of a homogeneous Newtonian ﬂuid over rigid spherical cells.81, 132 There are also computational analyses
of homogeneous non-Newtonian ﬂow over adhered leukocytes.133, 134 However, computationally, there have
been attempts to include red cells as rigid spheres,112 two-dimensional rigid ellipsoidal cells,11, 135 and two-
dimensional rigid rectangular cells with hemispherical caps.11 Experimentally, red cells have been modeled
as gelatin pellets104 and elastic6 and rubber7, 108 discs. In the eﬀort presented here, the ﬂow over a vessel
adhered leukocyte includes realistically deformable erythrocytes.136, 137
In order to examine the cell-substrate adhesion characteristics, it is common to study the ﬂow in a
parallel channel conﬁguration.81, 106, 107, 138–140 Goldman et al.141 presented a commonly used analytical
shear force estimation for a rigid sphere adhered to a planar wall in Newtonian ﬂow. However, a comparison
between the ﬂow around a leukocyte adhered to a planar channel and a leukocyte attached to the same size
tube indicates that the forces that the leukocyte experiences in these two conﬁgurations start to deviate in
magnitude when leukocyte to channel height and leukocyte to tube diameter ratios are larger than 20%.110
Computational models with homogeneous Newtonian blood
Sugihara-Seki109 uses a three dimensional ﬁnite-element method to solve for the ﬂow ﬁeld around the leuko-
cytes.142, 143 The resulting shear forces in this homogeneous ﬂow are symmetric along the centerline of the
sphere and the pressure forces are anti-symmetric, as expected. The shear stress is very small near the tube
walls and is maximum at the top of the sphere. The maximum shear force increases as the sphere-to-tube
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diameter ratio increases. The pressure forces are positive on the upstream side and negative on the down-
stream side and similarly they increase in magnitude with the sphere-to-tube diameter ratio. All of the
observations above are in line with our ﬁndings in the present work. Another representation of these forces
would be through lift, drag and torque. Spheres in Stokes ﬂow experience no lift. Sugihara-Seki109 shows
that when the sphere-to-tube diameter ratio is less than 30%, the drag is within 10% of that of a sphere
adherent to a plane. However, if the size ratio is more than 50%, the drag in the tube is more than 50%
larger than the drag on a sphere adhered to a plane.109 In the present study, we compare the forces exerted
on the wall-adhered leukocyte by ﬂowing red cells to two homogeneous Newtonian approximations: plasma
and eﬀective-viscosity homogenized blood.
In the same study by Sugihara-Seki,109 a single row arrangement of adhered cells leads to a decrease
in the drag forces as the cells get closer to each other. Periodic formation109 as well as ﬁnite number of
adhered cells have exhibit the same qualitative results.144 In this work, we consider one adhered leukocyte
in a periodic tube, therefore the conﬁguration is technically a row of leukocytes. However, the separation
distance between periodic leukocytes are twice the length of the leukocyte on the tube wall. We investigate
the inﬂuence of this separation distance on the forces and present the results in Chapter 4.
Studies have shown that normal forces on a wall-bound leukocyte, especially in the smallest of the
capillaries, are important.132, 145 We consider the normal forces on an adhered leukocyte as part of the
current eﬀort and to quantify speciﬁcally how the cellular character of blood enhances it. Furthermore, we
include realistic red blood cells and in Chapter 4, show how their presence increases the magnitude of the
normal forces that a wall-bound leukocyte experiences.
Wang and Dimitrakopoulos132 investigate diﬀerent components of the forces acting on a protuberance
attached to a tube wall in a Newtonian Stokes ﬂow. In larger vessels, the Newtonian homogeneous assumption
is better justiﬁed than in small capillaries.134 The ﬂowing red blood cells are not considered but are thought
to have an enhancing eﬀect on the ﬁndings.11 A spectral boundary element method is used to solve for the
ﬂow.146
Wang and Dimitrakopoulos132 examine a wide range of sizes and spreading angles are examined. The
presence of an adhered cell on the wall, signiﬁcantly increases the shear stress distribution on the cell relative
to the shear stress on the wall away from the cell. For a constant spreading angle, this ampliﬁcation is a
weak function of the size ratio of the cell to the tube. However, this correlation becomes stronger as the
size ratio gets larger. On the other hand, for a constant cell volume, the shear stress is a strong function of
the spreading angle. Note that spreading angle is deﬁned as the opposite angle to what we refer to as the
contact angle here. For small cell sizes, increasing the spreading angle (decreasing the contact angle) causes
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the total force to diminish. This is expected for this particular study because since the volume of the cell is
constant, less spreading means less surface area which in turn decrease the shear force that dominates the
total force for smaller cells. For larger cell sizes, the total force is dominated by the normal force and hence,
an increase in size as well as an increase in spreading angle, results in larger total force.132 It is concluded
that the normal component of the force is more signiﬁcant for the less spread cells.109, 110, 132 Spreading of
the cells or lack thereof, has a greater eﬀect in small vessels as opposed to the arteries and veins.107 Both
endothelial and leukocytes may spread into diﬀerent shapes.89 We shall see the same trends in Chapter 4;
however, the magnitude of the forces are magniﬁed by the presence of red blood cells.
Chang and Hammer147 study the inﬂuence of the direction of the applied forces to the adherent leukocyte.
Normal, tangential and shear forces are applied to spherical particles the same size as leukocytes. The torque
associated with the shear forces141, 148 are also examined. The results suggest that tangential forces are much
more disruptive of the bonds than the normal forces. Surface shear forces are even more eﬀective due to
the torque associated with them. Application of the force in an angle up to 80○ is almost as disruptive as
tangential forces and therefore, it is important to adhesion experiments that how accurately the force is
applied directionally.147 In Chapter 4, we present how the forces on a wall-bound leukocyte, in diﬀerent
directions, are aﬀected by the ﬂow of red blood cells. We compare these ﬁndings to a homogeneous Newtonian
ﬂow.
Large-scale similarity studies with model red cells
Performing in vivo and in vitro experiments at the scales of the microcirculation is diﬃcult, which has
motivated several similarity studies that employ larger systems. They match the non-dimensional parameters
of the physiological system to justify quantitative comparison. In such a study of the venule-leukocyte system
by Schmid-Scho¨nbein et al.,104 the geometric shapes were made similar to achieve kinematic similarity as
well as the dimensionless form of the governing equations and hence achieving dynamic similarity. In this
case the dimensionless variables of the model system match those of the real system.149 The dimensional
analysis justifying this approach developed by Lee and Fung150 is followed. Using high-speed photography,
they measure the similarity variables in their experiment.
Schmid-Scho¨nbein et al.104 report on the shear force on the leukocyte, which results in drag and is
transferred to the endothelial through the contact surface between the vessel and the leukocyte. The resulting
torque leads to an assumed non-uniform normal stress at the interface.104 If this torque exceeds the maximum
normal stress that the adhesion forces can resist, rolling is initiated. If the maximum shear stress on the
interface cannot sustain the drag on the leukocyte, the white cell will slide down the vessel. In other studies,
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a critical stress has been estimated both in vivo151 and in vitro152 beyond which leukocytes do not adhere to
the vessel wall. However, there is a disagreement (up to a factor of 10) between the values of in vivo and in
vitro.153 There are many suggestions for the source of this diﬀerence153 including the method of calculating
wall shear stress.
In the same paper,104 venule diameters of 20 to 55 μm are studied. The red cells are modeled with gelatin
pellets and the white cells with rigid spheres. It is acknowledged that the rigidity of the pellets has a greater
eﬀect on the shear force than their shape and that the deformability of red cells should be considered for
the quantiﬁcation of these relationships.104 Nevertheless, the presence of gelatin pellets has a great eﬀect
on enhancing the forces that the model leukocytes experience. Compared to when the model red cells are
absent, the estimated shear forces are doubled for HT = 20%, quadrupled for HT = 30% and more than
quintupled for HT = 40%.104 The shear stress at the leukocyte-endothelium interface, which is a result of
drag, as well as the normal stress at the contact surface, resulting from the torque on the leukocyte, follow
the same trend. A simple calculation indicates that a linear distribution of the normal stress at the interface
results in a maximum normal stress which is on the same order as the interfacial shear stress but it might
be several times larger.104
Schmid-Scho¨nbein et al.104 indicate that in their similarity study the maximum relative error of the shear
force on the leukocyte is about 49%. The deformability of the white cells are not considered. Since the red
cells are modeled by gelatin pellets, the apparent viscosity of the experiment is higher than that of blood.104
The authors believe that the most important neglected feature of the model system is the ﬂexibility of the
red blood cells.104 We are speciﬁcally considering the ﬂexibility of the red blood cells in their interaction
with the adhered leukocyte in the present work.
In another study, Chapman and Cokelet108 also calculate the forces on an adherent leukocyte using a
similarity study. The leukocyte is modeled as a rigid sphere adhered to a rigid smooth cylindrical tube.
Erythrocytes are modeled by rubber discs with a volume about a third of the sphere.113 The drag coeﬃcient
(Cd) is calculated as a function of Reynolds numbers ranging from 0.001 to 0.1. This relation then indicates
that Cd ×Re is a function of the leukocyte to tube diameter ratio for both when red cells are not present as
well as when they are. They observe a sharp and nonlinear increase in the Cd×Re values for diameter ratios
of more than 50%. For the 50% diameter ratio case, Cd×Re increases with hematocrit of up to 10%, however
it stays insensitive to hematocrit for a 33% diameter ratio case. They experience diﬃculty increasing the
hematocrit beyond 10% and the diameter ratio above 50% because of problems with rubber discs passing
the larger sphere. In Chapter 4, we examine hematocrits of upto 25% and leukocyte to tube diameter ratios
of up to 87.5%. The authors state that the rubber discs, representing red blood cells in their study, are a
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worst case scenario in terms of elsticity.108 In Chapter 4, we examine the elasticity of the red cells and their
eﬀect on the forces exerted on the wall-bound leukocyte.
Computational models with rigid red cells
A study by Migliorini et al.11 employs a Lattice Boltzmann technique154–157 in two dimensions. Leukocytes
are circular discs with stochastic adhesion59, 147, 158 and red cells are modeled as rigid ellipses. An empirical
van der Waals potential is used to prevent leukocytes from penetrating the vessel walls and this results in a
mathematical singularity.22 Tangential and normal forces as well as the torque on the leukocyte is studied
for three cases: no red cells, a single red cell colliding head on with the leukocyte, and a single red cell in
a ‘glancing’ collision with the leukocyte. The tangential force and the torque as well as the rolling velocity
experience a 10% increase as a red cell collides directly with the leukocyte and passes it. The pressure force
goes through a sign change that ﬁrst pushes the leukocyte against the wall and then pulls it back with
almost the same magnitude. However, the initial push which in turn causes the leukocyte to penetrate the
glycocalyx layer159 signiﬁcantly favors adhesion,15, 16, 18 enabling more bonds which cannot be broken by
the consequent pull. In the third case, when the red cell passes the leukocyte at the centerline of the tube
(twice the diameter of the leukocyte), the increases in forces are only about 2%. The authors suggest that
homogeneous systems cannot suﬃciently explain parameters like rolling velocity and the nature of contact
between the leukocyte and endothelium at the rolling and ﬁrm adhesion stages; red blood cell dynamics are
crucial.11
Tube vs. planar ﬂows
Planar ﬂows have commonly been used to explore the adhesion characteristics of leukocytes.81, 106, 107, 138–140
The results in one numerical study by Sugihara-Seki,109 which examines the forces on adhered leukocytes in
circular tubes,109 suggests that shear stresses compare favorably with results for spheres adhered to planar
substrates.106, 138 However, pressure forces are substantially diﬀerent in the two types of ﬂow. There are
no red cells present in that study.109 In another eﬀort by Sugihara-Seki,110 the hydrodynamic eﬀects on
the adhered cells are almost equal for planar and tubular walls when the sphere to channel height ratio and
sphere-to-tube diameter ratio is less than 20%.110 The results of this computational eﬀort110 matches that of
Pozrikidis.140 Presence of red cells and red cell aggregation changes the magnitude of these forces.15, 64, 104, 134
However, red cells are not present is Sugihara-Seki’s study.110 Based on these ﬁndings we choose a tubular
substrate, representing the blood vessels.
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Erythrocyte interactions with rolling leukocytes
Interactions between ﬂowing red blood cells and suspending or rolling leukocytes have been studied exten-
sively.6, 14, 135 In a couple of studies6, 135 expansion of vessels from capillary to post-capillaries and its eﬀect
on adhesion dynamics are considered. Their modeling techniques and how they fair against what we present
in Chapter 2 are of interest here.
In small capillaries, it has been observed, in vivo, that the leukocyte travels more slowly than the red
cells and therefore the red cells pile up behind it, at the same time, downstream from the leukocyte a red
cell depleted region forms that increases in length as the leukocyte travels further.6 With an in vitro model,
Schmid-Scho¨nbein et al.6 use rigid spheres to model leukocytes and elastic discs to model red cells. At the
diverging part of the vessel the discs overtake the sphere and push it to an asymmetric position which is
closer to the wall. This phenomenon favors capture at the wall, rolling and adhesion in the post-capillary
venules. The shape of erythrocytes seem to be key in this preferential displacement as when they were
replaced with spheres, the results became random.
In a more recent study by Sun et al.,135 adhesion in post-capillary venules is considered. The interaction
between a leukocyte and a number of erythrocytes as they exit a capillary and enter a post-capillary venule
is the subject of this eﬀort. A lattice Boltzmann technique154–157 is used to approximately solve the ﬂow
equations in a two-dimensional model. An adhesion model is employed for the leukocyte interactions with
the vessel wall.147, 160 The leukocyte is modeled as a rigid circular disc and red blood cells as rigid rectangles
with hemisphere caps. The eﬀect of rigid elliptic red cells is also considered. Expansion to diﬀerent size
post-capillaries as well as diﬀerent number of red cells trailing the rolling leukocyte are examined. It is
found that there are only speciﬁc combinations of post-capillary diameter and red cell stack size that causes
capture and rolling in the post-capillary venule. If the stack size is bigger than the optimum number, the
stack falls apart at the expansion and does not deliver the coherent push necessary for the capture of the
leukocyte. Elliptic red cells make more unstable aggregates and are not as eﬃcient as the rectangular red
cells in pushing the leukocyte toward the post-capillary walls.135
1.4.2 Forces on the endothelium
Endothelial cells respond to shear.161–164 These forces as well as the cell’s exposure time to them pro-
voke diﬀerent biochemical responses from the endothelial cells. One study in arteries, modeled as planes,
concludes that the endothelial cells respond to the ﬂow by minimizing the total force on their nuclei.165 En-
dothelial cells can sense shear and in response change intracellular calcium161 and nitric oxide163 in seconds
or minutes. If they are exposed to shear for longer, shear can aﬀect the adhesion receptor expression at
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the surface.164 In endothelial cells, shear stress aﬀects the production of prostacyclin and nitric acid,166, 167
hydraulic conductivity through signal transduction,168 and the regulation of occludin content and phospho-
rylation.169 In the presence of tumor necrosis factor-a, adhesion and migration induction of endothelial cells
get aﬀected by constant170 as well as oscillatory shear.171 It has been suggested that laminar shear stress
promotes anti-inﬂammatory behavior in endothelial cells, which reduces leukocyte attachment.170, 172 How-
ever, unsteady shear as well as cyclic strain enhances pro-inﬂammatory genes and therefore attachment.173
The glycocalyx layer on the surface acts as a mechano-transducer of the shear stress.174 Endothelial struc-
ture and functionality is aﬀected by shear stress,175 which causes rapid deformation of intermediate ﬁlament
networks.176
Forces on an out-of-line endothelial cell bulging into the lumen
The capillaries on the arteriolar side are 2 − 3 μm smaller in diameter and gradually or suddenly expand
when going to the venular side.6 Observations indicate that the capillary on the arteriolar side is smooth
with a ﬂat endothelium6 because on this side the endothelial cells and their nuclei are prolonged.177 On the
venous side, the endothelial cells are shorter with larger nuclei which bulge out into the lumen and cause
non-uniformities.177 While shear stresses on a ﬂat endothelium is not the subject of the current study, an
out-of-line endothelial cell6, 177 can be represented by a sector of a sphere.165 We consider this case and
present the forces as a function of spreading angle in Chapter 4.
Forces on the endothelium due to an adhered leukocyte
It has been suggested that in vivo, leukocyte-endothelium interactions are especially important in determin-
ing intravascular resistance.121 This resistance is fed back into the endothelium as hydrodynamic stresses.
In addition to adhered leukocytes, ﬂowing white blood cells178 and the leukocytes that plug the entrance to
the capillaries179 alter the resistance of the intravascular networks. Whole organ perfusion studies indicate
that under normal physiological conditions, 20% of the whole blood resistance comes from the white blood
cells.180 If activated, this number rises to 50 − 60%.180 However, it is not clear from whole organ studies
if this resistance is due to leukocyte adhesion in the post-capillaries, capillary plugging by leukocytes, or
leukocyte-erythrocyte aggregate formation.178 It has been hypothesized though that plugging is not primar-
ily responsible for the microvascular resistance as leukocytes tend to take preferential paths that precludes
their entrapment.181, 182 On the other hand, at low ﬂows, venule adhesion may contribute more to intravas-
cular resistance than plugging.181 Flow resistance has been studied in a single vessel121, 151 with a conclusion
that only six adhered leukocytes are enough to double the ﬂow resistance in a 25 μm vessel.151
15
Chapman and Cokelet7 study the shear stresses on endothelium due to the presence of a leukocyte.
Leukocytes are modeled as rigid spheres, rigid and smooth cylindrical tubes represent vessels and rubber
discs model erythrocytes. The pressure drop across the leukocyte and the region upstream and downstream
of the leukocyte that is disturbed by the presence of the leukocyte is of interest. Using this pressure drop
a Fanning friction factor is calculated for the disturbed region. They deﬁne the disturbed region as where
the streamlines are noticeably deﬂected compared to their original radial path (Figure 1.4). They perform
experiments with model red cells as well as computations without red cells. In experiments, the disturbed
region was within one tube diameter from the center of the leukocyte. This disturbed region grows as the
diameter ratio of the sphere to the tube increases.
Figure 1.4: A typical velocity ﬁeld in a vessel without any red cells.
Results of Chapman and Cokelet7 suggest that hematocrits of up to 20% has little eﬀect on the product
of the friction factor and Reynolds number. However, the Reynolds number includes some of the eﬀect
of hematocrit by accounting for it through the apparent viscosity. The product of the friction factor and
Reynolds number has a rapid increase for sphere-to-tube diameter ratio of more than 50%. This suggests
that large resistance from a few post-capillary vessels could potentially redistribute the ﬂow in a network.
The wall stresses in the disturbed region are signiﬁcantly larger than the undisturbed counterpart for these
large diameter ratios. Therefore, the authors caution against assuming these two wall shears as equal for
vessels smaller than 16 μm or when the leukocyte to vessel diameter ratio is more than 50%.7
Chapman and Cokelet7 conclude that when a single leukocyte adheres to the wall there are areas in its
vicinity where other leukocytes preferentially adhere due to lower wall shear stress and that in contrast there
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are also regions where the larger wall shear rate inhibits adhesion. These wall shear stresses control the
biochemical response of the endothelial cells as well.7
In another study by King et al.,112 the authors show how the presence of adhered leukocytes as well as
ﬂowing red blood cells alter the streamlines of the ﬂow. Acute inﬂammation was induced by pretreatment
of the vessels with tumor necrosis factor-α in order to promote leukocyte adhesion. In addition to the
experiments a set of multiparticle adhesive dynamics (MAD)19, 22 simulations are also performed. In the
simulation model the vessel wall is assumed to be an inﬁnite smooth plane. Erythrocytes are modeled as
rigid spheres with a volume of human erythrocytes (96 μm3 183). This study is of interest here primarily
because of the presence of the model red cells ﬂowing over wall-bound leukocytes.
King et al.112 show that the presence of the erythrocytes as well as the adherent leukocytes increases the
non-axial component of the ﬂow. However, in strong inﬂammatory conditions, where multiple leukocytes
adhere to the wall, the eﬀect is reduced. They show that the regions between consecutive adhered leukocytes
are practically not accessible by the ﬂow and therefore wall shear stress is signiﬁcantly reduced in these areas.
The authors speculate that the gradients in wall shear, from high shear regions to these low shear zones, could
be the key factor regarding endothelial cells’ response to shear, not purely the magnitude of the shear.112
Our simulation model is well suited to study stresses on the endothelium due to the presence of an
adherent leukocyte. Figure 1.5 shows how for a constant volume ﬂow rate the forces acting on the tube, and
hence endothelium, change due to the presence of a leukocyte, a leukocyte and a red cell and a leukocyte
in 25% hematocrit. The magnitude of the forces for when there is only one red cell and when there are
multiple red cells are almost the same. This is because at this particular conﬁguration, only one red cell at
a time can pass over the leukocyte. However, as we will see in Chapter 4, in the 25% hematocrit case the
leukocyte and the tube are exposed to forces with these magnitudes longer. This is compared to the single
red cell case, where the forces relax when the red cell leaves the small gap over the leukocyte.
1.4.3 Leukocyte deformation
Under shear stress, leukocytes deform into a tear drop shape,67 which reduces drag.131 Sugihara-Seki109
shows that ellipsoid shapes experience smaller shear and pressure peak compared to a sphere with the same
volume. This is the case for drag and torque as well. When there is no inclination angle, when one of the
axes of the ellipse is parallel to the ﬂow, the ellipsoid does not experience any lift.109 A change in the details
of the shape of the cell, while keeping its volume and height constant, seems to have minimal eﬀects on the
maximum values of shear and pressure forces acting on it. This is the case for drag and torque as well. Small
deformations of the leukocyte from a spherical shape usually lead to a negative lift that presses it against
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(a) No leukocyte. (b) No red cell.
(c) Single red cell. (d) 25% hematocrit.
Figure 1.5: Traction vectors on the vessel wall for a constant ﬂow rate of 28181 μm3/s over a 8.46 μm
diameter wall-bound leukocyte in a 11.28 μm diameter vessel. To keep the volume ﬂow rate constant, the
presence of the leukocyte and red cells aﬀect the pressure gradient along the tube, which in turn changes
the wall stresses. Vectors are scaled by their magnitude.
the vessel wall,109 hence promoting adhesion.
Other studies include deformable leukocytes in Newtonian184 and non-Newtonian ﬂuids .109, 133, 185–188
Computational models have estimated forces on spherical, hemispherical and tear shape protuberances on
parallel plates138, 140 as well as deformable spheres in tubes.109, 110 The dynamics of leukocyte deformation
between parallel plates have also been studied.106, 186, 187 Here, we do not consider the deformation of the
leukocyte.
1.4.4 Adhesion and rolling
The force balance between bond formation and peeling determines the rolling velocity,78, 189 therefore compu-
tational modeling of molecular bonds has been performed to quantify the dynamics of adhesion.76, 82, 190, 191
There are other sophisticated binding models between the leukocyte and the endothelium that have been
18
used in homogeneous Newtonian ﬂows,147, 192, 193 which are beyond the scope of the present work. There has
been quantiﬁcation of the interaction between the wall and the leukocyte by the number and the velocities
of rolling granulocytes, which has led to chemical intervention for adhesiveness based on an estimate of the
shear force.189, 194
1.5 Present approach
Several common approximations are used in the work presented here. Blood vessels are never exactly straight,
smooth cylindrical tubes as we will use. They can twist and turn with endothelial nuclei bulging out, making
them bumpy.195 Additionally, leukocytes are not rigid and can slightly deform to a tear drop.67, 196 Their
surface is not smooth.100 However, Stokes ﬂow is relatively insensitive to geometric details, and ﬂow proﬁles
re-establish quickly and therefore the shapes of the obstructions are not as important as the overall cross
section of the obstruction that the ﬂow sees.197 The major diﬀerence that we show is a signiﬁcant factor
in updating the conclusions commonly found in the literature is the fact that our model considers the high
ﬂexibility of the red blood cells with high ﬁdelity.136, 137
In our simulation model, red blood cells interact with the ﬂow and with each other. The algorithm solves
the boundary integral formulation speciﬁc to Stokes ﬂow in a periodic domain.198–201 In Chapter 2 we explain
how a smooth particle-mesh Ewald (SPME) method,202, 203 decomposes an otherwise slowly convergent sum
resulting from the formulation into a real (short range) and a Fourier (long range or smooth) sum that
converge much faster. The advantage of such methods is that by making use of fast Fourier transforms
(FFTs), the scale the computational cost of a system of size N becomes O(N logN) instead of O(N2).
These techniques appear necessary for simulations of this nature. As an example, the developed framework
is ideal for simulation of blood ﬂow in capillary networks (Figure 1.6) and blood cell ﬁltration.
The accuracy of this tool is established in Chapter 2. Considering the mismatch between the viscosity
inside and outside of the red blood cells leads to an implicit term that needs be solved for iteratively. This
iteration process essentially multiplies the cost of the algorithm by the number of iterations it needs. In
Appendix B, the performance of the iterative solver is investigated and possible ways for its improvement
are suggested and in some cases implemented.
In Chapter 2, the three-dimensional model is validated by measurements from the microcirculation. A
comparison between the apparent viscosity measured in vitro5 and by our simulation model shows excellent
agreement.136 Also, the relaxation time of an individual cell initially deformed from its minimum energy
shape is examined and the results, which are well within the experimental bounds,3 are presented. The
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results in Chapter 4 of this report mainly concentrate on the three dimensional version of the model.
(a) (b)
(c)
Figure 1.6: (a) Scanning electron micrograph of a microvascular corrosion cast of the capillary network
within a terminal villus of the human placenta.1 Reproduced with permission. (b) Model capillary network
used for this simulation. (c) Simulated blood ﬂow in a capillary network with model erythrocytes, leukocytes
and platelets.
Flow of red blood cells over a wall-adhered bump, representative of a leukocyte, is considered in Chapter 4.
The local and average forces exerted on the leukocyte for a number of inﬂuential parameters such as the
leukocyte to tube diameter ratio, ﬂow hematocrit, red cell mechanics, diﬀerent driving mechanisms (pressure
gradient and volumetric ﬂow rate), the spreading angle over the vessel wall, the relative size compared to
red blood cells, and computational constrains are studied. Results indicate that the forces are signiﬁcantly
enhanced compared to when there are no red cells present or when blood is considered homogeneous with
its apparent viscosity accounting for the more viscous red blood cells. The conclusions will be presented in
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Chapter 5.
1.6 Summary of findings
Here, we only consider the forces that the leukocyte experiences and not the forces exerted on the endothe-
lium. Figure 1.7 shows a sample of the diﬀerent cases that we examine in Chapter 4. For a ﬂow rate that is
kept constant by adjusting the driving pressure gradient as for the cases shown in this ﬁgure, we note how
the forces enhance signiﬁcantly by the presence of the red blood cells. The forces shown for the case with
no red cells present are computed for plasma. Even if the apparent viscosity of blood is considered for this
homogeneous ﬂow case, the forces increase by less than 4% for a hematocrit of 4% (one red cell scenario)
and by about 26% for a hematocrit of 25% (six-red-cell scenario). Compare these to almost 100% increase
when the red cells are present for both cases. For the homogenous approximation, the leukocyte does not
experience any negative axial force while in the presence of red cells the negative axial forces are on the
order of the positive ones. Another note is that in the homogeneous case the average traction in the lateral
and vertical directions are zero (symmetry in Stokes ﬂow), though this is not the case when red cells are
present. The diﬀerence in forces exerted on a wall-bound leukocyte due to the presence of individual red
cells compared to a homogeneous Newtonian assumption could lead to distinctively diﬀerent responses by
the leukocyte.
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(a) σx ∈ (−3.8,3.8) Pa. (b) σx ∈ (−6.0,6.0) Pa. (c) σx ∈ (−6.0,5.9) Pa.
(d) σy ∈ (−5.0,5.0) Pa. (e) σy ∈ (−13.4,8.6) Pa. (f) σy ∈ (−12.5,8.6) Pa.
(g) σz ∈ (0,6.2) Pa. (h) σz ∈ (−8.0,11.1) Pa. (i) σz ∈ (−9.6,13.2) Pa.
Figure 1.7: Traction contours for constant ﬂow rate of 28181 μm3/s on a 8.46 μm diameter wall-bound
leukocyte in a 11.28 μm diameter vessel (top view: ﬂow is from left to right).
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Chapter 2
Simulation Model
In this chapter we present the algorithm to simulate the interactions of large numbers of red cells ﬂowing
through vessel geometries that are comparable to the scale of the cells, where we can anticipate that the
cellular character of blood will be particularly important. Here the hematocrit can be as high as 30%, so
close interactions are expected and simulation of systems with a large number of red blood cells is a necessity;
for the studies discussed in Chapter 4 we simulate up to 20 cells.
These cells are highly deformable under physiological conditions. When at rest, they assume a biconcave
shape that is approximately 8 μm in diameter and 2 μm thick (Figure 1.3). We model the red blood cells as
ﬂexible neo-Hookean elastic membranes enclosing a hemoglobin solution. The membrane has a ﬁnite elastic
shear modulus and bending moment but strongly resists surface dilatation.117 We assume the hemoglobin
solution to be Newtonian114, 115 and based on limited evidence,116 its viscosity has been taken to be ﬁve
times that of plasma,116 which is also Newtonian. Cellular interactions with each other as well as with the
vessel walls lead to phenomena like the well-known non-monotonic change in apparent viscosity with vessel
diameter123, 204 and so-called plasma skimming at vessel bifurcations.205 This particulate character has been
shown responsible for leukocyte margination.14, 58, 62, 69 In the present work, we will show that the forces
exerted on a wall-bound leukocyte due to the presence of individual red cells are signiﬁcantly larger when
compared to a homogeneous Newtonian blood model.
As mentioned in Section 1.3.3, the ﬂow is assumed to be Stoksian in the microcirculation. Direct numeri-
cal simulation of cellular ﬂow systems are challenging despite the simple linear behavior of Stokes equations.
Some of the challenging issues are continuous change in the red cell geometry, red cell deformation, and
close-range interactions. Body ﬁtted mesh methods, such as Lagrangian-Eulerian methods, are computa-
tionally intensive due to the movement and regeneration of the mesh. This can be overcome by representing
the moving geometry on a ﬁxed mesh, which is the basis for immersed boundary and immersed interface
methods. These methods account for the cell-ﬂuid interactions by diﬀusing the membrane force onto the
ﬂuid mesh206 or by modifying the local discrete diﬀerential operators when their stencils cross into the cell
membrane.207 Two-dimensional immersed boundary methods have been used for cell–cell interactions as well
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as cellular ﬂow in small blood vessels.208, 209 Immersed ﬁnite-element210 and lattice-Boltzmann211 methods,
which account for the cell membranes by added body forces, have been used to model cell aggregation and
blood rheology. In these methods, in order to resolve close interactions, a ﬁne volumetric mesh or adaptive
meshing is required.212
Another approach to numerical discretization is to express the solution to the Stokes equations as surface
integrals over the interfaces and boundaries.198, 200 As a result, only these interfaces and boundaries need
to be discretized. Boundary integral formulations have been used for a single red cell is shear ﬂow115 and
axisymmetric cell motion in cylindrical tubes.213 The method presented here has been used to simulate large
numbers of red cells in two14 and three13, 136, 137 dimensions.
Nonlinear dependence of the membrane residual force on its deformation is particularly challenging in
red cell simulations. These non-linearities are a result of membrane stress-strain relations and the intrinsic
geometrical nonlinearities due to the ﬁnite membrane deformation. They manifest themselves as unphysical
growth of the high wavenumber modes by an aliasing mechanism. For a system with ﬁnite resolution, most
numerical schemes will alias the unresolvable portion of the this energy into the resolved portion.214 In
red cell simulations, aliasing errors can build up to form unphysical surface features like sharp corners and
cusps. Without physical or numerical dissipation, the growth in the high wave number modes leads to
instabilities.115 Numerical damping suppresses this problems but also deprecates the overall resolution of
the scheme.
To de-alias the solution in two dimensions, we represent the interface of the cells with N Fourier modes,
but all the nonlinear operations are done using typically 4N collocation points interpolated by the original
N modes.14 This alleviates the need for artiﬁcial dissipation. This approach is then generalized to the three
dimensional representation of the cells using spherical harmonics.
In this chapter we present the formulation and implementation of the three-dimensional approach. In
Section 2.1, we brieﬂy present the formulation and discuss various aspects of the algorithm in detail in
Sections 2.2 through 2.4. The de-aliasing procedure is discussed and demonstrated in Section 2.5. Treatment
of close range interactions between the red cells and volume preservation are presented in Sections 2.6 and 2.7.
The accuracy of the Ewald sum as a function of various numerical parameters is presented in Section 2.8.1.
Finally, two validation cases for our simulation model are presented in Section 2.8.2.
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2.1 Formulation and implementation
A generic three-dimensional cellular ﬂow domain is depicted schematically in Figure 2.1. The cells Di and
vessel walls W are embedded in a rectangular domain Ω = [0, L1]×[0, L2]×[0, L3]. The Newtonian viscosity
μ is that of blood plasma in Ω0, everywhere outside of the cells. The region outside of the vessel is included
in Ω0 since it facilitates the use of periodic Green’s function kernels, but the no-slip boundary condition on
the vessel walls prevents this exterior ﬂow from inﬂuencing the ﬂow in the vessel. The hemoglobin solution
within the cells has Newtonian viscosity λμ. Indirect experimental measurements suggest that this interior
viscosity is higher than the plasma viscosity but of the same order of magnitude.116 A viscosity ratio that
has been used in past simulations of red cells is λ = 5,115 which we also use. The ﬂow is driven by a pressure
gradient, so despite the periodic boundary conditions on the velocity, pressure has both a periodic and a
linearly varying component. The periodic part can be expressed as x ⋅ ⟨∇p⟩, where ⟨∇p⟩ is the mean pressure
gradient, which necessarily balances the net eﬀect of any wall friction.
The theory of the boundary integral formulation for Stokes ﬂow is well established.198–201 We brieﬂy
outline the general formulation for completeness and concentrate on the details central to the cellular ﬂow
system and our algorithm. The formulation is built upon the solutions of the Stokes equation with a point
force inhomogeneity,
0 = −∇p + μ∇2u + g δ(x − x0) 0 = ∇ ⋅ u, (2.1)
where p is the pressure and u is the velocity. The solutions for the ﬂuid velocity and stress are
ui(x) = 1
8πμ
Gij(x,x0)gj and σik(x) = 1
8π
Tijk(x,x0)gj. (2.2)
Here, the so-called Stokeslet G(x,x0) is periodic in Ω on both x and x0 and satisﬁes the zero mean ﬂow
condition ∫ΩG(x,x0)dx = 0. The so-called Stresslet T(x,x0) can be spatially decomposed into linear and
periodic parts,
Tijk(x,x0) = −8π
V
xjδik + T˘ijk(x,x0), (2.3)
where V = L1L2L3 is the volume of the domain, and the periodic part T˘ijk(x,x0) satisﬁes the constraint
∫Ω T˘(x,x0)dx = 0. The single-layer potential operator N and the double-layer potential operator K are
integral operators on a surface D that involve these Green’s functions as kernels. They map any surface
vector distribution ψ into
(NDψ)j(x0) = ∫
D
ψi(x)Gij(x,x0)dS(x), (2.4)
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Figure 2.1: A model microcirculatory vessel. The area denoted by Ω1,2,⋯ is occupied by the cells, and the
rest (Ω0) by plasma.
and
(KDψ)j(x0) = ∫
D
ψi(x)Tijk(x,x0)nk(x)dS(x). (2.5)
If the surface D is Lyapunov smooth, then both operators are weakly-singular and hence compact.215, 216
Taking D = ∪iDi to be the set of cell membranes, the surface velocity at any point x0 ∈D satisﬁes
uj(x0) = − 1
4πμ(1 + λ)(ND∪W f)j(x0) + 1 − λ4π(1 + λ)(KDu)j(x0) + 21 + λ ⟨uj⟩ , (2.6)
where the surface normal n in KD points into the plasma region Ω0 (see Figure 2.1), the force density f is
the sum of hydrodynamic forces acting on D and W , and ⟨u⟩ is the volume average of the velocity in Ω.
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Since it appears explicitly as a parameter, ⟨u⟩ is convenient for setting the strength of the ﬂow, but this
average also includes ﬂow outside the vessel. The no-slip condition on the vessel wall W is
0 = − 1
8πμ
(ND∪W f)j(x0) + 1 − λ
8π
(KDu)j(x0) + ⟨uj⟩ , (2.7)
which applies for any x0 ∈W and prevents the exterior ﬂow from inﬂuencing the ﬂow in the interior of the
vessel.
Since the inertia of cell membranes is negligible, the hydrodynamic traction f in (2.6) acting on the
membrane balances the residual force from the membrane’s internal stress. Hence f ∣D is explicitly calculated
from the cell membrane deformation and the stress–strain relation. As a result, u∣D and f ∣W are solved by
inverting (2.6) and (2.7) for any given ⟨u⟩.
The volume average velocity ⟨u⟩ is related to the mean pressure gradient ⟨∇p⟩, which is also an important
parameter for studying microcirculatory ﬂows. The average velocity implicitly determines the net wall
friction force and thus the mean pressure gradient,
⟨∇p⟩ = − 1
V ∫W f(x, t)dS(x), (2.8)
through the no-slip condition (2.7). The functional relation between ⟨u⟩ and ⟨∇p⟩ thus depends on the
size of the domain Ω and is therefore not generic. The explicit functional form of the dependence is not
easily realized even for relatively simple geometries. Thus, unlike mesh-based methods, it is not convenient
a priori to set either the pressure gradient or mean velocity in the vessel. However, this is not a signiﬁcant
limitation since a speciﬁc ⟨u⟩ corresponds to a speciﬁc time average of ⟨∇p⟩ and mean ﬂow in the vessel. It is
thus straightforward to set either of these iteratively (here we achieve a constant mean pressure gradient or
constant average tube velocity by employing this technique) or study a range of ﬂow conditions by varying⟨u⟩ as Freund14 did previously in two dimensions. If a speciﬁc mean pressure gradient is indeed required,
then unknowns u∣D, f ∣W and ⟨∇p⟩ can be solved from (2.6), (2.7) and (2.8), although this increases the
number of unknowns by a factor or three.
Through collocation, (2.6) and (2.7) are discretized into the linear system
⎛⎜⎜⎝
A11 A12
A21 A22
⎞⎟⎟⎠
⎛⎜⎜⎝
U
F
⎞⎟⎟⎠ =
⎛⎜⎜⎝
b1
b2
⎞⎟⎟⎠ , (2.9)
where U is all the velocity vectors for all discrete mesh points on cells and F is all the friction forces on
the discrete mesh points on the walls. The sub-matrices in (2.9) clearly correspond to cell-cell, cell-wall and
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wall-wall interactions.
A staggered time integrator updates the cell deformations from each time step tn to the next tn+1 = tn+Δt
with the following steps:
(i) Solve the surface velocity Un from
An11U
n = bn1 −An12Fn. (2.10)
(ii) Advance the cell surface coordinates by the forward Euler scheme:
Xn+1 =Xn +ΔtUn. (2.11)
(iii) Update the wall drag force by solving
An+122 F
n+1 = bn+12 −An+121 Un. (2.12)
Euler forward time stepping is shown here for simplicity and used in our example simulations; multi-step
time integration schemes such as Adams–Bashforth can be used without diﬃculty. Runge–Kutta schemes
are also straightforward in some cases, but become more diﬃcult to apply when a cell-cell collision removal
procedure is added between sub-time-steps as seems necessary in cases (see Section 2.6). The two linear
systems for U and F are solved with GMRES.217 The submatrix A11 in (2.9) represents the operator
I − (1 − λ)/[4π(1 + λ)]KD, and its condition number is bounded by the viscosity ratio λ. For matched
viscosity λ = 1, A11 = I, and the equation for U is explicit; when λ = 5, as for most of the demonstration
simulations, the system is well conditioned and no more than 10 iterations are needed to reduce the L2–
norm of the relative residual error to about 10−6. The determination of F, on the other hand, requires
solving a single-layer potential system whose condition number grows with wall mesh reﬁnement. For the
cylindrical tubes of Chapter 4, the maximum wall residual velocity is reduced to less than O(10−4) of ∥ ⟨u⟩ ∥
by 20 GMRES iterations. For a particular ﬂow or geometry, it is likely that the matrix condition can be
improved through eﬀective preconditioning218, 219 or by applying the no-slip condition through an indirect
formulation.220–222 While it is in principle possible to solve (2.9) directly, the scheme we use is simpler
and has been consistently stable. It also has been demonstrated to be accurate by Zhao et al.136 through
comparison with analytical and other accepted results.
In Appendix B, we extensively study the implicit linear system that arises for λ ≠ 1. A particularly
important aspect of this is that the system becomes singular at two limiting eigenvalues. When the viscosity
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inside the cells is relatively large or small. Deﬂation to remove these eigenvalues from the system as well
as two iterative methods to solve the system are presented in Sections B.10 and B.11, respectively. This
study is performed for the two-dimensional formulation of this problem but the principles apply to three
dimensions as well.
2.2 Cell surface representation and residual force calculation
The surface of each cell Di is mapped from a unit sphere S2 that is parameterized by the colatitude angle
θ ∈ [0, π] and the longitude angle φ ∈ [0,2π). Any function f on S2 is represented by a truncated series of
spherical harmonic functions,
f(θ,φ) = N−1∑
n=0
n∑
m=0
P¯mn (sin θi)(anm cosmφj + bnm sinmφj), (2.13)
yielding N2 total number of spherical harmonic modes. The normalized associated Legendre polynomials in
(2.13),
P¯mn (x) = 12nn!
!""#(2n + 1)(n −m)!
2(n +m)! (1 − x2)m2 dn+mdxn+m (x2 − 1)n, (2.14)
satisfy
∫ 1−1 P¯mn (x)P¯mn′ (x)dx = δnn′ . (2.15)
The mesh coordinates are uniform in φ and the roots of PN(cos θ) in θ. Both forward and backward
transforms are computed using the SPHEREPACK library.223, 224
Besides spectral accuracy, there are two main advantages to the spherical harmonic representation.
First, the diﬀerentiation of each modal function on the right-hand side of (2.13) is well deﬁned, without the
ambiguous behavior or singularities at the poles (θ = 0, π) that are encountered when using, say, standard
ﬁnite diﬀerences on S2. Secondly, the spherical harmonic representation has a uniform resolution over S2 in
that the truncated series (2.13) minimizes the L2–norm of the approximation error on S2. We note that the
number of modes is exactly half of the number of mesh points. For an arbitrary function with values deﬁned
on the 2N2 mesh points, a forward and backward discrete spherical harmonic transform does not recover the
original point values. Instead, it yields a distribution in which the highly oscillatory modes near the poles
are removed. This also removes any time step limitation associated with the close spacing of the collocation
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points near the poles: the eigenvalue of the Laplacian of each spherical harmonic mode is n(n+ 1), which is
far less than the inverse square of the mesh spacing near the poles.
On the cell surface, local coordinates are deﬁned by the two tangents a1,2 and the surface normal a3,
a1 = ∂x
∂θ
a2 = ∂x
∂φ
a3 = n = a1 × a2∣a1 × a2∣ . (2.16)
The ﬁrst and second fundamental forms, which are used in subsequent manipulations, have components
aij = ai ⋅ aj and bij = ai,j ⋅ n (i, j = 1,2). (2.17)
Each cell we model here has a stress-free biconcave reference shape set with a standard functional form.115, 213
The local deformation of the membrane is described by the surface deformation tensor F that maps the two
reference tangents aRk to ak and has the tensor form F = ∑2α=1 aα ⊗ aαR.
For an isotropic membrane, the Piola–Kirchhoﬀ stress only depends on the two strain invariants,225
I1 = λ21 + λ22 − 2 and I2 = λ21λ22 − 1, (2.18)
where λ1,2 are the eigenvalues of the left Cauchy-Green tensor V
2 = F ⋅FT . The elastic strain energy based
on a neo-Hookean model213 is
W = ES
4
(1
2
I21 + I1 − I2) + ED8 I22 , (2.19)
where ES is the elastic shear modulus and ED is the dilatation modulus, which acts as a penalty parameter
so that the surface dilatation is nearly unity. The in-plane Cauchy stress tensor is
τ = ES
2JS
(I1 + 1)V2 + JS
2
(EDI2 −ES)P, (2.20)
where P = I − n ⊗ n is the surface projection tensor and JS = λ1λ2 is the dilatation. The linear isotropic
model used for the bending moment is
Mαβ = −EB(bαβ − bαRβ ), (2.21)
where EB is the bending modulus. For a sphere of radius r, b = −P/r, hence a compression of a sphere
results in a positive bending momentum according to (2.21) as it should.
By applying the Stokes theorem to the local torque balance, the surface transverse tensor Q and the
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in-plane tension tensor N are deﬁned by
Mαβ∣α −Qβ = 0 (2.22a)
eαβ(Nαβ − bαγMγβ) = 0, (2.22b)
where the subscript ‘∣α’ denotes the covariant derivative to θα. Equation (2.22b) determines the antisym-
metric part of N, and the symmetric part is set by the constitutive law (2.20). Nevertheless, because of the
constitutive model (2.21) used for the bending moment M, the term bαγM
γβ in (2.22b) is symmetric about
α and γ, and so the antisymmetric part of N is always zero. By a local force balance, the hydrodynamic
surface traction f is determined via
Nαβ∣α − bβαQα + fβ = 0 (2.23a)
Qα∣α +Nαβbαβ + f3 = 0 (2.23b)
for β = 1,2. Because of the global mapping on each cell surface, all derivatives are obtained from the spherical
harmonic expansion and tensor algebra.
This model for the mechanics of the cell membranes is fairly general and has been used previously as
a model for blood cells.115, 213 Zhao et al.136 show that it provides a reasonable quantitative model for
ﬂowing cells. However, the overall algorithm we develop here is only loosely tied to this particular model of
the red-cell dynamics, so long as the cells remain intact. Topological changes, such as in cell lysis, would
require signiﬁcant modiﬁcation of the scheme because the spectral basis functions are restricted to sphere-
like topologies. Such cases aside, there are several other constitutive models and modeling approaches226–228
that are compatible with the overall proposed algorithm and which might have better predictive capabilities
in certain circumstances.
For any realistic constitutive model, the membrane will introduce nonlinearity to the linear ﬂow system,
thereby introducing the nonlinear mechanisms of numerical instability that appear to have hampered solution
in the past.115 The in-plane Cauchy stress is in general a nonlinear function of the deformation tensor and the
ﬁnite membrane deformation also introduces a geometric nonlinearity. Furthermore, the covariant derivative
involves projection of tensor derivatives along the local surface tangents, which is also a nonlinear operation
at ﬁnite deformation. All of these nonlinearities contribute to what are called aliasing errors in the context
of numerical solutions of the full nonlinear Navier–Stokes equations.214 Energy that is moved to unresolved
scales (high mode numbers) by nonlinear eﬀects is aliased back to resolved scales, where it facilitate a
spurious increase in the magnitudes of high-wave-number energy. Our approximate de-aliasing technique,
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which is discussed and demonstrated in Section 2.5, is essential for the overall eﬃciency of our algorithm.
2.3 Discretization of the no-slip wall boundaries
No-slip wall boundaries, such as the blood vessel walls, are discretized with a triangular surface mesh, on
which the surface force density is represented by second-order accurate linear boundary elements build upon
7-point Gauss qudratures.200 This is implemented in a collocation scheme whereby the residuals of (2.9)
at wall mesh points are constrained to be zero. The singular integrations on the wall are computed by
the widely-used Duﬀy quadrature rule.229 For nearly-singular close-range interactions this same singular
integration is used to improve accuracy, but a ﬁne wall mesh would be needed, of course, if the cells were
to approach very close to the wall. We have not found this to be restrictive in our computations because
Stokesian lifting suppresses close approaches to the wall and tends to maintain the well-known near-wall
cell-free layer. The cell deformation and wall force density in all our simulations are insensitive to wall mesh
reﬁnement when the wall mesh size is smaller than the gap width. Zhao et al.136 provide an example with a
wall reﬁnement which, at least for that case, shows that our typical resolution is more than suﬃcient. The
discretization of the cells, which as can be seen from the block matrix structure of the cell–wall system is
independent of the wall discretization. If resolving close cell–wall interaction were to become a challenge in
some application, it would be possible to incorporate any higher-resolution scheme for the wall,146 either
locally or globally, without changing the cell discretization.
2.4 Smooth particle-mesh Ewald (SPME) method
2.4.1 Green’s function splitting
The Stokes-ﬂow Green’s functions for periodic boundary conditions are calculated as an Ewald sum230 (see
Section C.2). To do this, both Green’s functions are decomposed into short-range singular (sr) and smooth
(sm) parts,
G =Gsr +Gsm and T = Tsr +Tsm.
The short-range part of the single-layer Green’s function G is
Gsrij(x,y) = ∑
a
erfc(r˜)(δij
r
+ rirj
r3
) + 2√
α
∑
a
e−r˜
2 (rirj
r2
− δij) , (2.24)
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where a = (n1L1, n2L2, n3L3) for integer n1,2,3, r = x − y + a is the vector of separation, and r˜ = √π/α r is
non-dimensional. The corresponding smooth part of G is
Gsmij (x,y) = 2αV ∑k≠0Φ1(k˜2)(k˜2δij − k˜ik˜j)ei2πk⋅(x−y), (2.25)
where k = (N1/L1,N2/L2,N3/L3) is the wave number and k˜ = √παk is non-dimensional. The function Φ1
in (2.25) is an incomplete γ-function deﬁned
Φγ(z) = ∫ ∞
1
e−zttγ dt. (2.26)
The periodic part of the Green’s function T has a similar decomposition:
T˘ srijl(x,y) = −8√πα ∑a Φ 32 (r˜2)r˜ir˜j r˜l (2.27)
and
T˘ smijl (x,y) = 2αV ∑k≠0(i2π)(kiδjl + kjδil + klδij)Φ0(k˜2)ei2πk⋅(x−y)
+ α2
πV
∑
k≠0
(i2π)3kikjklΦ1(k˜2)ei2πk⋅(x−y). (2.28)
Full derivations of (2.24) and (2.25) as well as (2.27) and (2.28) are presented in Appendix C. The Ewald
parameter α determines the length scale of the decomposition. The short-range part of the Green’s function
decays exponentially with separation distance when r˜ ≫ 1, so it is truncated at short distance without
introducing signiﬁcant error. The smooth part is represented by Fourier coeﬃcients that decay exponentially
fast with increasing wave numbers for k˜ ≫ 1.
2.4.2 Smooth component
The smooth part of the sum is calculated by the smooth particle–mesh Ewald sum (SPME) method.203, 231, 232
The central idea of SPME is to calculate the smooth Fourier Ewald sum on a uniform Cartesian mesh using
fast Fourier transforms. B-splines are used to distribute the source singularities from their locations on
the cells and walls to this regular mesh as well as to interpolate velocities computed on the mesh back to
the surfaces. That this mesh extends beyond the vessel as in Figure 2.1 might appear wasteful because it
amounts to discretizing regions of space where the ﬂow is not of interest. However, where there are no cells
there is little expense associated with this portion of the calculation. There are no short-range interaction
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to evaluate and no interpolation from the collocation points on the cells to the mesh and back. Proﬁling
shows that the entire forward and reverse FFT portion of the solver accounts for less than 20 percent of
the calculation for the ﬂows in tubes discussed in Chapter 4. This will increase for more complex geometry
vessels, for which more of the volume of the periodic domain would fall outside the vessel, but can be also
be signiﬁcantly reduced by selecting α values that further reduce the work on the FFT mesh.
2.4.3 Short-range component
The short-range part of the sum is computed directly to the desired accuracy, using a small but suﬃcient
number of close interactions. Convergence is rapid with increasing the range of included interactions because
of the exponential decay for r ≫ α1/2. However, the singularity at r = 0 requires additional attention. The
boundary integral of this singular kernel over a cell surface D has a general form
I(x0) = ∫
D
K(x,x0)f(x)dS(x)
= ∫S2 K(x(θ,φ),x0)f(x(θ,φ))J(θ,φ) sin θ dθdφ. (2.29)
where K is any Cartesian component of the physical part of the Green’s function and f(x) is any smooth
function over D. With the reference sphere S2 discretized by a N ×2N mesh as discussed in Section 2.2, the
average mesh spacing is h = √A/N2 where A is the cell surface area. When the distance d between point
x0 and surface D is much bigger than h, the kernel K(x,x0) is smooth over D and is well resolved by the
surface mesh. We take the threshold distance to be h1/2, so any x0 whose distance to D is greater than h1/2
is considered well separated from the surface. The surface integral (2.29) is thus computed by
I ≈ N∑
i=1
2N∑
j=1
K(xij ,x0)f(xij)Jijwij , (2.30)
where xij = x(θi, φj) is the coordinate of the quadrature point at (θi, φj), and wij is the quadrature weight.
Using the Gauss points in θ and uniform points in φ, the quadrature (2.30) converges exponentially with
mesh size h.
2.4.4 Singular and nearly-singular points
If x0 in (2.29) lies on or is close to D (i.e. 0 ≤ d < h1/2), then the Green’s function kernel is singular or
considered to be nearly singular, for which the quadrature (2.30) will have poor accuracy and in general will
not converge with h→ 0. Doing this in the nearly-singular case amounts in essence to local mesh reﬁnement
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for accurate evaluation of the integrals in the ‘lubrication limit’ of close inter-cell spacing. In both cases, the
singular surface integrals are computed by the method of ﬂoating partition of unity.233, 234 When x0 ∈ D, a
local polar patch centered on x0 is deﬁned on the reference sphere. For any other point x ∈ D, ρ(x,x0) is
deﬁned to be the distance along the great circle that connects x and x0 on S2. This coordinate is used in
the mask function
η(ρ) =
⎧⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎩
exp( 2e−1/t
t−1 ) for t = ρ/ρ1 < 1
0 forρ ≥ ρ1, (2.31)
where ρ1 is a cut-oﬀ radius. Since η(ρ) is smooth it is amenable to accurate quadrature calculations. With
η(ρ), the surface integral is split into two parts
I = I1 + I2
= ∫
D
K(x,x0)η(ρ(x,x0))f(x)dS(x) + ∫
D
K(x,x0)[1 − η(ρ(x,x0))]f(x)dS(x). (2.32)
The integrand of I1 has support only in the patch. To evaluate it, we ﬁrst transform to the local polar
coordinate system, which yields
I1 = ∫ 2π
0
∫ ρ1
0
K(x,x0)η(ρ)f(ρ,ϕ) sinρdρdϕ. (2.33)
For each ﬁxed ϕ ∈ [0,2π), the integrand is ﬁnite, though in general it is discontinuous across the pole. The
integral can nevertheless be calculated accurately by ﬁrst using Gauss quadrature along each radial line for
ρ from zero to ρ1 and then summing over ϕ, in which direction the integrand is periodic and thus evaluated
on a uniform mesh. The integral I2 in (2.32) is smooth over D since its integrand vanishes at x = x0, and
hence is accurately computed by the quadrature rule (2.30). Since the mask function changes from unity
at the center of the patch to zero on the patch boundary, the radius of the patch must be chosen so that
the integrand of I2 is well resolved by the surface mesh. In our calculations, we choose the patch radius
on the reference sphere to be ρ1 = π/√N so that the patch radius in R3 is O(h1/2). Inside the patch, √N
quadrature points are used in the ρ direction and 2
√
N in the ϕ direction, giving a point density that is
thus comparable to that of the surface mesh. The singular integration error is O(h3) by this choice of patch
size.234 Higher-order accuracy is achieved with larger polar patch sizes such that ρ1 ∝ N−β and β < 1/2,
albeit with more computational cost.
The quadrature points for I1 are deﬁned on the local polar coordinate patch, and do not coincide with
the surface mesh points. Interpolation is needed to evaluate the surface coordinates and other function
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values on those quadrature points, for which we use bi-cubic splines. Interpolating with the global spherical
harmonics would be more accurate, but spectral convergence would not be preserved because of the O(h3)
limitation above, so the expense is not justiﬁed. The overall scheme is more eﬃcient for the same formal
convergence rate using a spline interpolation. To construct the bi-cubic spline approximation for a function
f(θ,φ), we take advantage of the periodicity of functions on the unit sphere, without assuming any of the
additional restrictions of this particular geometry. We ﬁrst compute the function values of f on a surface
mesh that is uniform in both θ ∈ [0, π] and φ ∈ [0,2π) from the spherical harmonic coeﬃcients of f . The
domain of deﬁnition of f is then extended to θ ∈ [0,2π) by using the symmetry f(2π−θ, π+φ) = f(θ,φ). The
extended function is periodic in both directions, hence the function derivatives at nodes, needed to develop
the spline, are computed by fast Fourier transform.
For nearly-singular integration, the projection point of x0 on surface D is found ﬁrst as xp, and the
integral is split by the same partition of unity (2.32) with the polar coordinate patch centering around xp.
In all cases, to resolve the rapidly varying Green’s function kernel near xp in the polar patch, we use a sinh
transformation in radial direction to cluster the quadrature points near its center.235
2.5 Aliasing errors
Aliasing can arise from the ﬁnite resolution of any discretization of a nonlinear system, but is distinct from
the truncation errors associated with, say, diﬀerentiation schemes.214, 236, 237 As discussed in Section 2.2,
the cell surface residual force depends nonlinearly on the deformation, and the aliasing error introduced
by this nonlinearity is a potential source of numerical instability. These nonlinearities tend to broaden the
spectrum of the deformations of the cells. This is physically realistic; sharper features do form on the cells.
The turbulence energy cascade is a commonly cited example of this.214 A consequence of this nonlinear
spectral broadening is that energy is moved to scales that can not be resolved by the discretization. It would
be consistent with the selected resolution for this energy to be removed from the solution, but instead it is
aliased to the resolved scales,214, 236, 237 which can in turn drive additional aliasing and potentially lead to
numerical instability.
Dissipative numerical approximation or explicit ﬁltering can suppress instability due to aliasing, but
both degrade the accuracy of the solution for ﬁxed resolution. Increasing resolution also counters it, but at
the cost of more points as well as a more restrictive time step stability limits for explicit time integration.
The impact of the time step restriction is potentially severe. So-called de-aliasing procedures are preferable
since the resolved solution is not directly aﬀected and more resolution is not required just for the sake of
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countering what is usually a slowly growing instability. For the quadratic nonlinearity of the Navier–Stokes
equations, the well-known 3/2-rule eliminates aliasing errors.214, 236 In that case, the nonlinear operations
are performed with 50% more mesh points, followed by a ﬁltering of the solution. The nonlinearities in the
present formulation are higher order and non-polynomial, the second of which precludes exact de-aliasing.
Experimentation shows that a factor-of-three suﬃciently suppresses aliasing for most of our simulations in
Chapter 4. There are a few cases with conﬁned geometries that require de-aliasing factors of four or ﬁve.
We denote the larger mesh size by M . For example, for factor-of-two de-aliasing, the nonlinear calculations
are done on an M × 2M = 2N × 4N mesh for the truncated spherical harmonic representation (2.13).
2.6 Close range interactions
At the hematocrit simulated, the distance between neighboring cells can become small. Theoretically, the
distance should remain ﬁnite as predicted by lubrication theory, but without corrective measures contact
and penetration can occur due to the ﬁnite numerical errors in the surface velocity calculation and time
integration. In two-dimensional simulations, short-range repulsion forces have been designed that allow
close approach but prevent surface overlaps.14 Numerical experiments with this approach also suggest that
signiﬁcantly larger forces are needed in three dimensions because the contact region is initially point-like,
rather than line-like in two dimensions. That is, larger local forces applied at ‘points’ are needed to separate
three-dimensional cells than the local forces applied on ‘lines’ in two dimensions. As the repulsion force
should decay rapidly from the contact points, the mesh resolution needed for resolving the repulsion force
in the contact region will be greater than that for accurate surface representation and boundary integrals.
Therefore, here a purely kinematic collision detection and removal procedure is used instead of a repulsion
force. A small threshold hs separation is deﬁned, which for our demonstration simulations is set to be 2%
of the equivalent cell spherical radius. Whenever the distance of a cell surface mesh point, x, to another cell
surface is less than hs, this point is moved in the (xp − x) direction, where xp is the projection of x on the
other surface, until ∣x − xp∣ = hs. A similar approach is used for emulsion ﬂow simulation.222 For some of
the results presented here, the time-averaged maximum correction is up to a displacement of 0.1hs per time
step. In Chapter 4 we show that the forces experienced by a wall-bound leukocyte are insensitive to this
parameter below a value of 2% of of the equivalent cell spherical radius. No constraint was needed for close
interactions between the cells and the vessel walls. The well-known near-wall cell-free layer is consistent with
this. However, the constraint was needed when the cells interact with the leukocyte that protrudes into the
tube.
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The value of 2% of the equivalent cell spherical radius is equal to 56 nm. At these scales the molecular
interactions become important. For example, for erythrocyte–erythrocyte interactions, the length of a
ﬁbrinogen molecule which is known to be involved in cell aggregation238 is 45 nm,239 for erythrocyte–vessel
interactions, the glycocalyx layer is 50 to 500 nm on the endothelium,159 and for erythrocyte–leukocyte
interactions, adhesion molecules are located on small protuberances (microvilli) of 300 to 700 nm on the
surface of the leukocyte.159 Therefore, inclusion of lubrication layers at closer separation distances would
not necessarily represent a more realistic picture for close interactions.13 In another study, Migliorini et al.11
use an empirical van der Waals potential to prevent leukocytes from penetrating the vessel walls.
2.7 Volume constraint
Because of the incompressibility of the ﬂuids in this setup, there should not be any changes in cell volume.
However, ﬁnite numerical accuracy of the model leads to accumulation of changes in cell volume. A vari-
ational formulation of volume enforcement as a constraint yields a correction by adjusting the surface in
its normal direction. The formulation is identical to what was implemented earlier by Freund14 (repeated
in Section B.6) and also presented in Zhao et al.136 We will see in Chapter 4 that by using this volume
enforcement, the changes in volume of the cells are conﬁned to thousandths of a percent compared to a
few percent when left unconstrained. The eﬀect of this constraint on the resulting forces is statistically
negligible. However, the enforcement of the volume assures surface stability for long simulations.
Detail analysis of time step limitation, cell surface quadrature convergence and spatial and temporal
resolution can be found in Zhao et al.136 Sample ﬂows of red blood cells in a microvessel with and without a
wall-bound leukocyte are presented in Figure 2.2. Cases like the one shown in Figure 2.2(b) are the subject
of this investigation, the results of which are presented in Chapter 4.
2.8 Physical parameters
Although the results presented in Chapter 4 are in their dimensional form, the computations are performed
in a non-dimensional form. Following Pozrikidis,213 all quantities are non-dimensionalized by
● The equivalent cell radius a∗ ≈ 2.82μm, where a red cell has the same volume as a sphere of radius a∗.
● A reference shear rate k∗ = 100s−1, which gives a reference velocity U∗ = k∗a∗ = 282μm/s.
● The plasma viscosity μ∗ = 1.2 × 10−3kg ⋅m−1 ⋅ s−1.240
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(a) Flow in a capillary.
(b) Flow over a wall-bound leukocyte.
Figure 2.2: Sample simulations.
For the constitutive model discussed in Section 2.2, the following values are used for cell membrane shear
and bending modulus,
E∗S = 4.2 × 10−6N/m and E∗B = 1.8 × 10−19Nm. (2.34)
and their non-dimensional values are
ES = E∗S
μ∗k∗a∗
= 12.4 and EB = E∗B
μ∗k∗a∗3
= 0.0669. (2.35)
The membrane dilatational modulus is set as a penalty parameter ED = 200. With this value the local area
changes in the simulations presented in Chapter 4, stay within 10% for most of the cases and within 15%
for the most extreme geometries.
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2.8.1 Accuracy analysis
A test case of 100 point forces and 100 velocity points randomly distributed in a 5×5×5 (non-dimensionalized
by the equivalent radius of a cell) computational box is considered. The error in computing the velocities
from only the single-layer Green’s function, G (sum of (2.24) and (2.25)) is calculated by comparing with an
arbitrarily accurate Ewald sum, which is an independent expensive calculation but is only performed once.
We quantify the error by
 =!""# 1
N
N∑
n=1
(unE − un)2. (2.36)
The eﬀects of four diﬀerent parameters on the accuracy of the computations used in the SPME method
are considered. These variables are the Ewald splitting parameter, α, the cut-oﬀ radius for the short-range
part of the sum, rc, the resolution of the FFT mesh, Ki, and the order of the interpolation scheme used to
interpolate the smooth portion of the sum onto the FFT mesh and back, p.
For a given cut-oﬀ radius and FFT mesh resolution, it is clear from Figure 2.3 that there is an α that
minimizes error. The trends in Figure B.4 has been captured for computationally similar simulations of
Deserno and Holm231, 232 and Sierou and Brady.241 Eﬀorts have been made to estimate contributions to the
error from either sums but they are mainly for structured homogeneous systems.242, 243
It is clear as the cut-oﬀ radius gets larger for the same FFT mesh resolution, better accuracy is achieved
with an optimum α that increases with rc. As the FFT mesh resolution is reﬁned, the error drops further
but the optimum α decreases with Ki, the size of the spectrum. This behavior of α is expected because
increasing it, increased the relative contribution of puts more weight on the short range portion of the sum
and visa versa. As the FFT mesh gets reﬁned the accuracy increases dramatically for a given rc. However,
it is evident that beyond a certain resolution of the FFT mesh, the gain in terms of accuracy becomes small
while reﬁning the FFT mesh resolution greatly impacts the cost of the algorithm.
In terms of the interpolation order, the error is bounded by (2∣ki∣/Ki)p 244 and thus behaves like K−pi .
Figure 2.4 shows that our solution follows this trend as the order of the B-spline changes within the algorithm.
From (2.24) and (2.25), the error in the short range and smooth terms of the Stokeslet can be computed
separately. By choosing appropriate variables the error plots collapse onto each other independent of the
selected parameters (Figures 2.5 and 2.6).
2.8.2 Model validation
In this chapter we have presented the details of the algorithm used in our simulations. Here we present two
sets of comparisons against empirical data in order to quantitatively validate our computational model. In
40
10−2 10−1 100 101
10−10
10−8
10−6
10−4
10−2
100
α

Figure 2.3: The eﬀect of α, rc (0.15 to 1.55 in 0.1
intervals from top to bottom within each color) and
the FFT mesh resolution (20: —, 40: —, 60: —, 100:
—, 160: —, and 200: —) on the total error.
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Figure 2.4: The eﬀect of the interpolation order p (2:
—, 4: —, 6: —, 8: — and 10: —) on the total error
as a function of the FFT mesh resolution Ki in all
directions.
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Figure 2.6: The eﬀect of the FFT mesh resolution (60:
—, 80: —, 100: —, 120: —, 140: — and 160: — in
all directions) and α (0.01 to 10) on the error of the
smooth portion of the sum.
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one case we measure the time it take a red blood cell to relax from a deformed state to its minimum energy
bi-concave shape and compare to experimental results.2, 3 And in another case we calculate the apparent
viscosity of blood as a function of the vessel diameter and hematocrit and compare the to empirical ﬁts.123
Red cell relaxation time
The membrane constitutive model as well as selected mechanical properties for the cells are validated by
comparing the relaxation time of a deformed red blood cell to experimental data of Bronkhorsta et al.2, 3
Bronkhorsta et al.2, 3 have measured the relaxation time of individual red blood cells which have initially
been deformed into a parachute shape using optical traps (Figure 2.7). The red cell relaxation half times
Figure 2.7: A time sequence of a red blood cell shape recovery.2 Reproduced with permission.
they observed in their experiments range from about 75 to over 2000 ms, however for young cells the average
relaxation half time is 162 ms and for old cells it is 353 with a total average of 271 ms.
Following the same procedure and starting from a deformed state (Figure 2.8a), we measure the angle
within the parachute shape (increasing as the cell relaxes) and plot its supplementary angle (decreasing as
the cell relaxes). For diﬀerent viscosity ratios (Figure 2.9a) as well as diﬀerent bending moduli (Figure 2.9b),
bending being the dominant mechanism for relaxation of the cell. The results are well within the experimental
observations bounds.
Blood apparent viscosity
The cell–cell interactions as well as wall–cell interactions lead to a cell-free layer near the vessel walls and
increased concentration of red cells around the axial region. This phenomenon is responsible for a blood
rheology in narrow tubes that is diﬀerent from the bulk blood properties. F˚ahræus and F˚ahræus-Lindqvist
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(a) t = 0 (b) t = 20 ms (c) t = 40 ms (d) t = 60 ms (e) t = 80 ms
(f) t = 100 ms (g) t = 120 ms (h) t = 140 ms (i) t = 200 ms (j) t = 450 ms
Figure 2.8: Relaxation of a cell in a quiescent ﬂow from a deformed shape to a biconcave shape.
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(a) Relaxation of a deformed cell with λ = 5.0, 6.0, 6.5, 7.0,
and 8.0. Black curves are the experimental upper and lower
bounds.
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(b) Relaxation of a deformed cell with EB = 1.35 × 10
−19,
2.69×10−19, 4.03×10−19, 5.38×10−19, and 6.73×10−19 Nm.
Black curves are the experimental upper and lower bounds.
Figure 2.9: Comparison of relaxation times for a deformed cell obtained by the present simulation model
and experimental values.2, 3
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eﬀects are two well-known phenomena that are a direct consequence of axial migration of red blood cells.
F˚ahræus245 observed that since the average cell velocity is larger than the average blood velocity, due to
concentration of cells around the axis of the tube, the hematocrit contained in a tube (tube hematocrit)
is smaller than the hematocrit entering or leaving it (discharge hematocrit). F˚ahræus and Lindqvist204
observed that the apparent or eﬀective viscosity of blood is not solely a material property of the blood but
rather a property of the blood-tube system. Apparent viscosity of blood depends on the tube diameter,
hematocrit and ﬂow velocity. Pries et al.5 gathered the results of 18 diﬀerent studies over a wide range of
tube diameters and came up with a empirical parametric description of apparent blood viscosity relative to
viscosity of plasma
ηvitro = μapparent
μplasma
= 1 + (η0.45 − 1) (1 −HD)C − 1(1 − 0.45)C − 1 , (2.37)
where
η0.45 = 220 exp(−1.3D) + 3.2 − 2.44 exp(−0.06D0.645), (2.38)
is the relative apparent viscosity for a discharge hematocrit of 45% and
C = [0.8 + exp(−0.075D)](−1 + 1
1 + 10−11D12 ) + 11 + 10−11D12 . (2.39)
Since here we mostly deal with the tube hematocrit rather than the discharge hematocrit, we will be using
the empirical relation4
HT
HD
=HD + (1 −HD) [1 + 1.7 exp(−0.415D) − 0.6 exp(−0.011D)] , (2.40)
to relate the two. The relative apparent viscosity for diﬀerent tube diameters and tube hematocrits is
presented are Figure 2.8.2. To further validate the numerical model we examined blood ﬂow with diﬀerent
tube hematocrits through two vessel diameters. The relative apparent viscosities for diﬀerent cases presented
in Table 2.1 are plotted as symbols in Figure 2.8.2. These results are well within the residual error of the
actual experimental data compared to the empirical relations presented above.123
Table 2.1: Comparison of apparent viscosity obtained from simulations to experiments.
D (μm) HT (%) nc μa/μ0 from (2.37) μa/μ0 from simulation  (%)
10 20 4 1.18 1.30 10
10 30 6 1.30 1.43 10
10 40 8 1.45 1.58 9
20 10 13 1.02 1.14 11
20 20 26 1.31 1.18 10
20 30 39 1.51 1.44 5
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Figure 2.10: Relative apparent viscosity (μa/μ0 where μ0 is the plasma viscosity) as a function of tube
diameter and tube hematocrit (denoted on each curve). Solid curves are the empirical ﬁt4, 5 and the symbols
are the corresponding results from our simulations.
More validations of the method for axisymmetric ﬂow of red cells and apparent viscosity of blood as a
function of vessel diameter are available in Zhao et al.136 Freund and Orescanin13 study the cellular ﬂow in
small blood vessel using the methods presented above and present their results with detailed discussions.
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Chapter 3
Simulation Setup
This chapter discusses the basic design of the simulations, with results to be presented in Chapter 4. The
goal is to study the geometric as well as ﬂow factors that aﬀect forces on wall-adhered leukocytes. The
general simulation setup used for this is presented in Figure 3.1. The mean pressure gradient ⟨−∂p/∂z⟩,
drives the ﬂow in the positive z-direction. The average velocity with this model vessel is denoted by ⟨Uz⟩t.
The tube and sphere diameters are Dt and Ds, respectively. The periodic length of the tube is Lz. The
minimum separation distance136 between the red cells and the walls is δ, and θ is the contact angle between
the leukocyte and the cylindrical tube.
Figure 3.1: Simulation conﬁguration.
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3.1 Model leukocyte
Since the leukocyte is assumed to be rigid and stationary, it is represented as part of the no-slip surfaces in
the simulation, with the formulation discussed in Section 2.1. Like the vessel wall, it is then meshed with
triangular surface elements. These elements are more ﬁnely spaced on the leukocyte and coarser on the
cylindrical walls with a gradual transition toward the contact line between them (Figure 3.2). The traction
on the surface of the wall-bound leukocyte, presented in Chapter 4, are calculated on these surface elements
using second-order accurate linear boundary elements built upon seven-point Gauss quadratures136, 200 as was
discussed in Section 2.3. This is implemented in a collocation scheme, where the residuals of (2.9) at the mesh
points on the no-slip surfaces are constrained to zero. For all the cases presented in Chapter 4, the maximum
wall residual velocity is reduced to less than O(10−4) of the magnitude of the average volumetric velocity
20 GMRES iterations in most cases and up to 50 GMRES iterations for more constrained vessel/leukocyte
geometries.
(a) Perspective view. (b) Bottom view.
Figure 3.2: Combined leukocyte and wall mesh.
3.2 Flow conditions
3.2.1 Pressure-gradient/velocity relation
For the simulation results in Chapter 4, both constant pressure gradient as well as constant volumetric ﬂow
rate are considered. However, in the boundary integral formulation we employ (2.6), it is most natural to
impose the average velocity ⟨U⟩ in the whole periodic domain (see Figure 2.1). The concomitant pressure
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gradient is then computed from the losses due to the presence of the wall, but is not steady unless the box
averaged ﬂow rate, ⟨Q⟩, is adjusted to maintain it. Because the precise rheology of blood is not known
a priori and depends upon the instantaneous conﬁguration of the cells, it is not possible to anticipate the
pressure gradient that corresponds to any particular ⟨U⟩. Therefore, to achieve the desired constant pressure
gradient, a feedback system is used to continually adjust ⟨U⟩ as the simulation evolves. To demonstrate
the functionality of this feedback system, a sample case of Figure 3.3 is considered. Figure 3.4 shows the
mean pressure gradient and its error relative to the target value as the simulation evolves. This pressure
gradient results in a ⟨Uz⟩ in the periodic domain and ⟨Uz⟩t inside the tube. In Chapter 4 we discuss the
forces exerted on a wall-bound leukocyte by the ﬂowing red cells for cases where the mean pressure gradient
along the tube is kept constant.
Figure 3.3: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=6 (HT = 25.38%).
It is also possible to maintain a precise mean ﬂow rate in the vessel by appropriately adjusting ⟨U⟩. This
requires that a relationship between the pressure gradient and the tube velocity be determined. To ﬁnd this
correlation, Zhao et al.136 use an approximate, but suﬃciently accurate, series246 solution for the ﬂow rate
in the box but outside the tube. The external volume ﬂow rate is then given by
Qexternal = L4x
4πμ
⟨∂p
∂z
⟩ (lnχ−1 − 1.47644+ 2χ − 0.5χ2 − 0.0509713χ4 + 0.077465χ8
−0.109757χ12 + 0.122794χ16 − 0.146135χ20 + 0.244536χ24) +O(χ28), (3.1)
where χ = πD2t /4L2x is the volume fraction of the cylindrical tube in the whole computational domain. For
the simulations presented in Chapter 4, a Dt/Lz ratio of 0.8 is chosen. This leads to a value of 0.5 for χ
which makes (3.1) accurate to approximately 1 part in 109. The cross section of the domain is square with
length Lx, so the ﬂow rate inside the tube is then Qt = L2x ⟨Uz⟩−Qexternal, where ⟨Uz⟩ is the axial component
of the average velocity in the periodic domain.
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Figure 3.4: Flow conditions for a constant mean pressure gradient of 0.34043 (Pa/μm) λ = 1 and λ = 5 ;
Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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Equation (3.1) provides the needed link between ⟨Uz⟩ and the pressure gradient since it linearly relates
the pressure gradient to the average velocity outside the tube
∂p
∂z
∝ ⟨Uz⟩external . (3.2)
For each geometry presented in Chapter 4, a numerical experiment gives us the constant that relates the
pressure and the external average velocity and the same feedback system discussed above for ﬁxing pressure
gradient can be applied for velocity.
3.2.2 Average tube velocity
The numerical experiment is performed as follows. For any of the conﬁgurations we discuss in Chapter 4,
an average velocity for the whole domain is set and one simulation without any red cells is run. This
homogeneous ﬂow results in a constant pressure gradient. The velocity ﬁeld inside the tube is then calculated
from (2.6) on a suﬃciently ﬁne mesh to provide the average velocity inside the tube for any particular
conﬁguration (e.g., Figure 3.5). The typical cylindrical meshes used for this purpose had a resolution of
282 × 47 × 282 nm in radial, angular, and axial directions, respectively.
Figure 3.5: Velocity ﬁeld for a homogeneous Newtonian ﬂuid.
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Based on the dimensions of a square Lx = Ly domain and the round Dt tube we have
⟨Uz⟩L2x = ⟨Uz⟩t (πD2t /4) + ⟨Uz⟩external (L2x − πD2t /4), (3.3)
from which ⟨Uz⟩external is obtained. Knowing the pressure gradient and the external average velocity for this
experiment gives us the proportionality constant between the two. This constant is then used in the code
to adjust for the domain velocity so that the tube average velocity stays constant. The time histories of
the tube average velocity for most of the cases presented in Chapter 4 show small ﬂuctuations of less than
1% about the desired value using this feedback technique. For the largest tube velocity considered (1.41
mm/s) the mean pressure gradient, average domain velocity, average tube velocity and its error relative to
the target value are plotted in Figure 3.7 for the geometry shown in Figure 3.6
Figure 3.6: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=6 (HT = 25.38%).
3.3 Forces for a homogeneous blood model
To provide a point of comparison for the forces exerted on the wall-bound leukocyte for each geometry, we
also compute them for a homogeneous Newtonian blood model. The traction on the surface of the leukocyte
are obtained directly from the red-cell-free model of the previous section (Figure 3.8). Due to linearity of the
system, the forces from plasma, with a viscosity of 1.2 × 10−3 kgm−1s−1,240 are then scaled for the relevant
apparent viscosity for the higher hematocrit cases.123 Speciﬁc cases and values for these forces will be used
for comparison in Section 4.3.
Here and in Chapter 4 we denote the traction vector on the surface of the leukocyte by σ. Then, the
components of σ in lateral, vertical, and axial directions are σx, σy, and σz respectively. Figure 3.8 shows
that the lateral component of the surface tractions are symmetric with respect to the y − z and x − y mid-
planes of the sphere. Therefore, there is no net lateral force on the sphere. Similarly, in the vertical direction,
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Figure 3.7: Flow conditions for a constant average vessel velocity of 1.41 mm/s λ = 1 and λ = 5 ; Dt =
11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
(a) σx (b) σy (c) σz
Figure 3.8: Traction contours for a homogeneous Newtonian-ﬂuid model of the blood.
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the tractions are symmetric with respect to the x − z and x − y mid-planes and therefore, no net vertical
force. The only asymmetric component of the surface tractions is in the axial direction of the ﬂow. The
integral of these tractions results in drag on the wall-bound leukocyte.
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Chapter 4
Results
As summarized in Chapter 1, there are multiple studies that investigate the forces on a wall-bound leukocyte
experimentally and computationally. However, the eﬀects of interactions with realistically ﬂexible red cells
have not been taken to account. This is the subject of this chapter. Speciﬁcally, we compare the forces
experienced by the leukocyte in the presence of the red cells with homogeneous models of blood. For
the homogeneous model, we consider pure plasma and a Newtonian-ﬂuid blood model with its apparent
viscosity.123 For the red blood cells, we consider both the computationally convenient λ = 1, where the
viscosity inside and outside of the red cells is assumed to be the same, as well as the more realistic λ = 5.116
The factors that are expected to have an inﬂuence on the forces that the leukocyte experiences can be
categorized as geometrical, mechanical, physiological, and modeling. The geometrical parameters include the
leukocyte to tube diameter ratio, the periodic length of the tube which in turn changes the distance between
the periodic images of the leukocytes, and the contact angle between the leukocyte and the cylindrical tube
wall. Another nondimensional relation is the ratio of the red blood cell size to the wall-adhered cell. We
consider ratios that do not correspond to leukocytes as a possible model for larger cancer cells that might
be detached by ﬂow and cause metastasis.
The key ﬂuid mechanical factor is the mechanism by which the ﬂow is driven. For most of the cases studied
here the volume ﬂow rate inside the tube is kept constant, which provides a fundamental condition but does
not exactly correspond to any speciﬁc physiological conditions. An advantage of velocity speciﬁcation is
that it avoids decrease in tube velocity due to blockage of the tube by the leukocyte. Neglecting eﬀects of
the rest of the network, we therefore also consider constant pressure gradient cases for comparison.
In terms of physiology, tube hematocrit determines the number of red cells that will be interacting with
the leukocyte and the mechanical properties of the red cells contribute to the amount of force they apply
on the leukocyte. As discussed in Chapter 1, microcirculatory hematocrits are smaller than the systemic
hematocrit of blood which is about 45%, and we consider examples from within this range. We can also
anticipate that a single red cell interaction with the leukocyte can represent the range of behaviors at the
low end of the hematocrit range and in small capillaries where the red cells ﬂow in a single ﬁle regardless of
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hematocrit.123
There are numerical parameters like the ones discussed in Section 2.8.1 that aﬀect the accuracy of the
solution obtained by the solver. A group of these parameters are shared between the simulations but another
set, like the red cell surface mesh resolution and the wall mesh, are chosen on a per case basis. There are
also modeling factors introduced for the chosen constitutive model of the red blood cells that were discussed
in Section 2.2 and set in Section 2.8 based upon the known physiological properties of red cells which will be
tested in this chapter. Another modeling parameter is the minimum separation distance that is kinematically
enforced in order to keep the cells from penetrating each other as well as the no-slip surfaces as discussed in
Section 2.6; its eﬀect will be studied here.
Simulations presented in this chapter are computationally intensive. The largest, the 20-cell ﬂow in the
D = 6.0 vessel, required about two months of runtime on 16 processor cores of a cluster node. Unfortunately,
the parallelization of the code in its current form does now scale well beyond 16 or 32 cores. This is because
of the fact that in order to maintain an 8th-order interpolation scheme for the smooth part of the Ewald sum,
there needed to be 98 FFT mesh point or more per decomposed portion of the domain in the direction of the
ﬂow. Therefore, increasing the number of processors in turn requires increasing the FFT mesh resolution.
The largest part of the computational cost is from the numerical integration of the singular part of the
Green’s function. This cost, in turn, is mostly due to the interpolation of function values from the global
cell surface mesh to the local polar coordinate patch.
4.1 Reference cases
4.1.1 Setup
In order to study the forces on a wall-bound leukocyte in the presence of red blood cells, we consider two
reference conﬁgurations shown in Figure 4.1. The diﬀerence between the two cases is that one system is a
low-cell-density numerical experiment with a single red blood cell (HT = 4.23%) passing the vessel-bound
leukocyte, and the other has a tube hematocrit of 25.38%, which is typical of the microcirculation.8, 9 The
single-cell conﬁguration is representative of small capillaries where the red cells ﬂow in a single ﬁle, regardless
of hematocrit.123 The single-cell case will serve as a baseline case for extensive studies of single-red-cell cases.
In order to obtain more controlled results for the single-red-cell case, it is released on the center of the tube
laterally. Similarly, high hematocrit cases with HT = 25% are compared with the reference case with HT =
25%. The cells are initiated randomly for there high hematocrit conditions. In this section, we present details
for these two reference cases; in the next section the trends for each geometrical, mechanical, physiological
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and numerical parameter is presented as parameters are varied from these baseline conﬁgurations.
(a) 1 red cell, HT = 4.23%.
(b) 6 red cells, HT = 25.38%
Figure 4.1: Reference conﬁgurations; Tube diameter Dt = 11.28 μm, leukocyte diameter Ds = 8.46 μm, tube
periodic length Lz = 25.38 μm (see Figure 3.1 for deﬁnitions of these and additional parameters).
4.1.2 Geometry
Based upon the physiological ranges of dimensions and ﬂow conditions discussed in Section 1.3 and the non-
dimensionalization presented in Section 2.8, we selected a non-dimensional tube diameter of 4 and leukocyte
diameter of 3 for the reference cases. These values correspond to Dt = 11.28 μm and Ds = 8.46 μm, which
are within the physiological range for capillaries and neutrophils.
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The periodic length of the tube is chosen to be 3.0Ds, therefore there is a 2Ds distance between the leuko-
cyte and its periodic image. In their experimental model, Chapman and Cokelet7 show that for leukocyte-
to-tube diameter ratios of 0.1 to 0.85, the leukocyte disturbs the ﬂow ﬁeld around it within up to 1.5Dt for
their largest Ds/Dt ratio of 0.85. Representing this length in Ds yields 1.76Ds, which is less than 2.0Ds
between the leukocyte and its periodic image here. The eﬀect of the periodic length of the tube on the
leukocyte forces will be discussed in more details in the next section.
As expected, previous studies109, 132 have shown that how far the leukocyte extends across the tube seems
to have a signiﬁcant eﬀect on the forces that it experiences. Keeping the volume of the leukocyte constant,
the leukocyte extends into the ﬂow most when its contact angle with the vessel wall is zero. We use a fully
exposed spherical leukocyte model for both reference conﬁgurations (Figure 4.1).
4.1.3 Discretization
For the wall geometry, a total of 12735 triangular surface elements are used, 6588 of which are on the tube
and 6147 on the wall-bound leukocyte. As mentioned in Section 3.1, the mesh resolution on the leukocyte
(triangular elements of side 282 nm) is twice the one on the tube (triangular elements of side 564 nm). The
maximum wall residual velocity in (2.9) is driven down to values of O(10−4) with up to 20 GMRES iterations
for all the cases in this chapter. The forces on the wall-bound cell are insensitive to the wall mesh resolution
for ﬁner surface meshes.
The red cells are represented by a surface mesh as discussed in Sections 2.2 and 2.5. For the reference cases
here, we choose N = 24 beyond which, the surface features of the cell visually remain the same. Numerical
experiments of stability suggest that a de-aliasing factor of three is suﬃcient for the conﬁgurations in this
study. Therefore, the surface mesh resolution is M × 2M = 3N × 6N , where M denotes the larger mesh and
N the main mesh (see Section 2.5). We will show in Section 4.3 that for more constrained cases, where the
cell has to deform more to squeeze through the gap between the leukocyte and the vessel wall, a larger N
and de-aliasing factor are needed. On the other hand, when the cell does not have to deform substantially
to go through the gap, simulations are performed with coarser surface meshes. For the single cell cases, the
bi-concave cell is initialized on the centerline of the tube. For the high hematocrit cases the bi-concave cells
are randomly distributed throughout the length of the tube.
4.1.4 Flow conditions
For the reference cases here, volumetric ﬂow rate is kept constant by the feedback control procedure discussed
in Section 3.2. The reference ﬂow rate is Q = 28181 μm3/s, which corresponds to an average (over the
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cross section of the tube) tube velocity of ⟨Uz⟩t = 282 μm/s for this tube diameter. This tube velocity is
particularly physiologically relevant in the microcirculation (see Section 1.3.3). It results in a pseudo-shear
rate of ⟨Uz⟩t /Dt = 25.0 s−1 as has been reported.10, 123
Figures 4.2 and 4.3 show the eﬀectiveness of the feedback control procedure that keeps the average tube
velocity approximately constant. By increasing the pressure gradient when the red cells are passing through
the gap above the leukocyte, ﬂuctuations in the ﬂow rate are limited to less than 1% of the target ﬂow rate.
When λ = 5, a larger increase in pressure is needed to approximately maintain ﬂow rate. When HT = 25%
(Figure 4.3), the pressure gradient is higher overall relative to the single red cell case and that is because
of the larger apparent viscosity of the blood ﬂow at this hematocrit. The more frequent ﬂuctuations of the
pressure gradient and therefore, tube velocity, in the case of HT = 25%, is a result of the six red cells in
this system compared to one for Figure 4.2; every time a red cell passes through the narrow space between
the leukocyte and the vessel wall, the pressure gradient needs to adjust. The feedback process, designed to
keep the ﬂow rate constant, results in a tube velocity which is within 1% of the target value for the single
red cell case and within 2% for the high hematocrit case. This is deemed acceptable because we do not
anticipate that any of the results will be strongly sensitive to small variations in the ﬂow rate. Reducing
this variation would require a stiﬀer feedback mechanism to control the pressure gradient which in turn may
lead to smaller time steps for stability.
4.1.5 Red cell mechanics
The mechanical properties of the red cells are the ones presented in Section 2.8 following Pozrikidis.213 The
eﬀects of the shear and bending moduli on the forces exerted on the wall-bound leukocyte will be investigated
in Section 4.3. The surface dilatation modulus used here leads to area changes of up to 10% for the single
cell case and 15% for the HT = 25% case. A stiﬀer dilatation modulus will reduce this change in the cell
area but in turn will reduce the time step. Freund and Orescanin13 observe area changes of up to 6% for
the ﬂow of red cells in a small vessel in the absence of any obstacles. This is shown in Figures 4.7 and 4.8.
Finite numerical accuracy of the model leads to accumulation of changes in cell volume (Figures 4.4(a)
and 4.5). Using the technique mentioned in Section 2.7, the changes in volume of the cells are conﬁned
to thousandths of a percent (Figure 4.4(b) and 4.6). The resulting forces are insensitive to the application
of this constraint, however, using it maintains the target volume of the cells for long simulations. This
constraint is in place for the reference cases discussed here as well as all the other cases in Section 4.3.
The minimum separation distance δ (see Figure 3.1) between red cells with each other, the ﬁxed model
leukocyte, and the vessel wall is taken to be 2% of a∗ = 2.82 μm, the equivalent cell spherical radius (see
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Section 2.8) for the present reference cases (see Section 2.6). Zhao et al.136 show that the pressure drop in a
round tube changes by less than 2% by doubling and halving this distance. Freund and Orescanin13 argue
that at these scales, molecular interactions become important and therefore, resolving closer separations
does not necessarily improve the physical realism of the model. For the case of a wall-bound leukocyte, the
microvilli are 300 to 700 nm on the cells side and the glycocalyx layer is 50 to 500 nm on the endothelium side.
We will investigate the inﬂuence of this numerical parameter on the forces that the leukocyte experiences in
Section 4.3.
4.1.6 Forces on the wall-bound leukocyte
Components of the traction on the surface of the wall-bound leukocyte are presented in Figure 4.9 for the
single red cell and in Figure 4.10 for the HT = 25% cases. As plotted, the solid lines are the time histories of
the average as well as maximum tractions on the mesh points on the surface of the wall-adhered leukocyte.
The dashed lines, on the other hand, are two homogeneous ﬂuid cases: plasma and an apparent-viscosity-
homogenized blood model. The apparent viscosity of the latter case is from measurements that are ﬁtted
versus tube diameter and hematocrit.123
The surface averaged traction is deﬁned as
⟨σi⟩ = 1
As
∫
As
σids, (4.1)
where As is the surface of the wall-bound leukocyte. In Stokes ﬂow when red cells are not present, the net
forces on the sphere in the lateral and vertical directions (Figure 3.8) are zero because of the symmetry of
the geometry. Therefore, one fundamental diﬀerence between the homogeneous cases and when the cells are
present is the fact that the net forces on the leukocyte in the x and y directions are non-zero in the presence
of red blood cells. This is clear from Figures 4.9(b), 4.10(a) and 4.10(b).
Figure 4.9(a) shows a zero average traction in the x direction because we intentionally initiate the single
red cell at the center plane of the tube to eliminate the less important lateral complexity of the single cell
cases. The maximum tractions in the x direction are within the homogeneous bounds for the single cell case
when λ = 1 and up to 15% larger for λ = 5. In the HT = 25% case, the net force in the lateral x direction
is both positive and negative depending on from which side of the leukocyte the red cell is passing. The
magnitude of these net tractions are between −0.4 to 0.32 Pa which results in a lateral force of −89.9 to 47.2
pN. When HT = 25%, these maximum forces are larger than the homogeneous limit by up to 68% for λ = 1
and 87% for λ = 5.
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For both cases there is a net force toward the wall caused by the cells interacting with the leukocyte,
which can be anticipated to stabilize adhesion. These downward directed tractions for the single red cell
rise to 0.68 to 0.8 Pa, which translate to wall-ward force of 152.9 to 179.9 pN for λ = 1 and 0.88 to 0.95
Pa or 197.9 to 213.6 pN for λ = 5. For HT = 25%, these values are between 0.7 to 1.1 Pa or 157.4 to 247.3
pN for λ = 1 and 0.72 to 1.15 Pa or 161.9 to 258.6 pN for λ = 5. In terms of the maximum tractions in the
vertical direction, for the single cell case, these values are both negative (pushing the leukocyte toward the
vessel wall) and positive (pulling the leukocyte away from the tube). The upward force corresponds to the
red cell ﬂowing out of the region above the leukocyte. For the single cell case, these maximum tractions for
λ = 1 are up to 2.68 and 2.15 times the maximum tractions from plasma during the negative and positive
lift exertions, respectively. When λ = 5 these enhancements are at most 3.71 and 2.03 times larger than
the apparent-viscosity-homogenized model during the negative and positive lift exertions, respectively. For
HT = 25%, the maximum tractions are all in the form of negative lift on the leukocyte. The enhancement
in these maximum tractions are on average 2.58 and at most 5.13 times the ones from plasma when λ = 1
and on average 2.88 and at most 5.48 times the ones from the apparent-viscosity-homogenized model when
λ = 5.
The largest component of the tractions on the surface of the leukocyte is in the axial direction. Previous
studies estimate that under the wall shear stress of 0.2 to 2.5 Pa the drag force is going to be on the order
of 100 to 13000 pN for a homogeneous model of blood.109 In another in vitro study with a homogeneous
model of blood the drag is estimated at 40 to 250 pN at wall shears of 0.48 to 2.88 Pa for vessel diameters of
29 to 47 μm and zero hematocrit.104 In the same study, when erythrocytes are simulated by gelatin pellets,
drag force increases to 2340 pN for a hematocrit of 40%.104 In vivo, drag forces of 110 to 7610 pN have been
calculated at wall shears of 0.2 to 2.5 Pa for venule diameters of 23 to 49 μm.131
The axial tractions in Figures 4.9(c) and 4.10(c) show signiﬁcant increases both in a surface averaged
sense as well as point-wise local maximums. Drag on the leukocyte in geometries of our two reference cases is
79.1 pN, from plasma, and 100.1 pN, from a homogeneous blood with an apparent viscosity of 1.27 (obtained
from empirical relations with tube diameter and hematocrit123) for HT = 25% at this tube diameter. The
relative increase in these tractions with respect to the two homogeneous models discussed above are plotted
in Figures 4.9(d) and 4.10(d) for the single cell and HT = 25% cases, respectively. This relative increase is
calculated as follows
σ = (σ − σhomogeneous)
σhomogeneous
× 100. (4.2)
The shapes of the time histories of the axial traction are similar to the time histories presented in Migliorini
et al.,11 with two consecutive peaks per red cell pass. One peak corresponds to the cell entering the gap
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and pushing the leukocyte in the direction of ﬂow and the other is due to the red cell leaving the surface
of the leukocyte and therefore, pulling it in the direction of the ﬂow. These ﬁgures show an increase in the
average tractions in the axial direction of up to 29% for the single red cell and 53% for HT = 25% relative
to plasma and when λ = 1. Similarly, when λ = 5 and relative to the apparent-viscosity-homogenized blood,
these ampliﬁcations are up to 47% for both the single red cell and HT = 25% cases. In terms of the maximum
tractions, the increases relative to homogeneous models are up to 109% and 254% for λ = 1 and relative to
plasma and up to 112% and 160% for λ = 5 relative to a blood model that has been homogenized by its
apparent viscosity.
The increase in the tractions on the wall-bound leukocyte is due to the particulate character of blood.
Clearly a homogeneous model of blood, even if the viscosity is elevated to that of blood rather than plasma,
will miss key features of the forces on the leukocytes. In Section 4.3, we discuss diﬀerent parameters and
investigate in particular when a homogeneous model becomes accurate for diﬀerent predictions.
For ﬁve of the peaks of the streamwise average tractions in Figure 4.9(c), the location of the red cell over
the wall-bound leukocyte is presented in Figure 4.11. Since the magnitude of the average tractions in the
axial direction is much larger than the ones in the x and y direction, we focus only of the z component. It is
clear that the drag is maximized when the red cell is entering the gap and therefore, pushing the leukocyte
int the direction of the ﬂow. Remarkably, the maximum corresponds to, more or less, the same shape and
location of the red cell for λ = 1 and λ = 5. However, the shapes for matched and mismatched viscosity are
diﬀerent. This presentation is repeated in Figure 4.12 for the HT = 25% case, for ﬁve of the peaks of the
average tractions in the z direction. Again, the positions of the red cells are similar within each of the λ = 1
and λ = 5 ranges but only slightly diﬀerent between the two. For the high hematocrit case, there is always
a cell entering the gap, which is pushing the leukocyte in the direction of the ﬂow, and another cell leaving
the gap, which is drawing the leukocyte in the direction of the ﬂow.
The maximum components of traction presented in Figures 4.9(a)-4.9(c) and 4.10(a)-4.10(c) happen at
diﬀerent locations on the leukocyte for each directional component. If the magnitude of the traction vectors
is tracked in time, and then frozen when the maximum of this magnitude force ﬁeld peaks in time, the
position of red cells and the location of the maximum of the magnitude of these point-wise tractions on the
surface of the leukocyte, when this maximum is at its peak in time, is shown in Figure 4.13 for the single
cell case. For λ = 1, the maximum magnitude occurs when the red cell is leaving the leukocyte, and the
location of the magnitude is on the downstream side of the leukocyte. However, when λ = 5, this happens
earlier, when the red cell is directly over the leukocyte and the peak force is also atop the leukocyte. This is
also the case for HT = 25% (Figure 4.13). The reason for this behavior can be explained from Figures 4.11
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and 4.12. When σz is maximum for λ = 1, the red cell trailing edge is still extended, wrapping around the
leukocyte: it is more drawn out in the streamwise direction. This leaves more room for the passage of the
red cell, and therefore, the bottom side of the red cell is not forced as close to the surface of the leukocyte as
compared to the λ = 5 case. For larger λ, the red cell passes more slowly through the gap, which leads to the
formation of a thinner lubrication-like layer between it and the leukocyte as plasma is slowly displaced out
of it. The thinner this layer, the more stress is exerted by the red cell. The maximum pull, corresponding
to Figures 4.13 and 4.14 happens when the closest section of the red cell to the leukocyte is leaving the
surface.
The next ﬁve ﬁgures (4.15-4.23 for single red cell and 4.16-4.24 for HT = 25%) for each reference case
show a typical ﬂow-by of the red cell(s) when λ = 5. Figures 4.15 and 4.16 show the conﬁguration of the red
cells as they ﬂow by one complete tube length. The cells in the HT = 25% are colored by diﬀerent shades,
so they can be tracked easier. Figures 4.17-4.21 and 4.18-4.22 show the traction contours for each of the
three components for the same ﬂow-by. And ﬁnally, Figures 4.23 and 4.23 shows the time history of these
tractions similar to Figures 4.9 and 4.10, but only for one ﬂow-by.
4.1.7 Further observations
Time averaged local hematocrit contours, deﬁned as a time average of points inside the cells, are presented
in Figures 4.25 and 4.26 for the single red cells and HT = 25%, respectively. The three-dimensional cross
sections are useful because they show the distribution of the local hematocrit in the lateral direction. These
distributions suggest that the single cell spends 23% of the length of the simulation time in the low velocity
regions of the inlet/exit of the tube as well as immediately downstream from the gap as it leaves the leukocyte.
In the case of HT = 25%, the cells are up to 91% of the duration of the simulation present in the gap between
the leukocyte and the vessel wall for λ = 1 but the cell distribution over time is relatively uniform when λ = 5.
In both cases, there is clearly a cell-free layer near the vessel walls as well as the surface of the leukocyte.
As mentioned above, the single cell reference case was set up with the red cell on the plane of symmetry
of the tube with respect to the lateral direction so it would be expected to maintain symmetry in ±x and
its centroid would pass repeatedly over the centroid of the leukocyte. Figure 4.27 shows the trace of the
centroid of the red cell for its eleventh ﬂow-by in the simulation. It is clear that the cell remains at least
close to the symmetry plane, though it is slowing deviating from it. The details of the location of this cell
are shown in Figure 4.29, where we see that the centroid of the cell is moving to the side of the leukocyte
with each passing. Figure 4.29(b) shows that the cell is moving up and down as it passes the leukocyte and
it stays above the centerline for the entire simulation time. From Figure 4.29(c), the cell moves along the
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tube with approximately constant velocity even when λ is switched from 1 to 5. This is due to a higher
pressure response that in turn keeps the velocity constant (see Figure 4.2). Finally, Figure 4.29(d) shows
that the cell stays away from the tube walls by a distance of at least 400 nm. However, at times, it comes
as close as the minimum separation distance δ to the surface of the wall-bound leukocyte.
The location history of the 6 cells in the HT = 25% case, on the other hand, ﬂow asymmetrically around
the leukocyte in the x direction (Figure 4.30). Just like the single cell case, all the cells stay above the
centerline of the tube and move up and down as they clear the leukocyte (Figure 4.30). The cells all
move at the same constant speed along the tube and their speed stays constant for both λ = 1 and λ = 5.
Figure 4.29(d) shows that the cells are well outside the 56 nm minimum separation distance when interacting
with the cylindrical tube walls but occasionally, they come as close as the minimum separation distance δ
when interacting with the surface of the leukocyte.
4.2 A validation of forces from high hematocrit system of cells
Chapman and Cokelet108 present experimental results for a case with red cells (modeled by rubber discs),
which can be compared closely to one of the conﬁgurations presented in the next section. In this case Ds =
8.46 and Dt = 16.82 and therefore, Ds/Dt = 0.5. Based on their experiments for this Ds/Dt ratio and 40%
hematocrit, they obtain a drag force equal to 178.1 pN for an average tube velocity of ⟨Uz⟩t = 125.21 μm/s.
For the same geometry but with HT = 25%, our time-averaged surface-averaged axial traction, ⟨σz⟩, is 0.54
Pa from simulations. This yields
D = 121.2 pN, (4.3)
which is 32% lower than the experimental value. However, the experiments were performed at HT = 40%
which corresponds to an apparent viscosity that is 20% higher than the one at HT = 25%.123 Also, as we will
see in Section 4.3, stiﬀer model cells (in the case of the experiment) exert larger forces on the wall-bound
cell.
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(a) Mean pressure gradient along the tube.
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Figure 4.2: Flow conditions for a constant ﬂow rate of 28182 μm3/s for λ = 1 and λ = 5 ; Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 1 (HT = 4.23%).
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(a) Mean pressure gradient along the tube.
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(b) Average tube velocity; black line corresponds to the target
velocity of 282 μm/s.
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Figure 4.3: Flow conditions for a constant ﬂow rate of 28182 μm3/s for λ = 1 and λ = 5 ; Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC=6 (HT = 25.38%).
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Figure 4.4: Red cell volume change over the length of the simulation for λ = 1 and λ = 5 ; Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 1 (HT = 4.23%).
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Figure 4.5: Red cell volume change over the length of the simulation for λ = 1 and λ = 5 ; Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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(a) Cell 1 volume error: constrained.
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(b) Cell 2 volume error: constrained.
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(c) Cell 3 volume error: constrained.
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(d) Cell 4 volume error: constrained.
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(e) Cell 5 volume error: constrained.
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(f) Cell 6 volume error: constrained.
Figure 4.6: Red cell volume change after the volume constraint is applied over the length of the simulation
for λ = 1 and λ = 5 ; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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Figure 4.7: Red cell area change over the length of the simulation for λ = 1 and λ = 5 ; Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 1 (HT = 4.23%).
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Figure 4.8: Red cell area change over the length of the simulation for λ = 1 and λ = 5 ; Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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Figure 4.9: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 1 (HT = 4.23%). Time histories of
components of surface averaged tractions ⟨σ⟩ deﬁned by (4.1) for λ = 1 and λ = 5 and maximum tractions
σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the λ = 1 range and
apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to homogeneous is
presented in (d).
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Figure 4.10: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%). Time histories of
components of surface averaged tractions ⟨σ⟩ deﬁned by (4.1) for λ = 1 and λ = 5 and maximum tractions
σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the λ = 1 range and
apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to homogeneous is
presented in (d).
71
(a) t = 72.70 ms (b) t = 361.4 ms
(c) t = 120.8 ms (d) t = 409.3 ms
(e) t = 168.5 ms (f) t = 457.2 ms
(g) t = 216.2 ms (h) t = 505.3 ms
(i) t = 263.8 ms (j) t = 553.4 ms
Figure 4.11: Instances of maximum ⟨σz⟩, left column corresponds to λ = 1 and right to λ = 5; Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 1 (HT = 4.23%).
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(a) t = 309.2 ms (b) t = 571.3 ms
(c) t = 366.2 ms (d) t = 628.4 ms
(e) t = 402.2 ms (f) t = 694.0 ms
(g) t = 431.4 ms (h) t = 750.9 ms
(i) t = 467.0 ms (j) t = 807.5 ms
Figure 4.12: Instances of maximum ⟨σz⟩, left column corresponds to λ = 1 and right to λ = 5; Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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(a) t = 86.0 ms (b) t = 364.8 ms
(c) t = 134.2 ms (d) t = 412.6 ms
(e) t = 180.3 ms (f) t = 460.5 ms
(g) t = 229.7 ms (h) t = 508.6 ms
(i) t = 277.3 ms (j) t = 556.7 ms
Figure 4.13: Contours of σmax when it achieves its maximum local value, left column corresponds to λ = 1
where ∣σ∣max ∈ [0.0,13.19] and right to λ = 5 where ∣σ∣max ∈ [0.0,12.27]; Dt = 11.28 μm, Ds = 8.46 μm,
Lz = 25.38 μm and nRBC = 1 (HT = 4.23%).
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(a) t = 315.5 ms (b) t = 501.6 ms
(c) t = 353.6 ms (d) t = 527.9 ms
(e) t = 382.4 ms (f) t = 584.6 ms
(g) t = 408.1 ms (h) t = 640.5 ms
(i) t = 438.4 ms (j) t = 696.2 ms
Figure 4.14: Contours of σmax when it achieves its maximum local value, left column corresponds to λ = 1
where ∣σ∣max ∈ [0.0,21.94] and right to λ = 5 where ∣σ∣max ∈ [0.0,29.78]; Dt = 11.28 μm, Ds = 8.46 μm,
Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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(a) t = 531.4 ms (b) Δt = +5 ms
(c) Δt = +5 ms (d) Δt = +5 ms
(e) Δt = +5 ms (f) Δt = +5 ms
(g) Δt = +5 ms (h) Δt = +5 ms
(i) Δt = +5 ms (j) Δt = +5 ms
Figure 4.15: A ﬂow-by of the red cell when λ = 5 (side view: ﬂow is from left to right); Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 1 (HT = 4.23%).
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(a) t = 700.0 ms (b) Δt = +5 ms
(c) Δt = +5 ms (d) Δt = +5 ms
(e) Δt = +5 ms (f) Δt = +5 ms
(g) Δt = +5 ms (h) Δt = +5 ms
(i) Δt = +5 ms (j) Δt = +5 ms
Figure 4.16: A ﬂow-by of the red cells when λ = 5 (side view: ﬂow is from left to right); Dt = 11.28 μm,
Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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(a) t = 531.4 ms (b) Δt = +5 ms
(c) Δt = +5 ms (d) Δt = +5 ms
(e) Δt = +5 ms (f) Δt = +5 ms
(g) Δt = +5 ms (h) Δt = +5 ms
(i) Δt = +5 ms (j) Δt = +5 ms
Figure 4.17: Lateral (x-direction) tractions for a ﬂow-by of the red cell when λ = 5, σx ∈ [−5.56,5.53] Pa (top
view: ﬂow is from left to right); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 1 (HT = 4.23%).
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(a) t = 700.0 ms (b) Δt = +5 ms
(c) Δt = +5 ms (d) Δt = +5 ms
(e) Δt = +5 ms (f) Δt = +5 ms
(g) Δt = +5 ms (h) Δt = +5 ms
(i) Δt = +5 ms (j) Δt = +5 ms
Figure 4.18: Lateral (x-direction) tractions for a ﬂow-by of the red cells when λ = 5, σx ∈ [−9.48,9.20] Pa (top
view: ﬂow is from left to right); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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(a) t = 531.4 ms (b) Δt = +5 ms
(c) Δt = +5 ms (d) Δt = +5 ms
(e) Δt = +5 ms (f) Δt = +5 ms
(g) Δt = +5 ms (h) Δt = +5 ms
(i) Δt = +5 ms (j) Δt = +5 ms
Figure 4.19: Vertical (y-direction) tractions for a ﬂow-by of the red cell when λ = 5, σy ∈ [−13.37,7.58]
Pa (top view: ﬂow is from left to right); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 1
(HT = 4.23%).
80
(a) t = 700.0 ms (b) Δt = +5 ms
(c) Δt = +5 ms (d) Δt = +5 ms
(e) Δt = +5 ms (f) Δt = +5 ms
(g) Δt = +5 ms (h) Δt = +5 ms
(i) Δt = +5 ms (j) Δt = +5 ms
Figure 4.20: Vertical (y-direction) tractions for a ﬂow-by of the red cells when λ = 5, σy ∈ [−15.49,9.91]
Pa (top view: ﬂow is from left to right); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6
(HT = 25.38%).
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(a) t = 531.4 ms (b) Δt = +5 ms
(c) Δt = +5 ms (d) Δt = +5 ms
(e) Δt = +5 ms (f) Δt = +5 ms
(g) Δt = +5 ms (h) Δt = +5 ms
(i) Δt = +5 ms (j) Δt = +5 ms
Figure 4.21: Axial (z-direction) tractions for a ﬂow-by of the red cell when λ = 5, σz ∈ [0.0,11.12] Pa (top
view: ﬂow is from left to right); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 1 (HT = 4.23%).
82
(a) t = 700.0 ms (b) Δt = +5 ms
(c) Δt = +5 ms (d) Δt = +5 ms
(e) Δt = +5 ms (f) Δt = +5 ms
(g) Δt = +5 ms (h) Δt = +5 ms
(i) Δt = +5 ms (j) Δt = +5 ms
Figure 4.22: Axial (z-direction) tractions for a ﬂow-by of the red cells when λ = 5, σx ∈ [0.0,18.32] Pa (top
view: ﬂow is from left to right); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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Figure 4.23: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 for one ﬂow-by of the red cell. The symbols correspond to
each frame from Figures 4.15(a) through 4.15(j). The dashed lines are the homogeneous cases of plasma in
the λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range; Dt = 11.28 μm, Ds = 8.46 μm,
Lz = 25.38 μm and nRBC = 1 (HT = 4.23%).
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Figure 4.24: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 for one ﬂow-by of the red cells. The symbols correspond to
each frame from Figures 4.16(a) through 4.16(j). The dashed lines are the homogeneous cases of plasma in
the λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range; Dt = 11.28 μm, Ds = 8.46 μm,
Lz = 25.38 μm and nRBC = 6 (HT = 25.38%).
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(a) λ = 1.
(b) λ = 5.
Figure 4.25: Time averaged local hematocrit, H ∈ [0,0.23]; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm
and nRBC = 1 (HT = 4.23%).
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(a) λ = 1.
(b) λ = 5.
Figure 4.26: Time averaged local hematocrit H ∈ [0,0.91] ; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm
and nRBC = 6 (HT = 25.38%).
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(a) Top view.
(b) Side view.
Figure 4.27: Centroid location of the red cell in one ﬂow-by; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm
and nRBC = 1 (HT = 4.23%).
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(a) Top view.
(b) Side view.
Figure 4.28: Centroid location of the red cells in one ﬂow-by; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm
and nRBC = 6 (HT = 25.38%).
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(a) xc with respect to the center of the tube.
0 100 200 300 400 500 600−0.5
0
0.5
1
1.5
2
2.5
3
3.5
t (ms)
y c
(μ
m
)
(b) yc with respect to the center of the tube.
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(c) zc along the periodic tube.
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(d) Minimum radial distance to the tube wall.
Figure 4.29: Location history of the centroid of the red cell; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm
and nRBC = 1 (HT = 4.23%).
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(a) Cell 1.
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Figure 4.30: xc of the cells with respect to the center of the tube; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm
and nRBC = 6 (HT = 25.38%). Cell 5 is initiated from a diﬀerent location than the end of the λ = 1 simulations,
hence the discontinuity in the time history of its xc.
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(a) Cell 1.
0 200 400 600 800−4
−3
−2
−1
0
1
2
3
4
t (ms)
y c
(μ
m
)
(b) Cell 2
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Figure 4.31: yc of the cells with respect to the center of the tube; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm
and nRBC = 6 (HT = 25.38%). Cell 5 is initiated from a diﬀerent location than the end of the λ = 1 simulations,
hence the discontinuity in the time history of its yc.
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(a) Cell 1.
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Figure 4.32: zc of the cells along the periodic tube; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm and
nRBC = 6 (HT = 25.38%). Cell 5 is initiated from a diﬀerent location than the end of the λ = 1 simulations,
hence the discontinuity in the time history of its zc.
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Figure 4.33: Minimum radial distance of the red cells to the tube wall; Dt = 11.28 μm, Ds = 8.46 μm,
Lz = 25.38 μm and nRBC = 6 (HT = 25.38%). Cell 5 is initiated from a diﬀerent location than the end of the
λ = 1 simulations, hence the discontinuity in the time history of its δ.
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4.3 Particulate versus homogeneous blood model
In this section we discuss the eﬀect of diﬀerent geometrical, mechanical, physiological and numerical factors
on the forces that the leukocyte experiences. The geometrical parameters are: leukocyte to tube diameter
ratio, periodic length of the tube, leukocyte contact angle, and the relative scale of the red blood cells to
the tube and wall-adhered cell. The mechanical factors are the tube volume ﬂow rate and pressure gradient.
Physiological ones are tube hematocrit and mechanical properties of the red cells. The eﬀect of the minimum
separation distance enforced between the cells with each other and the vessel walls including the leukocyte
will also be considered.
For each case we then compare the forces that result from our cellular model of blood, where the interac-
tions of red cells with each other and the leukocyte are considered, to a homogeneous Newtonian ﬂuid model
for blood. When the viscosity ratio of the ﬂuid inside and outside of the red cells is unity, the homogeneous
ﬂuid is assumed to have the viscosity of the plasma. For the more realistic viscosity ratio λ = 5, results are
compared to an apparent-viscosity-homogenized model of blood from empirical data at the corresponding
tube diameter and hematocrit.123 The goal of this kind of comparison is to assess the homogeneous-blood
assumption and understand when such a model needs to be reﬁned to include the particulate character of
the blood. Here, we mostly focus on the wall-bound leukocyte and therefore its size is ﬁxed for most of
investigations. However, we also consider a larger wall-bound cell to observe the eﬀect of the scale of the
system relative to the size of the red cells. This larger wall-bound cell might represent a cancer cell, or a
cluster of cancer cells.
The setup and ﬂow conditions are variations of the reference cases of the previous section, the details of
which are presented in the following sections. The conﬁguration and traction history results of these cases
are available in Appendix A for reference. For the presented trends, each data point corresponds to resulting
tractions from one simulation conﬁguration.
Of particular interest is how in any particular case the red cells aﬀect the forces experienced by the wall-
bound leukocyte. The axial component is anticipated to be the strongest and therefore most important.
Similarly, the peak streamwise surface tractions are also documented. These types of forces potentially lead
to diﬀerent signaling pathways which result in diﬀerent responses from the cell (see Chapter 1).
Going back to the two reference cases presented in the previous section, relative increase in the axial
tractions compared to the homogeneous case from Figures 4.9(d) and 4.10(d) are the results we focus upon.
Figure 4.34 shows the same plots with the peaks of the surface averaged and maximum tractions marked
with symbols. The time average of the local maxima of the average and maximum tractions (denoted by
open symbols) as well as their global maxima (ﬁlled symbols) are used to represent each case in the trends
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presented next.
4.3.1 Dependence on tube hematocrit
One of the factors that aﬀects the forces on a wall-bound leukocyte is hematocrit. Starting with the single-
cell reference case (see Section 4.1), we increase the number of red cells in increments up to HT = 25% (the
second reference case in Section 4.1). This results in an increase in the tube hematocrit for the tube diameter
of 11.28 μm as indicated in Table 4.1.
All the cases have Ds = 8.46 μm, Dt = 11.28 μm, Lz = 25.38 μm, θ = 0○, Q = 28181 μm3/s, ⟨Uz⟩t =
282 μm/s, N = 24, and M/N = 3, where N is indicative of the N × 2N mesh on the red cells and M/N is
the de-aliasing factor used for the larger M × 2M mesh discussed in Section 2.5. The varying parameters
for the conﬁguration of these cases are presented in Table 4.1. The wall for these cases was discretized by
6588 triangular elements of side size 564 nm on the cylindrical tube and 6147 elements of side size 282 nm
on the wall-bound leukocyte. A sample visualization of each of the diﬀerent hematocrit cases are shown in
Figure 4.36. The traction histories of the cases with 2 and 4 red blood cells are presented in Appendix A
(Figures A.2 and A.4).
Table 4.1: Study of hematocrit: case speciﬁcations.
nRBC HT
1 4.23
2 8.46
4 16.92
6 25.38
Figure 4.37 shows that in terms of the average tractions on the surface of the leukocyte, across this range
of hematocrits and for this geometry, the tractions from the particulate model are 28 to 47% larger than
plasma for λ = 1 and 28 to 42% larger than apparent-viscosity-homogenized model of blood for λ = 5. The
maximum tractions are 100 to 250% larger compared to plasma for λ = 1 and 73 to 128% larger compared
to the apparent-viscosity-homogenized model of blood for λ = 5. These ﬁgures are even larger when the
absolute maxima are considered throughout the duration of the simulation. Therefore, at the scales of this
setup, for any of these hematocrits, a homogeneous assumption signiﬁcantly underpredicts the forces exerted
on the wall-bound leukocyte.
Figure 4.37 shows that when λ = 1, the increase in the axial surface-averaged as well as the maximum
traction increase with tube hematocrit. However, when λ = 5 the trend is diﬀerent. This is due to the
fact that the λ = 5 is compared against an apparent-viscosity-homogenized model whose apparent viscosity
is increasing with hematocrit (see Figure 4.35). Therefore, tractions that are not changing by much in an
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Figure 4.34: Time histories of components of the axial component of the surface averaged tractions ⟨σz⟩ for
—, λ = 1 with its peaks, ○ and their maximum, ● and —, λ = 5 with its peaks, ◻ and their maximum ∎ and
the maximum of tractions max(σz) for – –, λ = 1 with its peaks, △ and their maximum ▲ and – –, λ = 5
with its peaks ◊ and their maximum ⧫; Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm.
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Figure 4.35: Apparent viscosity as a function of hematocrit for the range discussed here.
(a) HT = 4.23% (nRBC = 1) (b) HT = 8.46% (nRBC = 2)
(c) HT = 16.92% (nRBC = 4) (d) HT = 25.38% (nRBC = 6)
Figure 4.36: Visualizations of cases with diﬀerent hematocrit.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.37: Increase in σz relative to a homogeneous blood model as a function of HT , the tube hematocrit.
For all the cases Dt = 11.28 μm, Ds = 8.46 μm, and Lz = 25.38 μm.
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absolute sense are being compared with a baseline that is increasing with hematocrit. The magnitude of
the tractions stays relatively constant for the 2 and 4 cell cases because the cells stagger throughout the
length of the tube and therefore, interact with the leukocyte one at a time. This results in tractions that are
close in magnitude to the tractions from one single red cell. In the case of 6 red cells in the vessel, multiple
cells interact with the leukocyte at any given time and therefore, the magnitude of the tractions start to
increase compared to when a single cell interacts with the leukocyte. We suspect that if the hematocrit is
increased further, more cells are forced to interact with each other in order to ﬁt through the gap between
the leukocyte and the vessel wall and therefore, this eﬀect accentuates.
4.3.2 Dependence on tube diameter
Previous studies present the eﬀect of the cell to tube diameter ratio on the forces as a function of the same
non-dimensional parameter.7, 108, 109, 109 However, here, since we are focusing on a leukocyte whose size
(8.46 μm) is ﬁxed, we present the results as a function of the tube diameter, which is varied for diﬀerent
simulations. This trend is studied for the single-cell cases as well as when the hematocrit is 25%.
All the cases haveDs = 8.46 μm, Lz = 25.38 μm, θ = 0○, and Q = 28181 μm3/s. Varying parameters for the
conﬁguration of these cases are presented in Table 4.2 and the details of the wall discretization are available
in Table 4.3. For all the cases the mesh size on the leukocyte is half the mesh size on the cylindrical wall.
The tube conﬁgurations are shown in Figure 4.38 for the single cell cases, and Figure 4.39 for the HT = 25%
cases. The traction histories for the cases, other than the reference ones from Section 4.1, are presented in
Appendix A (Figures A.6, A.8, A.10, and A.12 for the single red cell cases, and in Figures A.14 and A.16 for
the HT = 25% cases). With the increase in the tube diameter, the tube average velocity drops in order to
maintain a constant volume ﬂow rate, therefore, the pseudo shear rate drops even more rapidly, going from⟨Uz⟩t /Dt = 37.3 to 25, 17.5, 12.8, and 7.4 s−1 for Dt = 9.87, 11.28, 12.69, 14.1, 16.92 μm, respectively. The
pseudo shear rates reported for capillaries and venules are in this range.10
Table 4.2: Study of tube diameter: case speciﬁcations.
Dt (μm) nRBC HT ⟨Uz⟩t μm/s N M/N
9.87 1 5.78 368 32 5
11.28 1 4.23 282 24 3
12.69 1 3.25 223 24 3
14.10 1 2.58 180 16 3
16.92 1 1.74 125 16 3
11.28 6 25.38 282 24 3
14.10 10 26.09 180 16 3
16.92 15 26.48 125 16 3
100
Table 4.3: Wall discretizations for study of tube diameter.
Dt (μm) Tube # ele. Leukocyte # ele.
9.87 5870 6531
11.28 6588 6147
12.69 7510 6325
14.10 8228 6568
16.92 9892 6771
(a) nRBC = 1 (HT = 5.78%) (b) nRBC = 1 (HT = 4.23%)
(c) nRBC = 1 (HT = 3.25%)
(d) nRBC = 1 (HT = 2.58%)
(e) nRBC = 1 (HT = 1.74%)
Figure 4.38: Visualizations of cases with diﬀerent tube diameter with one red cell in the system.
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(a) nRBC = 6 (HT = 25.38%)
(b) nRBC = 10 (HT = 25.0%)
(c) nRBC = 15 (HT = 25.0%)
Figure 4.39: Visualizations of cases with diﬀerent tube diameter with HT = 25%.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.40: Increase in σz relative to a homogeneous blood model as a function of Dt, the tube diameter.
For all the cases Ds = 8.46 μm, Lz = 25.38 μm, and nRBC = 1.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
Dt (μm)
0
11 12 13 14 15 16 17
200
400
600
800
1000
1200
 m
ax
(σ
z
)
(%
)
(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.41: Increase in σz relative to a homogeneous blood model as a function of Dt, the tube diameter.
For all the cases or all the cases Ds = 8.46 μm, Lz ≈ 3Ds, and HT = 25%.
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Figure 4.40 shows that the average tractions on the surface of the leukocyte, across this range of tube
diameters for the one cell cases, from the cellular ﬂow model are 6 to 75% larger than plasma for λ = 1 and
4 to 42% larger than apparent-viscosity-homogenized model of blood for λ = 5. The maximum tractions are
13 to 175% larger compared to plasma for λ = 1 and 15 to 95% larger compared to the apparent-viscosity-
homogenized model of blood for λ = 5. These values are even larger when the global maxima of the average
and tractions are considered. When Dt = 9.87 case, with 32 × 64 red cell mesh (N × 2N) and a de-aliasing
factor of 5, the mismatched viscosity portion of the simulation was too computationally intense and therefore
not simulated. Also, for the maximum tractions, data is available only for Dt = 11.28, 14.1 and 16.92 μm.
For Dt = 16.92 μm (Figure A.12), only the last three peaks of the maximum tractions are considered because
the larger peaks have not settled to the steady state for this case and biased.
The trend in Figure 4.40 suggests that for low hematocrits (single red cell in this case), as the tube
diameter and hence the gap between the wall-bound leukocyte and the vessel wall increases, the eﬀect of
the individual red cell compared to a homogeneous assumption diminishes. This is expected as the cell has
enough room to pass the leukocyte without closely interacting with its surface. However, the results in the
HT = 25% case suggest a diﬀerent behavior.
The tractions when HT = 25% are completely diﬀerent than the low hematocrit cases. As Dt increases,
with a constant hematocrit, the number of the red cells in the system increases and the leukocyte is in
constant contact with the red cells. The increase in the average tractions relative to homogeneous even
slightly increases with larger Dts. This is more pronounced when λ = 1 because the λ = 5 cases are compared
to a homogeneous blood with larger apparent viscosity. Even at the low pseudo shear rates of these cases,
the average tractions are 47 to 79% larger than the tractions from plasma and 30 to 39% larger compared
to apparent-viscosity-homogenized case. The maximum tractions substantially increase as the leukocyte
interacts with more and more red cells at the same time when the tube diameter increases. This increase
is 145 to 471% for λ = 1 relative to plasma and 128 to 317% for λ = 5 relative to the apparent-viscosity-
homogenized case.
4.3.3 Dependence on tube periodic length
The periodic length of the tube is another factor that can aﬀect the tractions that the wall-bound leukocyte
experiences. The implications of the tube length is that the periodic image of the leukocyte, eﬀectively,
makes the conﬁguration of a single array of leukocytes. If the periodic length of the vessel is too short,
the red cells would not have enough time to recover from the deformations that they undergo while passing
the leukocyte. Here, we present the tractions on the wall-bound leukocyte for three conﬁgurations with
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Lz = 2Ds, 3Ds (reference) and 5Ds and for systems with only one red cell and HT = 25%.
All the cases have Ds = 8.46 μm, Dt = 11.28 μm, θ = 0○, Q = 28181 μm3/s, ⟨Uz⟩t = 282 μm/s, and N = 24.
Varying parameters for the conﬁguration of these cases are presented in Table 4.4 and the details of the
wall discretization are presented in Table 4.5. For all the cases 6147 elements are used on the wall-bound
leukocyte and the mesh size is half the mesh size on the cylindrical tube. The tube conﬁgurations are shown
in Figure 4.42 for the single cell cases and Figure 4.43 for the HT = 25% cases. The traction histories for
the cases, other than the reference ones from Section 4.1, are presented in Appendix A (Figures A.18 and
A.20 for the single red cell cases, and in Figures A.22 and A.24 for the HT = 25% cases).
Table 4.4: Study of tube periodic length: case speciﬁcations.
Lz (μm) nRBC HT M/N
18.21 1 6.25 3
25.38 1 4.23 3
44.53 1 2.27 3
18.21 4 25.0 4
25.38 6 25.38 3
44.53 11 25.0 3
Table 4.5: Wall discretizations for study of tube periodic length.
Lz (μm) Tube # ele.
18.21 4760
25.38 6588
44.53 11538
We have presented the increase in the tractions on the wall-bound leukocyte for the reference case of
Lz = 3Ds in Section 4.1. For both, the single cell case as well as when HT = 25%, shown in Figures 4.46 and
4.46, when Lz = 2Ds, the cells do not have enough time between interactions with the leukocyte to recover
their approximately parachute shape for this ﬂow condition. Therefore, they do not have to deform as much
as when they encounter the next leukocyte image. As the red cells ﬁnd more room to relax after they pass
the leukocyte for Lz = 3Ds and 5Ds, they have to deform more on their next pass and therefore, exert larger
tractions on the leukocyte both in an average sense as well as locally transient for HT = 25%. Note that only
the converged portion of the maximum tractions in the HT = 25% case of Lz = 2Ds when λ = 5 (Figure A.22)
is considered. The maximum tractions for a single red cell decrease with Lz.
The diﬀerences between the forces when Lz = 3Ds and 5Ds compared to computational savings of working
with Lz = 3Ds justiﬁes the use of the shorter periodic length for the simulations in this section.
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(a) nRBC = 1 (HT = 6.25%)
(b) nRBC = 1 (HT = 4.23%)
(c) nRBC = 1 (HT = 2.27%)
Figure 4.42: Visualizations of cases with diﬀerent tube periodic length with one red cell in the system.
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(a) nRBC = 4 (HT = 25.0%)
(b) nRBC = 6 (HT = 25.38%)
(c) nRBC = 11 (HT = 25.0%)
Figure 4.43: Visualizations of cases with diﬀerent tube periodic length with HT = 25%.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.44: Increase in σz relative to a homogeneous blood model as a function of Lz, the periodic length
of the tube. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, and nRBC = 1.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
Lz (μm)
15 20 25 30 35 40 45
50
100
150
200
250
300
 m
ax
(σ
z
)
(%
)
(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.45: Increase in σz relative to a homogeneous blood model as a function of Lz, the periodic length
of the tube. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, and HT = 25%.
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4.3.4 Dependence on leukocyte contact angle
Observations indicate that adhered cells do not always stay spherical.71, 106, 107 Also, if the protuberance
on the wall is representative of an out-of-line endothelial cell, its contact angle is then larger than zero and
therefore, is not a fully exposed sphere. Here, we study the eﬀect of the contact angle between the adhered
cell and the vessel wall. The cell is assumed to be a leukocyte with a constant volume. Therefore, as the
contact angle increases, the cells spreads further on the inside of the tube wall. The periodic length of the
tube is kept three times the projection of the spread leukocyte.
All the cases have an equivalent Ds = 8.46 μm, Dt = 11.28 μm, Q = 28181 μm3/s, ⟨Uz⟩t = 282 μm/s, and
M/N = 3. Varying parameters for the conﬁguration of these cases are presented in Table 4.6 and the details
of the wall discretization are presented in Table 4.7. For all the cases the mesh size on the leukocyte is half
the mesh size on the cylindrical tube. The tube conﬁgurations are shown in Figure 4.46 for the single cell
cases, and Figure 4.47 for the HT = 25% cases. The traction histories for the cases, other than the reference
ones from Section 4.1, are presented in Appendix A (Figures A.26, A.28, and A.30 for the single red cell
cases, and in Figures A.32, A.34, and A.36 for the HT = 25% cases).
Table 4.6: Study of leukocyte contact angle: case speciﬁcations.
Lz (μm) θ (degrees) nRBC HT N
25.38 0 1 4.23 24
25.66 45 1 4.18 24
37.51 90 1 2.74 16
52.17 135 1 1.92 16
18.21 0 6 25.38 24
25.66 45 6 25.0 24
37.51 90 9 25.0 16
52.17 135 13 25.0 16
Table 4.7: Wall discretizations for study of leukocyte contact angle.
Lz (μm) θ (degrees) Tube # ele. Leukocyte # ele.
25.38 0 6588 6147
25.66 45 8100 5492
37.51 90 12366 4590
52.17 135 18896 4802
Figures 4.48 and 4.49 indicate that as the cell gets more spread, the tractions that it experiences approach
the homogeneous limit. If the more spreading of the cell is interpreted as less frontal area exposed to the
ﬂow, then these results are consistent with the increase in tube diameter presented previously. As the contact
angle between the cell and the cylindrical substrate increases from 0 to 135 degrees, the relative increase in
the average tractions from a single red cell drops from 28 to 8 and 42 to 5% for λ = 1 and λ = 5 compared to
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(a) nRBC = 1 (HT = 4.23%)
(b) nRBC = 1 (HT = 4.18%)
(c) nRBC = 1 (HT = 2.74%)
(d) nRBC = 1 (HT = 1.92%)
Figure 4.46: Visualizations of cases with diﬀerent leukocyte contact angle with one red cell in the system.
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(a) nRBC = 6 (HT = 25.38%)
(b) nRBC = 6 (HT = 25.0%)
(c) nRBC = 9 (HT = 25.0%)
(d) nRBC = 13 (HT = 25.0%)
Figure 4.47: Visualizations of cases with diﬀerent leukocyte contact angle with HT = 25%.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.48: Increase in σz relative to a homogeneous blood model as a function of θ, the leukocyte contact
angle. For all the cases Dt = 11.28 μm, equivalent Ds = 8.46 μm, nRBC = 1, and Lz is three times the length
of the protuberance in the axial direction.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.49: Increase in σz relative to a homogeneous blood model as a function of θ, the leukocyte contact
angle. For all the cases Dt = 11.28 μm, equivalent Ds = 8.46 μm, HT = 25%, and Lz is three times the length
of the protuberance in the axial direction.
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plasma and apparent-viscosity-homogenized cases, respectively. This trend for HT = 25% is similar but the
relative increase in tractions are larger overall (47 to 28 and 47 to 12% for λ = 1 and λ = 5, respectively).
The maximum tractions follow the same trend and drop from 107 to 13 and 95 to 8% for the single cell
cases and 145 to 49 and 128 to 21% for the HT = 25% and for λ = 1 and λ = 5 compared to plasma and
apparent-viscosity-homogenized blood respectively.
4.3.5 Scale compared to red blood cells
Here we consider the case when the cell attached to the vessel wall is larger than a leukocyte. For example,
a T98 human glioblastoma cancer cell is about 30 μm in diameter.247 A larger wall-bound cell eﬀectively
represents a change in the scale of the conﬁguration relative to the size of the red cells. Keeping the Ds/Dt
ratio of 0.75 constant, we increase the overall scale of the conﬁguration by a factor of 1.5. This factor
results in a leukocyte size that is still in the physiological range of diﬀerent classiﬁcations of leukocytes (see
Section 1.3.1).
The parameters for the conﬁguration of the cases are presented in Table 4.8 and the details of the wall
discretization for each case is available in Table 4.9. For both cases θ = 0○, Q = 28181 μm3/s, M/N = 3, and
the mesh size on the wall-bound cell is half the mesh size on the cylindrical tube. The tube conﬁgurations
are shown in Figure 4.50 for the single cell cases, and Figure 4.52 for the HT = 25% cases. The traction
histories for the cases, other than the reference ones from Section 4.1, are presented in Figure A.38 for the
single red cell case, and Figure A.40 for the HT = 25% cases in Appendix A.
When we compare the increase in the axial tractions of the small and the large-scale conﬁgurations
in Figure 4.51, for the case of a single red cell, the enhancements due to the presence of the red cell are
much smaller both in the average as well as local point-wide sense. This result is in agreement with the
observations made for the eﬀect of the tube diameter on the tractions experienced by the wall-bound cell.
Here, the red cell only interacts with a small portion of the surface of the leukocyte and the gap between
the leukocyte and the vessel wall is large enough that does not require large deformations of the red cell.
However, in the HT = 25% case, the increase in the tractions are comparable between the small- and
large-scale conﬁgurations. This is the case for both average and maximum of the tractions in the axial
direction. These results are also consistent with the observations of the eﬀects of tube diameter on the
tractions. There, we also saw that even in larger tube sizes, when the wall-bound cell is in constant contact
with the red cells, the tractions from the particulate model are signiﬁcantly larger than the homogeneous
counterpart. The main diﬀerence between the small- and the large-scale conﬁgurations for when HT = 25%
is that the applied tractions from the large-scale conﬁguration are smoother than the small scale system.
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This is due to the interactions of a larger number of red cells with the vessel-adhered sphere compared to
the small-scale conﬁguration.
Table 4.8: Study of scale compared to red cell dimensions: case speciﬁcations.
Eqv. Ds (μm) Dt (μm) Lz (μm) nRBC HT ⟨Uz⟩t μm/s N
8.46 11.28 25.38 1 4.23 282 24
12.69 16.92 38.07 1 1.25 125 16
8.46 11.28 25.38 6 25.38 282 24
12.69 16.92 38.18 20 25.0 125 16
Table 4.9: Wall discretizations for study of scale compared to red cell dimensions.
Ds/DRBC (μm) Tube # ele. Leukocyte # ele.
1.5 6588 6147
2.25 14752 14785
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(a) Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=1
(HT = 4.23%).
(b) Dt = 16.92 μm, Ds = 12.69 μm, Lz = 38.07 μm, and nRBC=1 (HT = 1.25%).
Figure 4.50: Scale of the conﬁguration compared to the scale of the red cells.
4.3.6 Dependence on tube velocity
By changing the tube velocity, the volumetric ﬂow rate as well as the pseudo-shear rate change. In this
section, the tube velocity of the single cell and HT = 25% reference cases discussed in Section 4.1, is varied
from 282 μm to 141 μm/s, 564 μm/s, and 1.41 mm/s. The equivalent volumetric ﬂow rates for these cases
are going to be 14091 μm3/s, 56362 μm3/s, and 140905 μm3/s compared to 28182 μm3/s of the reference
cases. The corresponding pseudo-shear rates are then, 12.5 s−1, 50.0 s−1, and 250.0 s−1 compared to 25.0 s−1
for the reference cases.
The trends in Figure 4.54 and 4.55 suggest that as the tube velocity or pseudo shear rate increases,
the red cells do not have enough time to push the plasma between themselves and the leukocyte out and
therefore leave a thicker lubrication layer. As a result the forces approach the homogeneous limit at higher
velocities. However, even at 1.4 mm/s the average tractions are still 19% and 31% larger than tractions
from plasma when λ = 1 for the single cell and HT = 25% cases. These ampliﬁcations are 28% and 29%
for λ = 5 relative a apparent-viscosity-homogenized model. The maximum tractions are still 68% and 114%
larger than plasma for λ = 1 and 70% and 83% larger than tractions from an apparent-viscosity-homogenized
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(a) Dt = 16.92 μm, Ds = 12.69 μm, Lz = 38.07 μm, and
nRBC=1.
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(b) Dt = 16.92 μm, Ds = 12.69 μm, Lz = 38.07 μm, and
nRBC=1.
Figure 4.51: Time histories of the relative change compared to homogeneous for surface averaged axial
component of the tractions ⟨σz⟩ for λ = 1 and λ = 5 and maximum axial component of the tractions
max(σz) for λ = 1 and λ = 5 .
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(a) Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=6
(HT = 25.38%).
(b) Dt = 16.92 μm, Ds = 12.69 μm, Lz = 38.07 μm, and nRBC=20 (HT = 25.0%).
Figure 4.52: Scale of the conﬁguration compared to the scale of the red cells.
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(a) Dt = 4.0, Ds = 3.0, and Lz = 9.0.
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(b) Dt = 6.0, Ds = 4.5, and Lz = 13.5
Figure 4.53: Time histories of the relative change compared to homogeneous for surface averaged axial
component of the tractions ⟨σz⟩ for λ = 1 and λ = 5 and maximum axial component of the tractions
max(σz) for λ = 1 and λ = 5 ; Dt = 16.92 μm, Ds = 12.69 μm, Lz = 38.07 μm, and HT = 1.25%.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.54: Increase in σz relative to a homogeneous blood model as a function of ⟨Uz⟩t, the average tube
velocity. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC = 1.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.55: Increase in σz relative to a homogeneous blood model as a function of ⟨Uz⟩t, the average tube
velocity. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and HT = 25.38%.
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model for when λ = 5.
4.3.7 Dependence on tube pressure gradient
We also consider cases where the average pressure gradient along the tube is kept constant. Here, the average
tube pressure gradient is varied in the same range as the the pressure gradients that resulted in the average
tube velocities of the previous section.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.56: Increase in σz relative to a homogeneous blood model as a function of −⟨∂p∂z ⟩, the average tube
pressure gradient. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC = 1.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.57: Increase in σz relative to a homogeneous blood model as a function of −⟨∂p∂z ⟩, the average tube
pressure gradient. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and HT = 25.38%.
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The same overall trend as what was observed for average tube velocity is present for a change in average
pressure gradient in Figures 4.57 and 4.57. Larger mean pressure gradients along the tube result in a more
ﬂuid-like behavior of the particulate ﬂow. This is especially more pronounced in the maximum tractions
compared to the homogeneous cases of plasma and apparent-viscosity-homogenized blood. However, the
increase in the average tractions compared to homogeneous are much smaller than when the tube average
velocity was kept constant. This is due to the fact that when pressure gradient is constant, blockage of
the gap between the leukocyte and vessel wall leads to signiﬁcant drop in the tube velocity and therefore
tractions exerted on the leukocyte, while when the tube average velocity is kept constant the same blockage
causes the pressure gradient to increase in order to compensate and keep the velocity constant.
4.3.8 Dependence on red blood cell shear modulus
In order to demonstrate the eﬀect of red cell resistance to shear on the tractions exerted on the leukocyte,
the shear modulus of the red cells is halved and doubled compared to the reference cases presented in
Section 4.1. The other parameters of the conﬁguration are the same as the reference cases. The reference
value of 4.2×10−6 N/m for ES has been used by Pozrikidis213 while values of 6−9×10−6 N/m has also been
suggested by Hochmuth.117, 248 Also, Linderkamp and Meiselman249 suggest that during aging of the red
cells, their membrane shear elasticity increases by 20%. Therefore, our lower bound of ES/ES0 = 0.5 has no
physiological signiﬁcance and is presented to obtain a general trend as a function of the shear modulus of
the red cells.
Figures 4.58 and 4.59 suggest that as the shear modulus of the red cells increases, they exert only slightly
larger tractions on the leukocyte. In a way, the red cells behave more like rigid particles as their shear
modulus gets larger. For example, in malaria infected red blood cells, the invading organism changes the
molecular structure of the red cell, leading to increased rigidity.250 The trends in Figures 4.58 and 4.59
indicate that the experiments commonly performed with gelatin pellets104 and elastic6 and rubber7, 108 discs
as models for red blood cells may over-predict the forces that have been recorded on the leukocyte. This
insensitivity to the shear modulus indicates that the deformation of the membrane is not the primary cause
of the forces that the leukocyte experiences.
4.3.9 Red blood cell bending modulus
The bending resistance of the red cell membrane is thought to arise from the resistance of the lipid bi-
layer.251, 252 As illustrated in Section 2.8.2, the relaxation times of a single red blood cell are within the
bounds of empirical observations when the bending modulus is varied by a factor of 5. This wide range
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.58: Increase in σz relative to a homogeneous blood model as a function of ES , red cell shear
modulus. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC = 1. ES0 is the reference
shear modulus.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.59: Increase in σz relative to a homogeneous blood model as a function of ES , red cell shear
modulus. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and HT = 25.38%. ES0 is the
reference shear modulus.
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of bending moduli might represent diﬀerent age cells. Here, we also vary the bending modulus of the red
cells from its reference value of 1.8 × 10−19 N⋅m213 by a factor of 5 and 0.1 (with no physiological basis) for
the single red cell case and only a factor of 0.1 for HT = 25%. A large bending modulus for the HT = 25%
resulted in a computationally expensive case to simulate.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.60: Increase in σz relative to a homogeneous blood model as a function of EB , red cell bending
modulus. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC = 1. EB0 is the reference
bending modulus.
Figures 4.60 and 4.61 show that bending modulus does not seem to be a signiﬁcant factor for the tractions
exerted on the wall-bound leukocyte. The average tractions stay almost the same as the bending modulus
129
EB/EB0
0 0.2 0.4 0.6 0.8 1
30
35
40
45
50
55
 ⟨
σ
z
⟩
(%
)
(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.61: Increase in σz relative to a homogeneous blood model as a function of EB , red cell bending
modulus. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and HT = 25.38%. EB0 is the
reference bending modulus.
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is varied. The increase in the maximum tractions, when EB/EB0 = 0.1 for the single cell case, is due to the
fact that the ﬂoppier red cell conforms better to the shape of the leukocyte and gets closer to its surface.
4.3.10 Minimum separation distance
For the reference cases in Section 4.1, a value of 56 nm is numerically enforced as the minimum separation
between the cells with each other and the walls. At these scales the molecular interactions become important
and therefore resolving the gap further, would not necessarily improve the results (see Section 2.6). We
change this minimum separation to 28 nm as well as 112 nm and the resulting tractions on the leukocyte
virtually stay the same (Figures 4.62 and 4.63).
It is clear form Figures 4.63 and 4.63 that the results are insensitive to the minimum separation distance
below the chosen value of 56 nm, for the types of simulations throughout the present work. However, when
this distance is enforced at a larger value of 112 nm the tractions experienced by the leukocyte start to show
some decline because if the red cells are allowed to get closer, they exert larger tractions.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.62: Increase in σz relative to a homogeneous blood model as a function of δmin, minimum separation
distance between the red cell and the leukocyte. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz =
25.38 μm, and nRBC = 1.
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(a) σz averaged over the surface of the leukocyte, ⟨σz⟩: ○ and ◻,
average of the peaks of ⟨σz⟩ for λ = 1 and λ = 5 respectively; ● and
∎, the maximum of the peaks of ⟨σz⟩ throughout the simulation
for λ = 1 and λ = 5.
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(b) Maximum local σz on the surface the leukocyte, max(σz): △
and ◊, average of the peaks of max(σz) for λ = 1 and and λ = 5
respectively; ▲ and ⧫, the maximum of the peaks of max(σz)
throughout the simulation for λ = 1 and λ = 5.
Figure 4.63: Increase in σz relative to a homogeneous blood model as a function of δmin, minimum separation
distance between the red cells and the leukocyte. For all the cases Dt = 11.28 μm, Ds = 8.46 μm, Lz =
25.38 μm, and HT = 25%.
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Chapter 5
Conclusions
We have examined the forces on a wall-bound leukocyte due to interactions with ﬂowing red blood cells,
particularly how the cells increase the forces experienced by the leukocyte above what would be predicted
with a homogeneous-blood model. The previously reported magnitude of these forces were obtained by
either homogeneous models of blood or from interactions with elastic or rubber discs in experiments or
rigid discs in computations that were used as model red blood cells. Here, we model the red blood cells
as realistically deformable membranes that encapsulate a Newtonian ﬂuid with ﬁve times the viscosity of
a Newtonian plasma. The systems we consider have length scales comparable to the size of the cells, and
therefore the particulate character of blood is expected to play an important role in forces that the vessel-
adhered leukocyte experiences. We show that using a homogeneous assumption under-predicts the forces.
However, with particular sets of parameters, a homogeneous assumption may be appropriate. On the other
hand, using stiﬀer particles to model the red blood cells overpredicts the forces on a wall-bound leukocyte.
The setup for the simulations was discussed in Chapter 3. A rigid spherical model for the leukocyte
which is adhered to the wall is used. Mean pressure gradient along the tube as well as the tube average
velocity can be controlled to drive the ﬂow in the tube. Red-cell-free homogeneous Newtonian versions of
diﬀerent geometries are simulated for a point of comparison between the forces from the homogeneous and
the particulate model when individual red cells are considered.
In Chapter 4, we investigated the eﬀects of diﬀerent geometrical, mechanical, physiological, and numerical
factors on the forces that the leukocyte experiences from interacting with realistically modeled red blood cells.
The most important factors are: the amount of blockage of the tube by the leukocyte which is quantiﬁed
by the leukocyte to tube diameter ration; the periodic length of the tube, which determines the distance
between the leukocyte and its periodic image; the contact angle between the leukocyte and the tube, which
may be non-zero due to the fact that the leukocyte does not always stay a fully exposed sphere; the overall
scale of the system with respect to red blood cells, which plays a role in larger wall-adhered cells such as
cancer cells; the mechanism by which the ﬂow is driven, constant ﬂow rate or constant pressure gradient;
tube hematocrit; mechanical properties of the red cells; and, ﬁnally, the numerically enforced minimum
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separation distance between the red cells with each other as well as the vessel walls including the leukocyte.
To start this investigation, two reference cases were studied closely. With the physiologically relevant
dimensions, a capillary diameter of 11.28 μm and a neutrophil diameter of 8.46 μm are chosen. The leukocyte
is fully exposed, occupying 75% of the diameter of the tube. The cell surfaces are discretized adequately
where a de-aliasing mechanism prevents the build up of energy in the unresolved scales. The vessel wall as
well as the leukocyte are also discretized using triangular elements where the no-slip condition is enforced.
A constant average tube velocity of 282 μm/s is achieved by a feedback mechanism that adjusts the pressure
gradient accordingly. In one case, only on red blood cell ﬂows over the wall-bound leukocyte and in the
other case six, yielding a tube hematocrit of 25%.
The net traction on the surface of the wall-bound leukocyte leads to lift, drag, lateral force, and their
resulting torque, which is balanced by the adhesion forces between the leukocyte and the vessel wall. The
surface traction can also be represented as shear or normal stress. The maximum traction, however, can act
as a mechanical stimulus for the cell and lead to a number of mechano-biochemical responses.
The ﬁrst observation is that a wall-bound leukocyte does not experience any net lift or lateral force in
case of a homogeneous Stokes ﬂow. This is due to the symmetry of the geometry. However, when red cells
are present, there is a net downward force that pushes the leukocyte toward the wall, and thereby further
promotes adhesion. The magnitude of this negative lift is between 152.9 pN to 179.9 pN for λ = 1 and 197.9
to 213.6 pN for λ = 5 for the single cell case. For HT = 25%, the negative lift is 157.4 to 247.3 pN for λ = 1
and 161.9 to 258.6 pN for λ = 5. In the vertical direction, in the case of a single red cell, the the increase
(using 4.2) in the maximum tensions are up to 103%, when the cells are downstream from the leukocyte,
and 271%, when upstream, relative to an apparent-viscosity-homogenized model of blood. When HT = 25%,
these enhancements are on average 158 and 188% and at most 413 and 448%, when λ = 1 and 5 respectively.
Also, in presence of red cells, the leukocyte experiences an oscillating net lateral force as the red cells
pass it. The net lateral tractions are between −89.9 to 47.2 pN for the HT = 25% case. The maximum
point-wise lateral tractions are 15% for a single cell and 87% for HT = 25% larger than the apparent-
viscosity-homogenized blood model for the single cell and HT = 25% cases respectively.
As expected, the strongest forces are in the direction of the ﬂow. Drag on the leukocyte in geometries of
our two reference cases with Dt = 11.28, introduced in Section 4.1, is 79.1 pN from plasma 100.1 pN from
a homogeneous blood with an apparent viscosity of 1.27 for HT = 25%, obtained from empirical relations
with tube diameter and hematocrit. The two reference cases show an increase in the average tractions in
the axial direction of up to 29% for the single red cell and 53% for HT = 25% relative to plasma and when
λ = 1. Similarly, when λ = 5 and relative to the apparent-viscosity-homogenized blood, these magniﬁcations
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are up to 47% for both the single red cell and HT = 25% cases. In terms of the maximum tractions, the
increases relative to homogeneous models are up to 109% and 254% for λ = 1 and relative to plasma and up
to 112% and 160% for λ = 5 relative to a blood model that has been homogenized by its apparent viscosity.
The increase in the tractions on the wall-bound leukocyte mentioned above is due to the importance of
the red blood cells at these scales. These values show that the homogeneous assumption of blood, even if its
viscosity is increased to reported bulk values for blood, will lead to signiﬁcant errors for the conﬁgurations
as presented here. This motivated the investigation of several conﬁgurational factors, assessing how they
aﬀect the forces and how well a homogeneous blood model would perform.
Diﬀerent factors that can aﬀect the forces exerted on the wall-bound leukocyte can be geometrical:
leukocyte to tube diameter ratio, periodic length of the tube, leukocyte contact angle, and the relative scale
of the red blood cells to the tube and wall-adhered cell or mechanical: the tube volume ﬂow rate and pressure
gradient or physiological: hematocrit and mechanical properties of the red cells. There is also a possibility
that aspects of the model can be important, and these need to be assessed as well. Speciﬁcally, we considered
the minimum separation distance enforced between the cells with each other and the vessel walls including
the leukocyte.
Changing the tube hematocrit from 4% to 25% increases the tractions that the leukocyte experiences.
The relative increase in the surface average tractions compared to homogeneous models are 28 to 42% for
λ = 1 compared to plasma and 28 to 42% for λ = 5. The maximum tractions increase 100 to 250% relative
to plasma for λ = 1 and 73 to 128% relative to the apparent-viscosity-homogenized model of blood for λ = 5.
Therefore, even at the smallest of the hematocrits (4.23%), a homogeneous-ﬂuid assumption signiﬁcantly
under-predicts the forces exerted on the wall-bound leukocyte.
As expected, for larger vessels the dynamic importance of single red cells passing by the leukocyte
diminishes. When the tube diameter is enlarged from 9.87 μm to 16.92 μm, the increase in the average
tractions, when there is only one red cell in the system, drops from 75% to 6% relative to plasma for
λ = 1 and from 42% (corresponding to Dt = 11.28 μm) to 4% relative to the apparent-viscosity-homogenized
model for λ = 5. At the same time, the maximum tractions from 175% to 13% compared to plasma for
λ = 1 and from 95% to 15% compared to the apparent-viscosity-homogenized model of blood for λ = 5. At
high hematocrits, e.g., HT = 25%, the trend is reversed. This is due to the persistent near-contact between
the leukocyte and red blood cells. The increase in the average tractions in this case climbs from 47 to 79%
for λ = 1 relative to plasma and from 30 to 40% for λ = 5 relative to the apparent-viscosity-homogenized
model. The maximum tractions substantially increase as the leukocyte interacts with more and more red
cells simultaneously when the tube diameter increases. This increase is 145 to 471% for λ = 1 relative to
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plasma and 128 to 317% for λ = 5 relative to the apparent-viscosity-homogenized case.
The periodic images of the leukocyte, eﬀectively make the conﬁguration of a single array of leukocytes.
At short tube periodic lengths of the tube, the red cells do not have enough room to fully recover from
passing the leukocyte and have to pass it again while still deformed. Therefore, they do not deform as much
in the subsequent ﬂow-bys and therefore, exert less traction on the leukocyte. Increasing the length of the
tube beyond 3Ds and to 5Ds results in a 10% increase in the average traction on the surface of the leukocyte.
To account for non-spherical shapes, changing the contact angle between the cell and the vessel, while
keeping its volume constant indicate that for more spread out cells, the forces that it experiences approach
the homogeneous limit. As the contact angle between the cell and the cylindrical substrate increases from 0
to 135 degrees, the relative increase in the average tractions from a single red cell drops from 28% to 8% and
42% to 5% for λ = 1 and λ = 5 compared to plasma and apparent-viscosity-homogenized cases, respectively.
This trend for HT = 25% is similar, but the relative increase in tractions are larger overall (47% to 28% and
47% to 12% for λ = 1 and λ = 5, respectively). The maximum traction follow the same trend and drop from
107 to 13 and 95 to 8% for the single cell cases and 145 to 49 and 128 to 21% when HT = 25% for λ = 1 and
λ = 5 compared to plasma and apparent-viscosity-homogenized blood, respectively.
Keeping the leukocyte-to-tube diameter ratio constant, the scale of the problem is enlarged relative to
the size of the red cells. In the large scale conﬁguration, a single red cell does not increase the tractions
experienced by the leukocyte as much as the reference smaller scale conﬁguration. This is because the
red cell only gets to interact with the top portion of the larger wall-bound cell and also, the gap between
the leukocyte and the vessel wall is larger and the red cell can pass it without much deformation which
is essentially responsible for the tractions it exerts on the leukocyte. However, in the HT = 25% case, the
tractions from both conﬁguration scales are comparable and signiﬁcantly enhanced relative to homogeneous
models of blood. The only diﬀerent across these scales is that the large scale geometry produces smoother
traction responses.
When the tube ﬂow rate or pressure gradient increases, the time scale at which red cells squeeze out the
plasma between them and the surface of the leukocyte diminished. This leads to a thicker lubrication layer
and hence smaller forces. As the red cells ﬂow faster, the tractions that the leukocyte experiences approach
the values from the homogeneous model. However, when the mean pressure gradient is kept constant, the
overall increase in the tractions on the leukocyte are much smaller compared to cases where the mean ﬂow
rate is kept constant with the same magnitude pressure gradients. The reason behind this phenomenon is
the fact that in case of constant pressure gradient along the tube, any blockage results in a slow-down of the
ﬂow and therefore, smaller tractions on the leukocyte. In the constant ﬂow rate cases, blockage is followed
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by an increase in pressure gradient in order to maintain the ﬂow rate. For example, in a 11.28 μm diameter
vessel with a 8.46 μm leukocyte adhered to its wall, in order to maintain a 28181 μm3/s ﬂow rate, the mean
pressure gradient increases from 0.5 Pa/μm to 0.65 Pa/μm every time the red cell passes the leukocyte. It is
not clear if keeping the ﬂow rate constant is more physiologically relevant rather than keeping the pressure
gradient constant. Both conditions have been used in vitro.
In terms of the mechanical properties of red cells, the eﬀect of their shear modulus on the tractions that
they exert on the leukocyte is more dominant compare to their bending modulus. Stiﬀer red cells, like the
ones infected with malaria in which, the invading organism changes the molecular structure of the red cell
and increases its rigidity,250 cause larger tractions. Therefore, the experiments commonly performed with
gelatin pellets and elastic and rubber discs as models for red blood cells may over-predict the tractions that
have been recorded on the leukocyte.
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Appendix A
Simulation Results
Here we provide the conﬁguration overview and time histories of the force densities on the wall-bound
leukocyte for the cases discussed in Chapter 4.
Figure A.1: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=2 (HT = 8.46%).
Table A.1: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 25.38 0 2 8.46 28181 282 24 3
139
0 100 200 300 400 500 600 700−15
−10
−5
0
5
10
15
t (ms)
σ
x
(P
a)
(a)
0 100 200 300 400 500 600 700−30
−25
−20
−15
−10
−5
0
5
10
15
t (ms)
σ
y
(P
a)
(b)
0 100 200 300 400 500 600 700
5
10
15
20
25
t (ms)
σ
z
(P
a)
(c)
0 100 200 300 400 500 600 700
0
50
100
150
200
250
t (ms)
 σ
z
(%
)
(d)
Figure A.2: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and maximum
tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the λ = 1 range
and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to homogeneous
is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=2 (HT = 8.46%).
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Figure A.3: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=4 (HT = 16.92%).
Table A.2: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 25.38 0 4 16.92 28181 282 24 3
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Figure A.4: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and maximum
tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the λ = 1 range
and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to homogeneous
is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=4 (HT = 16.92%).
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Figure A.5: Dt = 9.87 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=1 (HT = 5.78%).
Table A.3: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 9.87 25.38 0 1 5.78 28181 368 32 5
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Figure A.6: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and maximum
tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the λ = 1 range
and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to homogeneous
is presented in (d); Dt = 9.87 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=1 (HT = 5.78%).
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Figure A.7: Dt = 12.69 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=1 (HT = 3.25%).
Table A.4: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 12.69 25.38 0 1 3.25 28181 223 24 3
145
0 100 200 300 400 500 600 700−2
−1.5
−1
−0.5
0
0.5
1
1.5
2
t (ms)
σ
x
(P
a)
(a)
0 100 200 300 400 500 600 700−5
0
5
t (ms)
σ
y
(P
a)
(b)
0 100 200 300 400 500 600 7000
2
4
6
8
10
t (ms)
σ
z
(P
a)
(c)
0 100 200 300 400 500 600 700
0
50
100
150
200
250
t (ms)
 σ
z
(%
)
(d)
Figure A.8: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and maximum
tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the λ = 1 range
and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to homogeneous
is presented in (d); Dt = 12.69 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=1 (HT = 3.25%).
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Figure A.9: Dt = 14.1 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=1 (HT = 2.58%).
Table A.5: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 14.1 25.38 0 1 2.58 28181 180 16 3
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Figure A.10: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 14.1 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=1 (HT = 2.58%).
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Figure A.11: Dt = 16.92 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=1 (HT = 1.74%).
Table A.6: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 16.92 25.38 0 1 1.74 28181 125 16 3
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Figure A.12: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 16.92 μm, Ds = 8.46 μm, Lz = 25.38 μm, and nRBC=1 (HT = 1.74%).
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Figure A.13: Dt = 14.1 μm, Ds = 8.46 μm, Lz = 26.09 μm, and nRBC=10 (HT = 25.0%).
Table A.7: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 14.1 26.09 0 10 25.0 28181 180 16 3
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Figure A.14: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 14.1 μm, Ds = 8.46 μm, Lz = 26.09 μm, and nRBC=10 (HT = 25.0%).
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Figure A.15: Dt = 16.92 μm, Ds = 8.46 μm, Lz = 26.48 μm, and nRBC = 15 (HT = 25.0%).
Table A.8: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 16.92 26.48 0 15 25.0 28181 180 16 3
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Figure A.16: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 16.92 μm, Ds = 8.46 μm, Lz = 26.48 μm, and nRBC = 15 (HT = 25.0%).
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Figure A.17: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 18.21 μm, and nRBC=1 (HT = 6.25%).
Table A.9: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 18.21 0 1 6.25 28181 282 24 3
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Figure A.18: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 18.21 μm, and nRBC=1 (HT = 6.25%).
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Figure A.19: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 44.53 μm, and nRBC=1 (HT = 2.27%).
Table A.10: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 44.53 0 1 2.27 28181 282 24 3
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Figure A.20: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 44.53 μm, and nRBC=1 (HT = 2.27%).
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Figure A.21: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 18.21 μm, and nRBC=4 (HT = 25.0%).
Table A.11: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 18.21 0 4 25.0 28181 282 24 4
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Figure A.22: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 18.21 μm, and nRBC=4 (HT = 25.0%).
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Figure A.23: Dt = 11.28 μm, Ds = 8.46 μm, Lz = 44.53 μm, and nRBC=11 (HT = 25.0%).
Table A.12: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 44.53 0 1 25.0 28181 282 24 3
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Figure A.24: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 44.53 μm, and nRBC=11 (HT = 25.0%).
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Figure A.25: Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 25.66 μm, θ = 45○, and nRBC=1 (HT = 4.18%).
Table A.13: Case speciﬁcations.
Eqv. Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 25.66 45 1 4.18 28181 282 24 3
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Figure A.26: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared
to homogeneous is presented in (d); Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 25.66 μm, θ = 45○, and
nRBC=1 (HT = 4.18%).
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Figure A.27: Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 37.51 μm, θ = 90○, and nRBC=1 (HT = 2.74%).
Table A.14: Case speciﬁcations.
Eqv. Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 37.51 90 1 2.74 28181 282 16 3
165
0 100 200 300 400 500 600−1.5
−1
−0.5
0
t (ms)
σ
x
(P
a)
(a)
0 100 200 300 400 500 600−4
−3
−2
−1
0
1
2
3
4
t (ms)
σ
y
(P
a)
(b)
0 100 200 300 400 500 6001
1.5
2
2.5
3
3.5
4
t (ms)
σ
z
(P
a)
(c)
0 100 200 300 400 500 600
0
10
20
30
40
50
60
70
80
t (ms)
 σ
z
(%
)
(d)
Figure A.28: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared
to homogeneous is presented in (d); Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 37.51 μm, θ = 90○, and
nRBC=1 (HT = 2.74%).
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Figure A.29: Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 52.17 μm, θ = 135○, and nRBC=1 (HT = 1.92%).
Table A.15: Case speciﬁcations.
Eqv. Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 52.17 135 1 1.92 28181 282 16 3
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Figure A.30: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 52.17 μm, θ = 135○, and
nRBC=1 (HT = 1.92%).
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Figure A.31: Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 25.66 μm, θ = 45○, and nRBC=6 (HT = 25.0%).
Table A.16: Case speciﬁcations.
Eqv. Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 25.66 45 6 25.0 28181 282 24 3
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Figure A.32: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared
to homogeneous is presented in (d); Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 25.66 μm, θ = 45○, and
nRBC=6 (HT = 25.0%).
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Figure A.33: Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 37.51 μm, θ = 90○, and nRBC=9 (HT = 25.0%).
Table A.17: Case speciﬁcations.
Eqv. Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 37.51 90 9 25.0 28181 282 16 3
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Figure A.34: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared
to homogeneous is presented in (d); Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 37.51 μm, θ = 90○, and
nRBC=9 (HT = 25.0%).
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Figure A.35: Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 52.17 μm, θ = 135○, and nRBC=13 (HT = 25.0%).
Table A.18: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
8.46 11.28 52.17 135 13 25.0 28181 282 16 3
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Figure A.36: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, equivalent Ds = 8.46 μm, Lz = 52.17 μm, θ = 135○, and
nRBC=13 (HT = 25.0%).
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Figure A.37: Dt = 16.92 μm, Ds = 12.69 μm, Lz = 38.07 μm, and nRBC=1 (HT = 1.25%).
Table A.19: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
12.69 16.92 38.07 0 1 1.25 28181 125 16 3
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Figure A.38: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 16.92 μm, Ds = 12.69 μm, Lz = 38.07 μm, and nRBC=1 (HT = 1.25%).
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Figure A.39: Dt = 16.92 μm, Ds = 12.69 μm, Lz = 38.18 μm, and nRBC=20 (HT = 25.0%).
Table A.20: Case speciﬁcations.
Ds (μm) Dt (μm) Lz (μm) θ (degree) nRBC HT Q (μm
3/s) ⟨Uz⟩t μm/s N M/N
12.69 16.92 38.18 0 20 25.0 28181 125 16 3
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Figure A.40: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 16.92 μm, Ds = 12.69 μm, Lz = 38.07 μm, and nRBC=20 (HT = 25.0%).
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Figure A.41: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=1 (HT = 4.23%), and⟨Uz⟩t = 141 μm/s.
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Figure A.42: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=1 (HT = 4.23%), and⟨Uz⟩t = 564 μm/s.
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Figure A.43: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=1 (HT = 4.23%), and⟨Uz⟩t = 1.41 mm/s.
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Figure A.44: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=6 (HT = 25.38%),
and ⟨Uz⟩t = 141 μm/s.
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Figure A.45: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=6 (HT = 25.38%),
and ⟨Uz⟩t = 564 μm/s.
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Figure A.46: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=6 (HT = 25.38%),
and ⟨Uz⟩t = 1.41 mm/s.
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Figure A.47: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=1 (HT = 4.23%), and−⟨∂p
∂z
⟩ = 0.25 Pa/μm.
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Figure A.48: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=1 (HT = 4.23%), and−⟨∂p
∂z
⟩ = 0.55 Pa/μm.
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Figure A.49: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=1 (HT = 4.23%), and−⟨∂p
∂z
⟩ = 0.85 Pa/μm.
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Figure A.50: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=1 (HT = 4.23%), and−⟨∂p
∂z
⟩ = 2.55 Pa/μm.
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Figure A.51: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=6 (HT = 25.38%),
and −⟨∂p
∂z
⟩ = 0.34 Pa/μm.
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Figure A.52: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=6 (HT = 25.38%),
and −⟨∂p
∂z
⟩ = 0.72 Pa/μm.
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Figure A.53: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=6 (HT = 25.38%),
and −⟨∂p
∂z
⟩ = 1.27 Pa/μm.
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Figure A.54: Time histories of components of surface averaged tractions ⟨σ⟩ for λ = 1 and λ = 5 and
maximum tractions σmax for λ = 1 and λ = 5 . The dashed lines are the homogeneous cases of plasma in the
λ = 1 range and apparent-viscosity-homogenized blood in the λ = 5 range. The relative change compared to
homogeneous is presented in (d); Dt = 11.28 μm, Ds = 8.46 μm, Lz = 25.38 μm, nRBC=6 (HT = 25.38%),
and −⟨∂p
∂z
⟩ = 3.19 Pa/μm.
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Appendix B
Two-dimensional implementation
In this appendix we present the implementation of the two-dimensional version of the approach presented in
Chapter 2. We brieﬂy present the formulation for a two-dimensional model (the full derivation is available
in Section C.1), its membrane representation and traction, as well as the vessel wall model. Then in
Section B.7 we demonstrate its accuracy and asses its computational cost. In Section B.9 we extensively
study the implicit linear system that arises and must be solved, when there is a mismatch of viscosity
between the inside and outside of the red cell membranes. A particularly important aspect of this is that
the system becomes singular at two limiting eigenvalues, when the viscosity inside the cells is relatively large
or small. The formulation for deﬂation of these eigenvalues out of the system is presented in Section B.10.
Two iterative methods to solve the system and their performance are presented in Section B.11.
B.1 Formulation
Following the formulation in Section 2.1, in two dimensions
uj(x0) = − 1
2πμ(1 + λ) ∫D fi(x)Gij(x,x0)ds(x)
+ 1 − λ
2π(1 + λ) ∫D ui(x)Tijk(x,x0)nk(x)ds(x)
+ 2
1 + λ ⟨uj⟩ . (B.1)
The equivalent equations for (2.24) and (2.25) as well as (2.27) and (2.28) in two dimensions are
Gsrij(x,y) = ∑
a
Φ1 (r˜2) δij
2
+∑
a
e−r˜
2 (rirj
r2
− δij) , (B.2)
Gsmij (x,y) = αV ∑k≠0Φ1 (k˜2) (k˜2δij − k˜ik˜j)ei2πk⋅(x,y), (B.3)
T˘ srijl(x,y) = −4√πα∑a Φ1(r˜2)r˜ir˜j r˜l, (B.4)
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and
T˘ smijl (x,y) = √αV ∑k≠0(i2√π)(kiδjl + kjδil + klδij)Φ0(k˜2)ei2πk⋅(x−y)
+ 2α3/2√
πV
∑
k≠0
(i2π)2kikjklΦ1(k˜2)ei2πk⋅(x−y), (B.5)
where k = (N1/L1,N2/L2,N3/L3) is the wave number and k˜ = √παk is non-dimensional. The function Φ1
in (2.25) is an incomplete γ-function deﬁned
Φγ(z) = ∫ ∞
1
e−zttγ dt. (B.6)
An approximation to Φ1 is used from Abramowitz and Stegun
253 which has the form
0 ≤ x ≤ 1 ∶ E1(x) = a0 + a1x + a2x2 + a3x3 + a4x4 + a5x5 − ln(x) +O(2 × 10−7)
1 ≤ x < ∞ ∶ E1(x) = x4 + b1x3 + b2x2 + b3x + b4
xex(x4 + c1x3 + c2x2 + c3x + c4) +O(2 × 10−8),
(B.7)
where a1 through c4 are constants. Smooth particle-mesh Ewald (SPME) method (see Section 2.4) is then
used to calculate the smooth portions of the Ewald sums.
B.2 Cell surface representation and traction
Red cell resistance to deformation comes solely from their membrane, which is a lipid bilayer supported
by a network of extremely elastic spectrin molecules.254, 255 The membrane is strongly resistant to area
changes but at the same time shows weak resistance to bending. Leukocytes are modeled as relatively stiﬀ
membranes.185
In our model a linear tension and bending contribute to the traction f , within the membrane.115 Tension
has a form
τ = T ( ds
ds0
− 1), (B.8)
where T is the tension modulus, s(s0) is the local arc length and s0 is the referential arc length when the
cell is in its tension free length of l0 which is greater than 2πr0, the perimeter of a circular reference cell.
Bending moment is
b =M(C −C0), (B.9)
where M is the bending modulus, C(s0) is the local curvature and C0 is a constant reference curvature.
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Ultimately the traction comes from
f = ∂τ
∂s
t + ∂
∂s
(∂b
∂s
n) . (B.10)
B.3 Initial condition
The cells are initialized as circles. With l0 > 2πr0 (see Section B.2), the cells are under compression and
therefore they transition to their minimum energy biconcave shape where they are essentially tension free.
This process happens fairly quickly and it is computationally cheap. Figure B.1 shows this process for a
single cell in a quiescent ﬂow.
(a) t = 0 (b) t = 700 dt (c) t = 900 dt
(d) t = 1100 dt (e) t = 2000 dt (f) t = 4000 dt
Figure B.1: Relaxation of a cell in a quiescent ﬂow from a circular to a biconcave shape.
B.4 Wall boundaries
For walls, one could include the images of the free-space Green’s functions to form new Green’s functions
that include the walls,256 but this would restrict us to only simple geometries. Instead we use a penalty-like
method commonly used in ﬁnite-element formulations. We impose the no-slip condition on boundaries that
are not ﬁxed in space and are allowed to move by an arbitrarily small amount.14 The points on the wall
construct Δsw elements that are not coupled to each other. They are simply ﬁxed to their reference location,
xw, by a virtual spring (Figure B.2), then
Δσw = −kw(x − xw) (B.11)
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Figure B.2: Wall setup.
The velocity at the points on the wall goes through the same formulation as the other points on the cell
membranes. The spring constant kw is selected to be large enough so that the wall movements are small
compared to the other dynamic features of the system. The results have been shown to be insensitive to kw,
however the spring constant restricts the stability limit of the time integrator.
B.5 Aliasing errors
The membrane dynamics are governed by the ﬁnite-deformation thin-shell equations257 but they are a highly
nonlinear diﬀerential system even for linear constitutive models. We evaluate f , the traction needed by the
ﬂow solver, using global spectral basis functions. This method has several advantages over ﬁnite-element
or other formulations. It has super-algebraic convergence which minimizes the number of points needed to
represent the membrane(s) that leads to huge savings in the ﬂow solver. But more importantly it facilitates
dealiasing.214 The nonlinearity of the ﬁnite deformation formulation of thin-shell mechanics for the cell
membranes leads to a buildup of energy in high wavenumbers. This buildup is slow, leading to long-time
instability of the algorithms.213 Polynomial ﬁltering is often applied to suppress the instabilities caused by
the process,258 but this will dissipate deformations at all scales. As mentioned in Section 2.5, de-aliasing
removes this small unresolvable energy outright, before it aﬀects the resolved wave numbers carried in the
simulations.14, 136, 137
B.6 Cell area
In principal, the boundary integral formulation preserves the area of the two dimensional cell, but the discrete
version of it, presented in Section B.1, performs this only approximately. The errors in between consecutive
time steps are negligible but since these systems sometimes run for tens of thousands of time steps this error
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could grow. To prevent such a build up, following Freund,14 we constrain the area of each cell
A = 1
2
∫
Ωc
x.nds, (B.12)
by seeking perturbations z that minimize
I = λ [∫
Ωc
1
2
(x − z).nds −A0] + ∫
Ωc
z.zds, (B.13)
where A0 is the initial area of the cell and λ is a Lagrange multiplier. The variation I,
δI = δλ [∫
Ωc
z.n
2
ds + (A −A0)] + ∫
Ωc
δz.(2z + λ
2
n)ds, (B.14)
is zero for the z we seek. For arbitrary δz, the second term gives
z = −λn
4
, (B.15)
and with this and for arbitrary δλ, the ﬁrst term gives
λ = 8A −A0
P
, (B.16)
where P is the perimeter of the cell before the correction. Since z ∝ n, this correction does not aﬀect n,
which is consistent with neglecting the variation of n in B.14. This correction is applied every time step and
has an approximately relative magnitude of 0.001%.
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B.7 Performance analysis
In (B.1), assuming a viscosity ratio of λ = 1 eliminates the term implicit in u. This yields much less expensive
computations since there is no linear system to solve, as will be discussed further in Section B.9. However,
for the case of red blood cells, λ = 5 and viscosity mismatch must be taken into account.
B.7.1 Accuracy
Following Section 2.8.1, there are four parameters that can determine the accuracy and cost of a simulation:
the splitting parameter α, the cut-oﬀ radius for the short range sum rc, the resolution of the underlying FFT
mesh of the smooth portion of the sum Ki, and the order of the interpolation scheme used to interpolate
the smooth sum onto the mesh and back. A systematic process has been employed to investigate the eﬀect
of these parameters on the accuracy of the results.
A test case was conducted where 16 cells of diﬀerent sizes with diﬀerent traction in their membrane ﬂowed
in a period box of size 15 × 15, nondimensionalized by the equivalent radius of cells, r0. The background
velocity is a sinusoidal shear of the form
u∞ =U∞ sin(4πy
Ly
) . (B.17)
Figure B.3 shows a visualization of the simulation after the transient time has passed. At this instance the
solution for diﬀerent sets of parameters is compared with an arbitrarily accurate Ewald sum with a large
cut-oﬀ radius and large FFT mesh beyond which, the error converges to the minimum threshold achievable
computationally. This is an independent expensive calculation but it is done only once. We quantify error
by
 =!""# 1
N
N∑
n=1
(uEn − un)2. (B.18)
For a given cut-oﬀ radius and FFT mesh resolution, it is clear from Figure B.4 that there is an α that
minimizes error. The trends in Figure B.4 have been captured for computationally similar simulations of
Deserno and Holm231, 232 and Sierou and Brady.241 Eﬀorts have been made to estimate contributions to the
error from either sums but they are mainly for structured homogeneous systems.242, 243
As the cut-oﬀ radius gets larger for the same FFT mesh resolution, better accuracy is achieved with an
optimum α that increases with rc. Note that the accuracy saturates around ε ≈ 10−8, which is the ﬂoor for
the error, enforced by the substituted ﬁt of (B.7) for the exponential integrals. As the FFT mesh resolution
is reﬁned, the error drops further but the optimum α decreases with Ki, the size of the spectrum. This
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Figure B.3: Test case for evaluating the accuracy of the method in two dimensions.
behavior of α is expected because increasing it increases the relative contribution of the short range portion
of the sum and visa versa.
By varying rc and at the same time varying α to maintain the best performance from the short range
sum, we are in essence tracking the minimum values for the optimum α’s of Figure B.4. The curves following
these points are shown in Figure B.5. As the FFT mesh gets reﬁned the accuracy increases for a given rc.
However, it is evident that beyond a certain resolution of the FFT mesh, the gain in terms of accuracy
becomes small while reﬁning the FFT mesh resolution greatly impacts the cost of the algorithm.
In terms of the interpolation order, the error is bounded by (2∣k∣/K)p 244 and thus behaves like K−p.
Figure B.6 shows that our solution follows this trend as the order of the B-spline changes within the algorithm.
B.8 Computational cost
This section follows the same steps as in Frenkel259–261 in order to determine the computational cost of each
portion of the Ewald sum. Let’s assume a uniform distribution of points in a square computational domain.
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Figure B.4: The eﬀect of α, rc and the FFT mesh resolutions of 64× 64, 128× 128, 256× 256, and 512× 512
on the error.
10−1 100
10−9
10−8
10−7
10−6
10−5
10−4
10−3
10−2
10−1

rc
Figure B.5: The eﬀect of rc and the FFT mesh reso-
lutions of 64 × 64, 128 × 128, 256 × 256, and 512 × 512
on the error.
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Figure B.6: The eﬀect of the order of the interpolation
scheme on the error; p = 2, p = 3, p = 4, p = 5, and
p = 6. The dashed lines correspond to K−p for each
interpolation order.
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Then the number of points within a disc with radius rc would be
Nrc = πr2cL2 N, (B.19)
and the equivalent number of discs of radii rc per computational domain would be
nrc = L2πr2c , (B.20)
therefore the computational cost of calculating the short range portion of the sum
tr ∝ N2rcnrc or tr = τr πr2cL2 N2, (B.21)
where τr is the time it takes to calculate the real part for one point. The other signiﬁcant factor in the total
computational cost is calculation of the Fourier part of the integral. By taking advantage of the FFTs the
cost per evaluation is
tf ∝K2 logK or tf = τfK2 logK, (B.22)
where K is the number of grid points in each dimension (square for now), and τf is the time of evaluation
per mesh point. The force interpolation to and from the grid as well as making the neighbor lists for the
real part scale as N . Therefore the total cost per time step comes down to
t = τr πr2c
L2
N2 + τfK2 logK. (B.23)
An optimum α makes the leading error terms in the real and Fourier parts of the sum, to be of the same
order. Recalling the leading error terms of each part
εr ∝ exp(−πr2max
α
) , (B.24)
where the maximum distance between two points cannot exceed the cut-oﬀ radius, hence
rmax = rc, (B.25)
and
εf ∝ (1 + παk2max) exp (−παk2max) , (B.26)
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where the maximum wavenumber is
kmax = K
L
. (B.27)
For an optimum α
ε = exp(−πr2c
α
) = exp(−παK2
L2
) , (B.28)
which leads to an explicit relation between the three unknown key parameters which need to be determined
αK
L
= rc. (B.29)
But from the real part of the error one could extract
α = −πr2c
ln ε
, (B.30)
which ultimately relates the FFT mesh resolution to the cut-oﬀ radius
rc = − ln ε
π
L
K
. (B.31)
Substituting for rc in (B.23)we have
t = τr (log ε)2N2
π
K−2 + τfK2 logK. (B.32)
Minimizing the equation yields
dt
dK
= −2τr (log ε)2N2
π
K−3 + τf (2K logK +K) = 0, (B.33)
and multiplying by K3 gives
2τfK
4 logK + τfK4 − 2τr (log ε)2N2
π
= 0. (B.34)
Solving (B.34) results in
K = exp [1
4
W (4τre2(log ε)2N2
τfπ
) − 1
2
] , (B.35)
where W is the Lambert W-function function which satisﬁes
W (x) exp [W (x)] = x. (B.36)
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This approximation is made rather naively. It only provides us with an estimate for the computationally
optimum FFT mesh resolution. A full estimate is needed to get the suitable combination of (α, rc,K). This
can be done empirically, meaning, we have to follow the same steps as we did in section B.7.1 and map the
accuracy of a particular case, then pick a few set of parameters that satisfy the accuracy requirements (along
a horizontal line on Figure B.4) and ﬁnd the set that minimizes CPU time. If Kolafa et al.242 or Deserno
and Holm231, 232 were to be followed in order to estimate the errors, membrane forces and local geometries
are needed to get a full estimate of the error and that requires running some test cases.
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B.9 Mismatched viscosity
As a linear system (B.1) has the form
u =R + βAu, (B.37)
where
β = 1 − λ
1 + λ (B.38)
It is well known that at the limiting cases of λ→ 0 (β → 1), air bubble, and λ →∞ (β → −1), solid particle,
the solution does not converge (analytically) or converges very slowly (numerically).200 This behavior is due
to the presence of certain eigenfunctions in the generalized homogeneous integral equation
u = β∗Au, (B.39)
which lead to singularities at these two limits.200, 262, 263 In three dimensions A has eigenvalues λA = 1 of
multiplicity one and λA = −1 of multiplicity six.264 In two dimensions the multiplicity of these eigenvalues
are one and three respectively. From the equation above, it can be seen that when β = 1 or β = −1 these
eigenvalues of A result in a singular system.
Matrix A is not explicitly formed throughout the computational process. Instead the matrix vector
multiplication of Au is computed using same methods as in calculating R. However, for analyzing its
properties it is possible to form the matrix A using a perturbation method. We consider a case with 2 cells.
At several instances after the ﬂow is developed the following conﬁgurations are studied. The reason for these
six conﬁgurations is to observe how diﬀerent interactions between cells in both a smaller domain (higher
hematocrit) and a larger one (lower hematocrit) aﬀects the structure of matrix A. There are 80 points per
cell and two velocity components per point, hence A is 320 × 320. The vector u has the form
u = [ u11 u12 u21 u22 ⋯ uNp1 uNp2 , ]T (B.40)
where the superscripts are the point indices and subscripts indicate the two velocity components. Therefore,
A consists of 2 by 2 blocks whose components are collectively presented in each of the Figures B.8-B.13. The
inﬂuence of points on diﬀerent velocity components of each other is evident from the ﬁgures. This structure,
resulting from cell-cell interactions, could potentially be used as a pre-conditioner for matrix A.
Figures B.14-B.19 show the eigenspectrum of A for conﬁgurations shown in Figure B.7. These ﬁgures
show the +1 and −1 eigenvalues existing for all these diﬀerent cases. A deﬂation formulation, as described
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(a) Case a (b) Case b (c) Case c (d) Case d
(e) Case e (f) Case f
Figure B.7: 2 cells in 6 × 6 (cases a-d) and 16 × 16 (cases e and f) domains.
in the next section, will eﬀectively remove these eigenvalues from the system.
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Figure B.8: Matrix A and its components for the case shown in Figure B.7(a).
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Figure B.9: Matrix A and its components for the case shown in Figure B.7(b).
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Figure B.10: Matrix A and its components for the case shown in Figure B.7(c).
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Figure B.11: Matrix A and its components for the case shown in Figure B.7(d).
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Figure B.12: Matrix A and its components for the case shown in Figure B.7(e).
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Figure B.13: Matrix A and its components for the case shown in Figure B.7(f).
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Figure B.14: Eigenvalues of the matrix formation (Figure B.8(a)) for conﬁguration in Figure B.7(a).
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Figure B.15: Eigenvalues of the matrix formation (Figure B.9(a)) for conﬁguration in Figure B.7(b).
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Figure B.16: Eigenvalues of the matrix formation (Figure B.10(a)) for conﬁguration in Figure B.7(c) .
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Figure B.17: Eigenvalues of the matrix formation (Figure B.11(a)) for conﬁguration in Figure B.7(d).
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Figure B.18: Eigenvalues of the matrix formation (Figure B.12(a)) for conﬁguration in Figure B.7(e).
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Figure B.19: Eigenvalues of the matrix formation (Figure B.13(a)) for conﬁguration in Figure B.7(f).
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B.10 Deflation of the stresslet
Starting from the Fredholm integral equation of the second kind for the velocity of the points on the
membrane(s)
ui(xm) = Ri(xm) − β
2π
N∑
n=1
Tijk(xnm)uj(xn)nk(xn)Δs0(xn) ds
ds0
∣n for m = 1, ...,N, (B.41)
where
β = 1 − λ
1 + λ, (B.42)
we discussed in section B.9 that at the two limits of λ → 0 and λ → ∞, the system becomes singular. In
practice, when the value of λ is too large or too small the iterative scheme becomes expensive to solve for u.
To accelerate the iterative process, we deﬂate B.41 by using the eigenfunctions of the homogeneous integral
equation or its adjoint corresponding to λ→ 0 and λ→∞.200, 265 The deﬂated system, then, is given by
u′i(xm) = Ri(xm) − β2π N∑n=1Tijk(xnm)u′j(xn)nk(xn)Δs0(xn) dsds0 ∣
n
− Nc∑
p=1
β
Lpc
ni(xm)Npc∑
q=1
u′j(xq)pnj(xq)pΔs0(xq)p dsds0 ∣qp
+ Nc∑
p=1
β
⎡⎢⎢⎢⎢⎣ 1Lpc
Npc∑
q=1
u′j(xq)pΔs0(xq)p dsds0 ∣qp
+ uˆ(3)j (xm)Npc∑
q=1
u′(xq)p.uˆ(3)(xq)pΔs0(xq)p ds
ds0
∣q
p
⎤⎥⎥⎥⎥⎦ ,
(B.43)
where Lc is the perimeter of each cell, Nc is the number of cells, Npc is the number of points per cells. uˆ
(3),
which expresses rotation about the z axis, is deﬁned as
uˆ(3)(x) = e3 × (x − xC){∑Npcq=1 [e3 × (xq − xC)] . [e3 × (xq − xC)]Δs0(xq) dsds0 ∣q}1/2 , (B.44)
where e3 is the unit vector in the z direction and x
C is the location of the centroid of each cell. The deﬂated
system in B.43 indeed does not carry +1 and −1 eigenvalues as shown in ﬁgures B.22. The iterative solver
is then applied to the deﬂated system. Finally, to recapture the original velocity vector
u(xm) = u′(xm)+ β
1 + β Nc∑p=1
⎡⎢⎢⎢⎢⎣ 1Lpc
Npc∑
q=1
u′j(xq)pΔs0(xq)p dsds0 ∣qp + uˆ(3)j (xm)
Npc∑
q=1
u′(xq)p.uˆ(3)(xq)pΔs0(xq)p ds
ds0
∣q
p
⎤⎥⎥⎥⎥⎦ .
(B.45)
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B.11 Iterative methods: GMRES vs BiCGSTAB
We now consider a more complex conﬁguration of 16 cells, 40 points per cell in a 30 × 30 domain. The A
Figure B.20: 16 cells in a 30 × 30 domain.
matrix and its components at this instance are shown in Figure B.21. The marginal eigenvalues are present in
Figure B.22(a). A deﬂation process as formulated in Section B.10, eﬀectively removes them (Figure B.22(b)).
The eﬀect of deﬂation on the convergence history of the iterative process using generalized minimum residual
(GMRES217, 266) method with restart is presented in Figure B.23 for a wide range of viscosity ratios. As
the size of the Krylov subspace m is increased, the solution converges faster, however it is more expensive
to use a larger subspace. This trend becomes more pronounced as the viscosity ratios approach the two
marginal values of (∞ and 0). Expanding the size of the Krylov subspace beyond 30 has a small eﬀect on the
performance of GMRES on the non-deﬂated system. Deﬂation on the other hand improves the performance
of GMRES by two folds for λ = 0.01 and almost three folds for λ = 100, but it has little eﬀect on smaller
viscosity ratios. Note that for the deﬂated system, increasing the size of the Krylov subspace is not as
eﬀective as when the system is near singular.
Another method for non-symmetric matrices that was examined for this iterative process is stabilized bi-
conjugate gradient (BiCGSTAB267, 268). To observe the speed up gained by deﬂation and BiCGSTAB more
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(a) Matrix A
(b) 11 components (c) 12 components
(d) 21 components (e) 22 components
Figure B.21: Matrix A and its components for the case in Figure B.20.
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(a) Eigenspectrum without deﬂation.
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(b) Eigenspectrum with deﬂation.
Figure B.22: Eigenvalues of the matrix formation (Figure B.21(a)) for conﬁguration in Figure B.20.
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(a) Convergence without deﬂation.
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(b) Convergence with deﬂation.
Figure B.23: Convergence of GMRES for diﬀerent values of viscosity ratio and Krylov subspace size (solution
to the case in Figure B.20); — m = 3, – – m = 10, – ⋅ m = 30, ⋯ m = 60.
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clearly, number of iterations (Figure B.24) and CPU run times (Figure B.25) for a wide range of viscosity
ratios (separated by 7 orders of magnitude) and a number of Krylov subspace sizes are presented. The
branches without deﬂation could not be explored further since the solver failed to converge for these nearly
singular cases. Subﬁgure (b) in each ﬁgure corresponds to a zoomed-in version of the range of interest for
red blood cells (λ = 5). BiCGSTAB cuts the number of iterations by 3 folds for some cases but since it uses
two matrix-vector multiplies per iteration compared to one for GMRES, its performance in terms of CPU
time becomes comparable to deﬂated GMRES. However, for the upper bound limit of the viscosity ratio, as
the cells become rigid particles, BiCGSTAB requires only half the CPU time needed by any of the deﬂated
GMRES cases.
Looking closely at the zoomed-in ﬁgures, for the range of viscosity ratios that we are interested in,
deﬂation improves the performance of the GMRES. This speed-up, though small, can make a diﬀerence
when the system needs to be solved thousands or millions of times.
Figures B.26, B.27(a) and B.27(b) show bigger systems of 50 and 100 cells. The 100 cell case is studied
in two diﬀerent domains of size 27× 27 and 50× 50. The performance of GMRES and BiCGSTAB for these
cases are presented in Figures B.28-B.33. Figures B.32 and B.33 reveal that if the cells are in a conﬁned
domain (high hematocrit with more cell-cell interactions), the system becomes more expensive to solve.
The performances of GMRES and BiCGSTAB with respect to the size of the system they are solving
are presented in Figures B.34 and B.35. Figure B.34 shows the trend for the number of iterations and CPU
time for λ = 50 as the system gets larger. From the two diﬀerent points at Np = 4000, it is clear that
hematocrit aﬀects the conditioning of the system. The point with the larger value in both subﬁgures for the
CPU time and number of iterations corresponds to 100 cells of area π (non-dimensional) in a 27×27 domain.
In this case the hematocrit is 43%. On the other hand the point with the smaller value is a less expensive
computation with better conditioning of the iterative process. This point corresponds to a conﬁguration
with a hematocrit of 12.5%. This is the case for the deﬂated system as well. Figure B.34 shows the same
comparison for λ = 5 which is the viscosity ratio of the red blood cells. It is clear that the diﬀerence between
various Krylov subspace sizes as well as deﬂated GMRES and GMRES without deﬂation and BiCGSTAB
becomes less pronounced as the viscosity ratio deviates from the limiting values of ∞ and 0.
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(a) Number of iterations vs. viscosity ratio.
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(b) A zoomed-in region of interest (the viscosity ratio for red blood cells is 5).
Figure B.24: A comparison between GMRES and BiCGSTAB number of iterations for the conﬁguration in
Figure B.20; m is the size of the Krylov subspace for the GMRES method.
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(a) CPU time vs. viscosity ratio.
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(b) A zoomed-in region of interest (the viscosity ratio for red blood cells is 5).
Figure B.25: A comparison between GMRES and BiCGSTAB CPU time for the conﬁguration in Figure B.20;
m is the size of the Krylov subspace for the GMRES method.
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Figure B.26: 50 cells in a 40 × 40 domain.
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(a) Domain size: 27 × 27.
(b) Domain size: 50 × 50.
Figure B.27: 100 cells in 27 × 27 and 50 × 50 domains.
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(a) Number of iterations vs. viscosity ratio.
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(b) A zoomed-in region of interest (the viscosity ratio for red blood cells is 5).
Figure B.28: A comparison between GMRES and BiCGSTAB number of iterations for the conﬁguration in
Figure B.26; m is the size of the Krylov subspace for the GMRES method.
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(a) CPU time vs. viscosity ratio.
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(b) A zoomed-in region of interest (the viscosity ratio for red blood cells is 5).
Figure B.29: A comparison between GMRES and BiCGSTAB CPU time for the conﬁguration in Figure B.26;
m is the size of the Krylov subspace for the GMRES method.
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(a) Number of iterations vs. viscosity ratio.
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(b) A zoomed-in region of interest (the viscosity ratio for red blood cells is 5).
Figure B.30: A comparison between GMRES and BiCGSTAB number of iterations for the conﬁguration in
Figure B.27(a); m is the size of the Krylov subspace for the GMRES method.
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(a) CPU time vs. viscosity ratio.
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(b) A zoomed-in region of interest (the viscosity ratio for red blood cells is 5).
Figure B.31: A comparison between GMRES and BiCGSTAB CPU time for the conﬁguration in Fig-
ure B.27(a); m is the size of the Krylov subspace for the GMRES method.
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(a) Number of iterations vs. viscosity ratio.
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(b) A zoomed-in region of interest (the viscosity ratio for red blood cells is 5).
Figure B.32: A comparison between GMRES and BiCGSTAB number of iterations for both conﬁgurations
in Figure B.27; ﬁrst set in the legend of the ﬁgure corresponds to B.27(a) and the second set corresponds
to B.27(b). m is the size of the Krylov subspace for the GMRES method.
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(a) CPU time vs. viscosity ratio.
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(b) A zoomed-in region of interest (the viscosity ratio for red blood cells is 5).
Figure B.33: A comparison between GMRES and BiCGSTAB CPU time for both conﬁgurations in Fig-
ure B.27; ﬁrst set in the legend of the ﬁgure corresponds to B.27(a) and the second set corresponds to B.27(b).
m is the size of the Krylov subspace for the GMRES method.
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Figure B.34: The eﬀect of size of the system on GMRES, deﬂated GMRES and BiCGSTAB methods for
λ = 50. The two data points at Np = 4000 correspond to the 27 × 27 domain, — (no deﬂation) and ⋯
(deﬂated), and the 50 × 50 domain, – – (no deﬂation) and – ⋅ (deﬂated).
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Figure B.35: The eﬀect of size of the system on GMRES, deﬂated GMRES and BiCGSTAB methods for
λ = 5. The two data points at Np = 4000 correspond to the 27×27 domain, — (no deﬂation) and ⋯ (deﬂated),
and the 50 × 50 domain, – – (no deﬂation) and – ⋅ (deﬂated).
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Appendix C
Periodic Solution of the Stokes
Equation
Following Hasimoto,230 the governing equations are the Stokes equation
μ∇2u = ∇p +F∑
n
δ(x − xn), (C.1)
and continuity ∇.u = 0, (C.2)
with u being the velocity, μ viscosity, p pressure, F the force vector, δ(x − xn) the Dirac’s delta function,
and
xn = n1a(1) + n2a(2) + n3a(3) (n1, n2, n3 = 0,±1,±2, . . .). (C.3)
and
τ0 = a(1). [a(2) × a(3)] , (C.4)
being the volume of the unit cell determined by the basic vectors a(1) = (L(1),0,0),a(2), and a(3). Expanding
u and −∇p in Fourier series we have
u =∑
k
uˆke
−i2πκ.x, (C.5)
−∇p = ∑
k
Pˆke
−i2πκ.x, (C.6)
with
κ.a(i) = ki, (C.7)
where ki is the integer index and κi is the wave number index. Thus
κiL
(i) = ki ⇒ κi = ki
L(i)
. (C.8)
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Multiplying (C.1) and (C.2) by exp(i2πκ.x)/τ0 and integrating over τ0, we get
−4π2μκ2uˆk = −Pˆ + F
τ0
, (C.9)
and
κ.uˆk = 0, (C.10)
therefore, for k = 0
Pˆ0 = F
τ0
. (C.11)
Taking the scalar product of (C.9) with κ yields
κ.Pˆk = κ.F
τ0
= κ.P0 (C.12)
or
Pˆk = (κ.F)κ
κ2
. (C.13)
Substituting (C.13) into (C.9) gives
uˆk = 1
4π2μτ0
[(κ.F)κ
κ4
− F
κ2
] . (C.14)
Equations (C.5) and (C.6) with (C.11) to (C.14) are the periodic fundamental solutions to the Stokes equation
for the ﬂow past a periodic array of point forces. The components of velocity in Cartesian coordinates are
ui = u∞i − 14πμ (FiS1 −Fj ∂2S2∂xi∂xj ) . (C.15)
Similarly, the components of the pressure gradient are
− ∂p
∂xi
= Fi
τ0
− 1
4π
Fj
∂2S1
∂xi∂xj
, (C.16)
whose integral then is
p = −Fixi
τ0
+ 1
4π
Fj
∂S1
∂xj
. (C.17)
S1 and S2 are given by
S1 = ∇2S2 = 1
πτ0
∑
k≠0
e−i2πκ.x
κ2
, (C.18)
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and
S2 = − 1
4π3τ0
∑
k≠0
e−i2πκ.x
κ4
. (C.19)
Therefore,
ui = u∞i − 14π2μτ0 ∑k≠0(Fiκ2 − κjFj , κkκ4 ) e−i2πκjxj , (C.20)
and − ∂p
∂xi
= P0i + ∑
k≠0
κjFjκk
τ0κ2
e−i2πκjxj . (C.21)
One could rewrite (C.15) and (C.16) in the form
ui = u∞i − Gij2dπμFj , (C.22)
with d being the number of dimensions and
Gij
2dπμ
= (δij∇2 − ∂2
∂xi∂xj
)S2, (C.23)
and
p = pi
2dπ
Fi, (C.24)
where
pi
2dπ
= −xi
τ0
+ 1
4π
∂S1
∂xi
. (C.25)
Finally, the stress tensor σij is deﬁned as
σij = 1
2dπ
TijkFk = −pδij + μ( ∂ui
∂xj
+ ∂uj
∂xi
) . (C.26)
To evaluate S1 and S2, Ewald sum
269, 270 is a technique which does a remarkable job of splitting the very
slowly convergent sum into two exponentially fast converging sums. We consider the identity
1
κ2m
= πm
Γ(m) ∫ ∞0 e−πκ2ββm−1dβ, (C.27)
multiplying by e−i2πκ.x and sum over κ excluding κ = 0 yields
σm = ∑
k≠0
1
κ2m
e−i2πκ.x. (C.28)
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Thus,
S1 = 1
πτ0
σ1, (C.29)
and
S2 = − 1
4π3τ0
σ2. (C.30)
Using the identity in (C.27)
σm = πm
Γ(m) ∫ ∞0 ∑k≠0 e−πκ2ββm−1e−i2πκ.xdβ. (C.31)
For the term ∑k≠0 e−πκ2βe−i2πκ.x, as an ansatz, we start with
f(x) = τ0
βd/2 ∑n e −π∣x−xn∣2β . (C.32)
Expanding f in Fourier space
f(x) = ∑
k
fˆke
−i2πκ.x, (C.33)
then
fˆk = 1
τ0
∫
τ0
f(x)ei2πκ.xdx. (C.34)
Substituting for f(x) from (C.32) we get
fˆk = 1
τ0
∫
τ0
τ0
βd/2 ∑n e −π∣x−xn∣2β ei2πκ.xdx. (C.35)
Since
ei2πκ.x
n = ei2π kiL(i) niL(i) = 1, (C.36)
then
ei2πκ.x = ei2πκ.(x−xn), (C.37)
therefore,
fˆk = 1
βd/2 ∑n ∫τ0 e −π∣x−xn∣2β ei2πκ.(x−xn)dx. (C.38)
Solving the integral over the inﬁnite volume yields
fˆk = 1
βd/2 ∭ +∞−∞Yudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod\udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod^
d times
e
−π∣x∣2
β ei2πκ.xdx = e−πκ2β , (C.39)
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and consequently from equations (C.32), (C.33), and (C.39)
τ0
βd/2 ∑n e −π∣x−xn∣2β = ∑k e−πκ2βe−i2πκ.x. (C.40)
Going back to (C.31), we break it into two parts, one from 0 to α and one from α to ∞. Adding and
subtracting a term corresponding to k = 0 to the ﬁrst portion of the integral, we get
σm = πm
Γ(m)
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
∫ α
0
∑
k
(e−πκ2ββm−1e−i2πκ.x − βm−1)dβYudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod\udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod^
I
+ ∫ ∞
α
∑
k≠0
e−πκ
2ββm−1e−i2πκ.xdβYudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod\udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod^
II
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
.
(C.41)
A change of variable (diﬀerent for each part of the integral) and substitution of Ewald theta transformation
of (C.40) yields
I:
β = α
ξ
, (C.42)
then
∫ α
0
( τ0
βd/2 ∑n e −π∣x−xn∣2β βm−1 − βm−1)dβ = −∑n ∫ 1∞ τ0ξd/2αd/2 e −π∣x−xn∣2ξα (αξ )
m−1 α
ξ2
dξ
− ∫ 1∞ (αξ )m−1 αξ2 dξ= − τ0αm−d/2∑
n
∫ 1∞ e −π∣x−xn∣2ξα ξ−m+d/2−1dξ
− αm ∫ 1∞ ξ−m−1dξ.
(C.43)
With the incomplete Γ function
φν(x) = ∫ ∞
1
e−xξξνdξ, (C.44)
which has the following properties
φ′ν = −φν+1, (C.45)
and
xφν = e−x + νφν−1, (C.46)
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I becomes
I = τ0αm−d/2∑
n
φ−m+d/2−1 (π∣x − xn∣2
α
) − αm
m
. (C.47)
For the second part of the integral
II:
β = αξ, (C.48)
then
II = ∫ ∞
1
∑
k≠0
e−πκ
2αξ(αξ)m−1e−i2πκ.xαdξ
= αm ∑
k≠0
e−i2πκ.x ∫ ∞
1
e−πκ
2αξξm−1dξ
= αm ∑
k≠0
e−i2πκ.xφm−1(πκ2α).
(C.49)
Substituting I and II back into (C.41)
σm = πmαm
Γ(m) [τ0α−d/2∑n φ−m+d/2−1 (π∣x − xn∣2α ) − 1m + ∑k≠0 e−i2πκ.xφm−1(πκ2α)] , (C.50)
and using (C.45) we have
∂σm
∂xi
= πmαm
Γ(m) [−τ0α−d/2∑n 2πα (xi − xni )φ−m+d/2 (π∣x − xn∣2α )
+ ∑
k≠0
−i2πκie−i2πκ.xφm−1(πκ2α)] , (C.51)
and
∂2σm
∂xi∂xj
= πmαm
Γ(m) [−τ0α−d/2∑n 2πα δijφ−m+d/2 (π∣x − xn∣2α )
+ τ0α−d/2∑
n
(2π
α
)2 (xi − xni )(xj − xnj )φ−m+d/2+1 (π∣x − xn∣2α )
− ∑
k≠0
4π2κiκje
−i2πκ.xφm−1(πκ2α)] .
(C.52)
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C.1 Two dimensions
Going back to (C.15), and d = 2 along with equation C.30 we have
ui = u∞i − 14πμ (δij ∂2∂x2k − ∂
2
∂xi∂xj
)S2Fj
= u∞i − Gij2dπμFj
= u∞i + 116π4μτ0 π2α2Γ(2) {δij [−τ0α ∑n 2πα 2φ−1 (π∣x − xn∣2α )
+ τ0
α
∑
n
(2π
α
)2 (xk − xnk)(xk − xnk)φ0 (π∣x − xn∣2α )
− ∑
k≠0
4π2κ2e−i2πκ.xφ1(πκ2α)] + [δij τ0
α
∑
n
2π
α
φ−1 (π∣x − xn∣2
α
)
− τ0
α
∑
n
(2π
α
)2 (xi − xni )(xj − xnj )φ0 (π∣x − xn∣2α )
+ ∑
k≠0
4π2κiκje
−i2πκ.xφ1(πκ2α)]}Fj
= u∞i + 14πμΓ(2) {−δij2 ∑n φ−1 (π∣x − xn∣2α )
+ π
α
∑
n
[δij(xk − xnk)(xk − xnk) − (xi − xni )(xj − xnj )]φ0 (π∣x − xn∣2α )
+ πα2
τ0
∑
k≠0
(κiκj − δijκ2)e−i2πκ.xφ1(πκ2α)}Fj .
With
Γ(2) = 1, (C.53)
φ0(x) = ∫ ∞
1
e−xξdξ = e−x
x
, (C.54)
φ1(x) = e−x
x
+ φ0
x
= 1 + x
x2
e−x, (C.55)
from (C.46) and
φ−1(x) = E1(x) = ∫ ∞
x
e−ξ
ξ
dξ, (C.56)
then
ui = u∞i − 14πμ {∑n [δij2 E1 (π∣x − xn∣2α )
+ (xi − xni )(xj − xnj ) − δij(xk − xnk)(xk − xnk)∣x − xn∣2 e −π∣x−xn∣2α ]
+ 1
πτ0
∑
k≠0
δijκ
2 − κiκj
κ4
e−i2πκ.x(1 + πκ2α)e−πκ2α}Fj ,
(C.57)
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therefore,
Gij = ∑
n
{δij
2
E1 (π∣x − xn∣2
α
) + e −π∣x−xn∣2α [(xi − xni )(xj − xnj )∣x − xn∣2 − δij]}
+ 1
πτ0
∑
k≠0
δijκ
2 − κiκj
κ4
e−i2πκ.x(1 + πκ2α)e−πκ2α} . (C.58)
For pressure, using (C.29), (C.17) then becomes
p = −Fixi
τ0
+ 1
4π2τ0
Fj
∂σ1
∂xj
, (C.59)
and consequently using (C.51), we have
p = − Fixi
τ0
+ 1
4π2τ0
πα [−τ0
α
∑
n
2π
α
(xj − xnj )φ0 (π∣x − xn∣2α )
+ ∑
k≠0
−i2πκje−i2πκ.xφ0(πκ2α)]Fj , (C.60)
which simpliﬁes to
p = {−δijxj
τ0
− 1
2π
[∑
n
xj − xnj∣x − xn∣2 e −π∣x−xn∣2α + iτ0 ∑k≠0 κjκ2 e−i2πκ.xe−πκ2α]}Fj . (C.61)
The stress tensor σij (note the diﬀerence between σij , the stress tensor, and σm deﬁned in C.28) is deﬁned in
(C.26). For convenience, we rewrite (C.22) and (C.24) so that the constants are included in the deﬁnitions
of Gij and pi, meaning
ui = u∞i +GijFi, (C.62)
and
p = piFi. (C.63)
Then σij becomes
σij = [−pkδij + μ(∂Gik
∂xj
+ ∂Gjk
∂xi
)]Fk. (C.64)
With the rewritten Gij and pi and (C.57) and (C.61) we have
Gij = − 1
4πμ
{∑
n
{δij
2
E1 (π∣x − xn∣2
α
) + e −π∣x−xn∣2α [(xi − xni )(xj − xnj )∣x − xn∣2 − δij]}
+ 1
πτ0
∑
k≠0
δijκ
2 − κiκj
κ4
e−i2πκ.x(1 + πκ2α)e−πκ2α} , (C.65)
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and
pi = −δijxj
τ0
− 1
2π
[∑
n
xj − xnj∣x − xn∣2 e −π∣x−xn∣2α + iτ0 ∑k≠0 κjκ2 e−i2πκ.xe−πκ2α] . (C.66)
Taking the derivative of Gij from (C.53) and using (C.45)
∂Gij
∂xl
= 1
4πμ
{δij
2
∑
n
φ0 (π∣x − xn∣2
α
)[2π(xl − xnl )
α
]
+ π
α
∑
n
[2δij(xl − xnl ) − δil(xj − xnj ) − δjl(xi − xni )]φ0 (π∣x − xn∣2α )
− π
α
∑
n
[δij(xk − xnk)(xk − xnk) − (xi − xni )(xj − xnj )]φ1 (π∣x − xn∣2α )[2π(xl − xnl )α ]
+ πα2
τ0
∑
k≠0
(κiκj − δijκ2)(−i2πκl)e−i2πκ.xφ1(πκ2α)} ,
(C.67)
therefore,
∂Gik
∂xj
+ ∂Gjk
∂xi
= 1
4πμ
{∑
n
{π
α
φ0 (π∣x − xn∣2
α
)[δik(xj − xnj ) + δjk(xi − xni )]}
+ π
α
∑
n
φ0 (π∣x − xn∣2
α
) [2δik(xj − xnj ) + 2δjk(xi − xni )
− δij(xk − xnk) − δji(xk − xnk) − δkj(xi − xni ) − δki(xj − xnj )]
− π
α
∑
n
2π
α
φ1 (π∣x − xn∣2
α
){∣x − xn∣2 [δik(xj − xnj ) + δjk(xi − xni )]
− 2(xi − xni )(xj − xnj )(xj − xnj )}
− πα2
τ0
∑
k≠0
2πiφ1(πκ2α)e−i2πκ.x [2κiκjκk − κ2(δikκj + δjkκi)]} .
(C.68)
Including the pressure terms and substituting for φ0 and φ1, (C.64) becomes
σij
Fk
= Tijk
4π= δijxk
τ0
− 1
4π
∑
n
2δij(xk − xnk)∣x − xn∣2 e −π∣x−xn∣2α + i2πτ0 ∑k≠0 δijκkκ2 e−i2πκ.xe−πκ2α
+ 1
4π
∑
n
e−
π∣x−xn∣2
α
2δik(xj − xnj ) + 2δjk(xi − xni ) − 2δij(xk − xnk)∣x − xn∣2
− 1
4π
∑
n
e−
π∣x−xn∣2
α (1 + π∣x − xn∣2
α
)⎡⎢⎢⎢⎢⎣
2δik(xj − xnj ) + 2δjk(xi − xni )∣x − xn∣2
− 4(xi − xni )(xj − xnj )(xj − xnj )∣x − xn∣4 ]
− i
2πτ0
∑
k≠0
(1 + πκ2α) e−πκ2αe−i2πκ.x 2κiκjκk − κ2(δikκj + δjkκi)
κ4
,
(C.69)
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simpliﬁed to
σij
Fk
= Tijk
4π= δijxk
τ0+ 1
π
∑
n
e−
π∣x−xn ∣2
α (1 + π∣x − xn∣2
α
) (xi − xni )(xj − xnj )(xj − xnj )∣x − xn∣4
− 1
2α
∑
n
e−
π∣x−xn∣2
α [δik(xj − xnj ) + δjk(xi − xni )]
+ i
2πτ0
∑
k≠0
[(1 + πκ2α) e−πκ2αe−i2πκ.x (δijκk + δikκj + δjkκi
κ2
− 2κiκjκk
κ4
)
− παδijκke−i2πκ.xe−πκ2α] .
(C.70)
Looking at the third term in (C.70), we have
1
τ0
∭ +∞−∞Yudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod\udcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymodudcurlymod^
d times
e−
π∣x∣2
α ei2πκ.xxidx = (−1)d iα3/2α(d−1)/2
τ0
e−πακ
2
κi, (C.71)
therefore, in two dimensions (d = 2)
∑
n
e−
π∣x−xn ∣2
α (xi − xni ) = iα2τ0 ∑k≠0 e−i2πκ.xe−πακ2κi, (C.72)
and thus the third term in (C.70) becomes
− 1
2α
∑
n
e−
π∣x−xn∣2
α [δik(xj − xnj ) + δjk(xi − xni )] = − iα2τ0 ∑k≠0 e−i2πκ.xe−πακ2(δikκj + δjkκi). (C.73)
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Substituting it in (C.70), we have
σij
Fk
= Tijk
4π= δijxk
τ0+ 1
π
∑
n
e−
π∣x−xn∣2
α (1 + π∣x − xn∣2
α
) (xi − xni )(xj − xnj )(xj − xnj )∣x − xn∣4
− iα
2τ0
∑
k≠0
e−i2πκ.xe−πακ
2(δijκk + δikκj + δjkκi)
+ i
2πτ0
∑
k≠0
(1 + πκ2α) e−πκ2αe−i2πκ.x (δijκk + δikκj + δjkκi
κ2
− 2κiκjκk
κ4
)
= δijxk
τ0
+ 1
π
∑
n
e−
π∣x−xn∣2
α (1 + π∣x − xn∣2
α
) (xi − xni )(xj − xnj )(xj − xnj )∣x − xn∣4
− iα
2τ0
∑
k≠0
e−i2πκ.xe−πακ
2(δijκk + δikκj + δjkκi)
+ i
2πτ0
∑
k≠0
e−πκ
2αe−i2πκ.x [δikκj + δjkκi + δijκk
κ2
− 2κiκjκk
κ4
(1 + πκ2α)]
+ iα
2τ0
∑
k≠0
e−πκ
2αe−i2πκ.x(δikκj + δjkκi + δijκk).
(C.74)
Ultimately, Tijk has the form
Tijk = 4πxk
τ0
δij + 4∑
n
e−
π∣x−xn∣2
α (1 + π∣x − xn∣2
α
) (xi − xni )(xj − xnj )(xj − xnj )∣x − xn∣4
+ i
τ0
∑
k≠0
e−πκ
2αe−i2πκ.x [2δikκj + δjkκi + δijκk
κ2
− 4κiκjκk
κ4
(1 + πκ2α)] . (C.75)
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C.2 Three dimensions
Starting with (C.23) and (C.30), and using (C.52) and its symmetric component
∂2σm
∂xi∂xi
= πmαm
Γ(m) [−τ0α−d/2∑n 2πα d φ−m+d/2 (π∣x − xn∣2α )
+ τ0α−d/2∑
n
(2π
α
)2 (xk − xnk)(xk − xnk)φ−m+d/2+1 (π∣x − xn∣2α )
− ∑
k≠0
4π2κ2e−i2πκ.xφm−1(πκ2α)] ,
(C.76)
Gij becomes
Gij = (δij∇2 − ∂2
∂xi∂xj
)S2
= − 1
4π3τ0
πmαm
Γ(m) {−τ0α−d/2∑n 2πα (d − 1) δijφ−m+d/2 (π∣x − xn∣2α )
+ τ0α−d/2∑
n
(2π
α
)2 [δij ∣x − xn∣2 − (xi − xni )(xj − xnj )]φ−m+d/2+1 (π∣x − xn∣2α )
− ∑
k≠0
4π2 (δijκ2 − κiκj) e−2πiκ.xφm−1(πκ2α)} .
(C.77)
Multiplying −α2/τ0 through and pulling (2π)2 out with m = 2 and Γ(2) = 1 we have
Gij = (2π)2
4π
{α−d/2∑
n
{ α
2π
(d − 1) δijφ−2+d/2 (π∣x − xn∣2
α
)
+ [(xi − xni )(xj − xnj ) − δij ∣x − xn∣2]φ−1+d/2 (π∣x − xn∣2α )}
+ α2
τ0
∑
k≠0
(δijκ2 − κiκj)e−2πiκ.xφ1(πκ2α)} .
(C.78)
With d = 3 we have
φ−2+d/2 = φ−1/2 =√π
x
erfc(√x), (C.79)
and with (C.46) then
xφ1/2 = e−x + 1
2
φ−1/2, (C.80)
therefore,
φ−1+d/2 = φ1/2 = e−x
x
+ 1
2
√
π
x
erfc(√x)
x
. (C.81)
Also,
φ1(x) = e−x
x
+ φ0
x
= 1 + x
x2
e−x. (C.82)
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Then
Gij = π {α−3/2∑
n
{ α
2π
(3 − 1)δij√ πα
π∣x − xn∣2 erfc(
√
π
α
∣x − xn∣)
+ 1
π/α∣x − xn∣2 [(xi − xni )(xj − xnj ) − δij ∣x − xn∣2] [e−π/α∣x−xn∣2
+ 1
2
√
πα
π∣x − xn∣2 erfc(√πα ∣x − xn∣)]}
+ α2
τ0
∑
k≠0
(δijκ2 − κiκj) e−2πiκ.xφ1(πκ2α)}
= π ⎧⎪⎪⎨⎪⎪⎩α−3/2∑n
⎧⎪⎪⎨⎪⎪⎩α
3/2
π
δij
erfc (√π
α
∣x − xn∣)∣x − xn∣
+ α
π
(xi − xni )(xj − xnj )∣x − xn∣2 [e−π/α∣x−xn∣2 +
√
α∣x − xn∣erfc(
√
π
α
∣x − xn∣)]
−α3/2
π
δij
2
erfc (√π
α
∣x − xn∣)∣x − xn∣ − δij απ e−π/α∣x−xn∣2⎫⎪⎪⎬⎪⎪⎭+ α2
τ0
∑
k≠0
(δijκ2 − κiκj) e−2πiκ.xφ1(πκ2α)} ,
(C.83)
and with (C.82)
φ1(πκ2α) = 1 + πκ2α
π2κ4α2
e−πκ
2α, (C.84)
we have
Gij = ∑
n
⎧⎪⎪⎨⎪⎪⎩[
(xi − xni )(xj − xnj )∣x − xn∣2 + δij2 ] erfc (
√
π
α
∣x − xn∣)∣x − xn∣
+ [(xi − xni )(xj − xnj )∣x − xn∣2 − δij] e−π/α∣x−x
n∣2√
α
⎫⎪⎪⎬⎪⎪⎭+ 1
πτ0
∑
k≠0
δijκ
2 − κiκj
κ4
e−2πiκ.x(1 + πκ2α)e−πκ2α.
(C.85)
Now starting from (C.26) with (C.24)
1
2dπ
Tijk = − pk
2dπ
δij + μ
2dπμ
(∂Gik
∂xj
+ ∂Gjk
∂xi
) , (C.86)
therefore,
Tijk = −pkδij + (∂Gik
∂xj
+ ∂Gjk
∂xi
) . (C.87)
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Consequently with (C.25), (C.29), and (C.51)
∂σ1
∂xk
= πα [−τ0α−d/2∑
n
2π
α
(xk − xnk)φ−1+d/2 (π∣x − xn∣2α ) ∑k≠02πiκke−2πiκ.xφ0(πκ2α)] , (C.88)
and then
pk = − 2dπxk
τ0+ 2d−2
τ0
α [−τ0α−d/2∑
n
2π
α
(xk − xnk )φ−1+d/2 (π∣x − xn∣2α ) − ∑k≠0 2πiκke−2πiκ.xφ0(πκ2α)] ,
(C.89)
and
−pkδij = 2dπxk
τ0
δij
+ 2dα−d/2π∑
n
δij(xk − xnk )φ−1+d/2 (π∣x − xn∣2α ) − 2dαπτ0i ∑k≠0 δijκke−2πiκ.xφ0(πκ2α).
(C.90)
Going back to (C.87) and multiplying (C.78) by 4π2/4π2 we have
Gij = 1
4π
{α−d/2+1∑
n
2π (d − 1) δikφ−2+d/2 (π∣x − xn∣2
α
)
− α−d/2∑
n
(2π)2 [δik ∣x − xn∣2 − (xi − xni )(xk − xnk)]φ−1+d/2 (π∣x − xn∣2α )
+ α2
τ0
4π2 ∑
k≠0
(δikκ2 − κiκk) e−2πiκ.xφ1(πκ2α)} ,
(C.91)
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then with (C.45)
∂Gik
∂xj
= 1
4π
{−α1−d/22π∑
n
(d − 1)δik 2π
α
(xj − xnj )φ−1+d/2 (π∣x − xn∣2α )
− α−d/2(2π)2∑
n
[δik2(xj − xnj ) − δij(xk − xnk) − δjk(xi − xni )]φ−1+d/2 (π∣x − xn∣2α )
+ α−d/2(2π)2∑
n
[δik ∣x − xn∣2 − (xi − xni )(xk − xnk)] 2πα (xj − xnj )φd/2 (π∣x − xn∣2α )
−4π2α2
τ0
∑
k≠0
(δikκ2 − κiκk)2πikje−2πiκ.xφ1(πκ2α)}
= − α−d/2π(d − 1)∑
n
δik(xj − xnj )φ−1+d/2 (π∣x − xn∣2α )
− α−d/2π∑
n
[δik2(xj − xnj ) − δij(xk − xnk) − δjk(xi − xni )]φ−1+d/2 (π∣x − xn∣2α )
+ α−d/2−12π2∑
n
[δik ∣x − xn∣2 − (xi − xni )(xk − xnk)] (xj − xnj )φd/2 (π∣x − xn∣2α )
+ 2π2α2
τ0i
∑
k≠0
(δikκ2 − κiκk)kje−2πiκ.xφ1(πκ2α).
(C.92)
Similarly,
∂Gjk
∂xi
= − α−d/2π(d − 1)∑
n
δjk(xi − xni )φ−1+d/2 (π∣x − xn∣2α )
− α−d/2π∑
n
[δjk2(xi − xni ) − δij(xk − xnk) − δik(xj − xnj )]φ−1+d/2 (π∣x − xn∣2α )
+ α−d/2−12π2∑
n
[δjk ∣x − xn∣2 − (xj − xnj )(xk − xnk)] (xi − xni )φd/2 (π∣x − xn∣2α )
+ 2π2α2
τ0i
∑
k≠0
(δjkκ2 − κjκk)kie−2πiκ.xφ1(πκ2α).
(C.93)
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Then, adding (C.90), (C.92), and (C.93) yields
Tijk = 2dπxk
τ0
δij
+ α−d/2π∑
n
[2dδij(xk − xnk)
− (d − 1)δik(xj − xnj ) − 2δik(xj − xnj ) + δij(xk − xnk) + δjk(xi − xni )
−(d − 1)δjk(xi − xni ) − 2δjk(xi − xni ) + δij(xk − xnk) + δik(xj − xnj )]φ−1+d/2 (π∣x − xn∣2α )
+ α−d/2−12π2∑
n
[δik ∣x − xn∣2(xj − xnj ) − (xi − xni )(xj − xnj )(xk − xnk)
+ δjk ∣x − xn∣2(xi − xni ) − (xi − xni )(xj − xnj )(xk − xnk)]φd/2 (π∣x − xn∣2α )
− 2dαπ
τ0i
δij ∑
k≠0
κke
−2πiκ.xφ0(πκ2α)
+ 2π2α2
τ0i
∑
k≠0
(δikκjκ2 − κiκjκk + δjkκiκ2 − κiκjκk) e−2πiκ.xφ1(πκ2α)
= 2dπxk
τ0
δij
+ α−d/2π∑
n
[(2d + 2)δij(xk − xnk) − dδik(xj − xnj ) − dδjk(xi − xni )]φ−1+d/2 (π∣x − xn∣2α )
+ α−d/2−12π2∑
n
[δik ∣x − xn∣2(xj − xnj ) + δjk ∣x − xn∣2(xi − xni )
− 2(xi − xni )(xj − xnj )(xk − xnk)]φd/2 (π∣x − xn∣2α )
− 2dαπ
τ0i
δij ∑
k≠0
κke
−2πiκ.xφ0(πκ2α)
+ 2π2α2
τ0i
∑
k≠0
(δikκjκ2 + δjkκiκ2 − 2κiκjκk) e−2πiκ.xφ1(πκ2α).
(C.94)
With d = 3, (C.81), (C.82),
φ0(x) = ∫ ∞
1
e−xξdξ = e−x
x
, (C.95)
and
xφ3/2(x) = e−x + 3
2
φ1/2, (C.96)
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which yields
φ3/2(x) = e−x + 32 e−x+ 12
√
π
x
erfc(√x)
x
x= e−x
x
+ 3
2
e−x
x2
+ 3
4
√
π
x
erfc(√x)
x2= x + 3/2
x2
e−x + 3
4
√
π
x
erfc(√x)
x2
,
(C.97)
we have
Tijk = 8πxk
τ0
δij
+ α−3/2π∑
n
[10δij(xk − xnk) − 3δik(xj − xnj ) − 3δjk(xi − xni )] e−π∣x−x
n ∣2
α + α1/2∣x−xn∣erfc (√πα ∣x − xn∣)
π∣x−xn∣2
α+ α−5/22π2∑
n
[δik ∣x − xn∣2(xj − xnj ) + δjk ∣x − xn∣2(xi − xni )
− 2(xi − xni )(xj − xnj )(xk − xnk)] ⎡⎢⎢⎢⎢⎣
π∣x−xn∣2
α
+ 3
2
π2∣x−xn∣4
α2
e−
π∣x−xn ∣2
α + 3
4
√
α∣x − xn∣ erfc (
√
π
α
∣x − xn∣)
π2∣x−xn∣4
α2
⎤⎥⎥⎥⎥⎦
− 8απ
τ0i
δij ∑
k≠0
κke
−2πiκ.x e−πκ
2α
πκ2α
+ 2π2α2
τ0i
∑
k≠0
(δikκjκ2 + δjkκiκ2 − 2κiκjκk)e−2πiκ.x 1 + πκ2α
π2κ4α2
e−πκ
2α
= 8πxk
τ0
δij
+∑
n
⎧⎪⎪⎪⎨⎪⎪⎪⎩[10δij(xk − xnk) − 3δik(xj − xnj ) − 3δjk(xi − xni )]
⎡⎢⎢⎢⎢⎣1/
√
αe−
π∣x−xn ∣2
α∣x − xn∣2 + erfc (
√
π
α
∣x − xn∣)∣x − xn∣3
⎤⎥⎥⎥⎥⎦
+ δik ∣x − xn∣2(xj − xnj ) + δjk ∣x − xn∣2(xi − xni ) − 2(xi − xni )(xj − xnj )(xk − xnk)∣x − xn∣4⎡⎢⎢⎢⎢⎣(2πα ∣x − xn∣2 + 3) e
−π∣x−xn∣2
α√
α
+ 3
2
erfc (√π
α
∣x − xn∣)∣x − xn∣
⎤⎥⎥⎥⎥⎦
⎫⎪⎪⎪⎬⎪⎪⎪⎭+ 1
τ0i
∑
k≠0
[−8δij κk
κ2
e−πκ
2αe−2πiκ.x
+ 2δikκjκ2 + δjkκiκ2 − 2κiκjκk
κ4
e−2πiκ.x (1 + πκ2α) e−πκ2α] .
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Collecting the coeﬃcients for each of the functions then
Tijk = 8πxk
τ0
δij
+∑
n
{[10δij(xk − xnk)∣x − xn∣2 − 3δik(xj − xnj )∣x − xn∣2 − 3δjk(xi − xni )∣x − xn∣2
+ δik 2π
α
(xj − xnj ) + δjk 2πα (xi − xni )− 4π
α
(xi − xni )(xj − xnj )(xk − xnk)∣x − xn∣2 − 6(xi − xni )(xj − xnj )(xk − xnk)∣x − xn∣4
+ 3δik(xj − xnj )∣x − xn∣2 + 3δjk(xi − xni )∣x − xn∣2 ] 1√αe−π∣x−xn∣2α
+ [10δij(xk − xnk)∣x − xn∣2 − 3δik(xj − xnj )∣x − xn∣2 − 3δjk(xi − xni )∣x − xn∣2
+ 3δik(xj − xnj )
2∣x − xn∣2 − 3δjk(xi − xni )2∣x − xn∣2 − 3(xi − xni )(xj − xnj )(xk − xnk)∣x − xn∣4 ] erfc (
√
π
α
∣x − xn∣)∣x − xn∣ ⎫⎪⎪⎬⎪⎪⎭+ 1
τ0i
∑
k≠0
[−8δijκk
κ2
+ 2δikκj
κ2
+ 2δjkκi
κ2
− 4κiκjκk
κ4
+2παδikκj + 2παδjkκi − 4πακiκjκk
κ2
] e−πκ2αe−2πiκ.x.
(C.99)
Following the same process as for (C.32)
f(x) = ∑
n
2π
α
(xj − xnj ) 1√αe −π∣x−xn∣2α , (C.100)
then
fˆk = 1
τ0
∫
τ0
[∑
n
2π
α3/2
(xj − xnj )e −π∣x−xn∣2α ] e2πix.κdx. (C.101)
With identity (C.36), we have
fˆk = 1
τ0
∫
τ0
[∑
n
2π
α3/2
(xj − xnj )e −π∣x−xn∣2α e2πi(x−xn).κ]dx
= 1
τ0
∫
R3
2π
α3/2
xje
−π∣x∣2
α e2πix.κdx
= 2πiακj
τ0
e−πκ
2α.
(C.102)
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Finally,
Tijk = 8πxk
τ0
δij
+∑
n
{[10δij(xk − xnk)∣x − xn∣2 − (4πα ∣x − xn∣4 + 6) (xi − xni )(xj − xnj )(xk − xnk)∣x − xn∣4 ] 1√αe−π∣x−xn∣2α
+ [10δij(xk − xnk) − 3δik(xj − xnj ) − 3δjk(xi − xni )
2∣x − xn∣2 − 3(xi − xni )(xj − xnj )(xk − xnk)∣x − xn∣4 ] erfc (
√
π
α
∣x − xn∣)∣x − xn∣ ⎫⎪⎪⎬⎪⎪⎭+ 1
τ0i
∑
k≠0
[2δikκj + δjkκi − 4δijκk
κ2
− 4κiκjκk
κ4
(1 + πκ2α)] e−πκ2αe−2πiκ.x.
(C.103)
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